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Abstract 
Assessment of the cardiac response during exercise remains challenging. So far, no ready-to-
use, accurate methods for assessment of biventricular function have been available. However, 
such a method could greatly improve assessment of cardiac physiology, early detection and 
prognostic stratification of heart diseases. In this PhD a new technique for quantification of 
cardiac function during exercise with cardiac magnetic resonance imaging (exercise CMR) 
was developed. Subsequently, this method was utilized to answer the core questions of this 
PhD project: 1) What is the role of the sub-pulmonary ventricle in cardiac function during 
exercise? and 2) What is the impact of its absence in patients with Fontan circulation? In this 
thesis, the process of development and validation of exercise CMR was presented. This 
showed that exercise CMR is a valid tool for assessing cardiac volumes during exercise. 
Next, exercise CMR was used to investigate the fundamental physiological mechanism of 
biventricular cooperativity during exercise in the healthy heart. These experiments 
demonstrated that the RV plays a key role in biventricular synergy and is vital in optimization 
of cardiac performance during exercise. Subsequently, exercise CMR was used to investigate 
the impact of the absence of the RV on exercise haemodynamics in patients with Fontan 
circulation. These results showed that the absence of a sub-pulmonary ventricle significantly 
impairs cardiac performance during exercise in patients with Fontan circulation and that the 
physiological heart rate response to exercise is inappropriate in the single-ventricle 
circulation. Selective heart rate inhibition improves acute exercise haemodynamics in this 
small group of patients and might be a potential new treatment target for optimization the 
Fontan circulation. Finally, the potential added value of computational modelling for the 
diagnostic interpretation of stress / exercise exams was evaluated. It was demonstrated that 
computational models can help improve diagnostic assessment of stress examinations in 
patient with Fontan circulation. This thesis present the results of a cross-disciplinary, 
translational research project that involved the fields of MRI physics, image processing, 
mathematical modelling and medicine. It demonstrates the value of such cross-disciplinary 
work for clinical medicine. 
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Chapter 1  Introduction 
1.1  Motivation 
In the recent decades, quantitative assessment of cardiac function using non-invasive imaging 
has become routine in clinical cardiology practice. This development has improved 
prognostic stratification and therapy planning and reduced the need for invasive assessment 
in patients with heart diseases [1]. However, current state of the art imaging techniques only 
allow high quality imaging at rest. This means that diagnostic and prognostic assessment of 
heart disease is limited to detection of abnormalities that occur in the heart at its most relaxed 
state. Therefore, some pathological abnormalities can be missed or only be detected in a very 
late stage of disease.  
In essence, the heart is a mechanical pump. In order to maintain adequate supply of oxygen 
during stress, the heart has a large reserve capacity, the so-called cardiac reserve. It can 
increase cardiac output up to 6x its resting values by increasing ejection of blood 
(contraction) and frequency of pumping (heart rate) [2]. This response significantly increases 
the amount of work for the heart. During exercise, cardiac oxygen consumption per minute 
increases up to nearly 500-600% resting values [3].  
Investigating the functional reserve of the heart has great potential value for clinical 
cardiology and research. It can improve early detection and prognostic stratification of 
cardiac disease, but also allows for investigation of key (patho-)physiological mechanism that 
involve not only the heart but also the circulation [4]. The latter is especially important in 
patients with complex congenital heart diseases in whom a mix of cardiac and circulatory 
abnormalities often play a significant role.  
The value of assessing cardiac function during exercise is widely recognized. However, all 
currently available exercise examinations have limitations that impede assessment of 
biventricular function. Cardiopulmonary exercise testing (CPET) allows identification of an 
abnormal exercise response of the heart, but the lack of imaging data means the mechanism 
underlying the abnormal response can often not be identified. Exercise echocardiography and 
exercise radio-nucleotide ventriculography provide images of the heart. However the quality 
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of imaging during exercise is suboptimal, resulting in inaccuracies in measurements of 
cardiac function [5]. Furthermore, both techniques only allow accurate quantification of left 
ventricular (LV) function, hereby ignoring the right ventricular response.  
Cardiac magnetic resonance imaging (CMR) is the current gold standard for non-invasive 
assessment of cardiac function and allows measurements of both left and right ventricular 
function and quantification of blood flow [1]. Conventional CMR requires ECG gating and 
breath-held acquisitions that collect image data over multiple heartbeats. This prohibits any 
bodily movement and therefore imaging can only be performed at rest. In recent years, 
several CMR research group have developed highly accelerated ‘real-time’ non-ECG gated, 
free breathing CMR sequences that allow imaging during or directly after physiological 
exercise [4, 6–8]. These techniques have shown promising results for quantification of 
biventricular function during exercise, however through-plane motion of the heart during 
heavy breathing significantly impacts accuracy of the cardiac volume measurements [9]. 
Manual processing of the images, by selecting target images for volume classification on 
each slice in a predefined breathing state, overcomes these inaccuracies but is very time-
consuming and therefore also not desirable for frequent use in clinical studies [4]. 
As no good techniques currently exist, comprehensive imaging studies of the heart during 
exercise are scarce. As a result, fundamental mechanisms of cardiac function during exercise 
have remained unknown. One of the largest gaps in current knowledge is what the exact role 
of the RV is in the biventricular heart. The RV has often been viewed as a weak, supportive 
pump. However, recent evidence of the importance of RV function in exercise performance 
[10] and its impact on the course of cardiac diseases typically linked to the LV [11, 12] seems 
to suggest that the RV plays a key role in overall cardiac function, especially during exercise 
and other forms of stress. The RV and LV are very different in structure, function and loading 
conditions. This suggests distinct roles for the two ventricles in the operation of the 
biventricular heart. It therefore seems logical that the two ventricles work highly 
cooperatively to optimize total cardiac performance. However, too date such a mechanism 
remains unidentified and the two ventricles are still generally viewed as individual entities 
[13].  
Stroke volume (SV) is the ultimate functional output of cardiac contraction. During exercise, 
the heart maintains SV despite a striking decrease in ejection and, especially, filling times as 
a consequence of the increase in heart rate (HR) [14–16]. This means that the heart must use 
its functional reserve during exercise to maintain ejection and filling. If there is a 
fundamental synergy between RV and LV function in the heart, it is likely that this 
mechanism plays a central role in the heart’s ability to maintain SV during exercise. 
Therefore, investigation of SV preservation during exercise is likely to allow identification of 
the mechanism of biventricular cooperation. 
Establishing the role of the RV in cardiac function is relevant for understanding cardiac 
physiology in general. However, for patients with a Fontan circulation this understanding is 
pivotal. The Fontan circulation is a surgically established single-ventricular circulation [17]. 
It is a palliative treatment option for patients in whom one of the two ventricles in 
functionally unable to support the circulation. As a consequence, the Fontan circulation lacks 
a sub-pulmonary pump. While lifesaving, patients with Fontan circulation experience a 
burden of morbidity and profound exercise intolerance [18]. In particular, a constant and 
progressive decline in cardiac performance is observed in nearly all Fontan patients with age, 
resulting in premature failure of the circulation and a decreased life expectancy. The cause 
and pathway of this seemingly inevitable decline to failure of the Fontan circulation is 
unclear [19]. As a result, no current therapy has been recognized that successfully halts or 
slows down the decline in function in Fontan patients. It seems obvious that the absence of a 
sub-pulmonary ventricle plays a crucial role in development of failure. This makes 
understanding of the biventricular synergy in the heart, in particular the role of the RV in this 
synergy, key to the understanding of the general principles of Fontan haemodynamics.  
Besides understanding the general principles of Fontan haemodynamics, patient-specific 
investigation of mechanisms of heart failure in patients with Fontan circulation also remains 
challenging. Due to the complexity and unusual physiology of the Fontan circulation, 
conventional non-invasive imaging parameters and invasive pressure measurements often fail 
to identify clear causes of failure. Therefore, several specialized centres, including our Guys’ 
and St Thomas Hospital and Evelina Children’s Hospital, utilize detailed, combined 
diagnostic cardiac catheter and CMR exams (XMR) during dobutamine stress to provide 
better diagnostic assessment of patients developing failure of the Fontan circulation [20]. 
These exams provide a wealth of information in the form of simultaneous measurements of 
invasive pressures and CMR derived blood flow and cardiac volumes. Unfortunately, 
interpretation of these results remains challenging. All the obtained measurements are 
interrelated and the complexity of the circulation makes it hard to interpret all this data in an 
integrated, comprehensive way.  
Computational modelling methods could potentially improve the ability to identify causes of 
failure in patients with Fontan circulation. Over recent years, highly detailed multi-scale 
biomechanical models of the heart and circulation have been developed. These models have 
shown their efficacy in predictions of cardiac physiology in both acquired and congenital 
heart diseases [21–23]. Cardiovascular computational modelling frameworks are build based 
on experimentally derived physical principles from the macro-structural level down to the 
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level of the sarcomere [24]. By integrating multiple measurements of cardiac and vascular 
function into such a modelling framework, a comprehensive overview of the state of the 
cardiovascular system can be obtained. This patient-specific, calibrated model then allows to 
determine the impact of key factors of the cardiovascular system (such as contractility and 
stiffness of the heart, vascular resistance, venous return propagation and heart rate) in the 
development of heart failure in individual patients. Therefore, such models are potentially 
well suited to enhance the diagnostic assessment of stress / exercise investigations in patients 
with Fontan circulation whom develop heart failure.  
In summary, there is currently a lack of accurate, comprehensive non-invasive imaging for 
assessment of biventricular function during exercise / stress. This has restricted the 
investigation of the role of the sub-pulmonary ventricle (RV) in fundamental cardiac 
physiology. In turn, this limits our understanding of the impact of absence of the sub-
pulmonary ventricle in patients with Fontan circulation, and the potential implications for 
treatment of these patients. Improved techniques for cardiac imaging during exercise and 
better use of quantitative methods to integrate data of diagnostic stress and exercise exams 
have the potential to enhance the understanding of physiological mechanisms in the heart in 
health and disease, both on population level as well as in individual patients.   
This thesis aimed to: 1) address the shortcomings of imaging during exercise by developing a 
new method for CMR during exercise (Exercise CMR) and 2) utilize the developed Exercise 
CMR method to investigate the role of the RV in cardiac function and the impact of its 
absence in the Fontan circulation. To achieve this goal, cross-disciplinary translational 
imaging and image analysis methods needed to be developed involving the fields of MRI 
physics, image-processing, mathematical modelling and clinical medicine. In this thesis the 
results of this process are presented. First, the Exercise CMR method was developed and 
validated. This method was subsequently used to investigate the biventricular cooperation in 
SV preservation and augmentation during exercise in healthy individuals. After this, the 
impact of absence of the RV on exercise haemodynamics in Fontan patients was investigated 
and a potential new treatment target for optimization of cardiac function in Fontan patients 
was identified. Finally, the potential role of a computational modelling framework in aiding 
patient-specific diagnostic assessment of patients with Fontan circulation undergoing an 
XMR dobutamine stress exam was evaluated. An overview of the original contributions and 
the outline of this thesis are provided in the sections below.  
1.2  Contributions 
The original contribution of this thesis in the field of exercise imaging and clinical cardiology 
can be summarized as follows:  
Developed an accurate, fast Exercise CMR imaging and processing 
framework. Accurate quantitative assessment of biventricular cardiac function during 
exercise has remained challenging. Real-time CMR imaging has shown promising results, but 
bodily motion currently still complicates accurate assessment. In this thesis, a new method 
for CMR during exercise is presented to overcome the current limitations. The developed 
framework for image acquisition and image processing allows imaging during physiological 
exercise while automatically correcting breathing and exercise motion. Using a pipeline for 
retrospective respiratory and cardiac gating, real-time images where converted to 
conventional cine stacks. This method enhanced usability of Exercise CMR and experimental 
evaluation showed improved accuracy of quantification of volumes over other techniques.  
Defined the role of the RV in the healthy heart during exercise. The two 
ventricles of the heart are very different in structure, function and loading conditions. This 
suggests that they have distinct roles in cardiac function and cooperate to optimize total 
cardiac performance. Whereas clinical observations have shown that the RV must have a 
significant impact of LV function, the mechanism underlying this cooperation, and the 
importance of the RV in this mechanism, remains largely unknown. In this thesis the 
experiments that were designed to investigate this cooperative mechanism between RV and 
LV function are presented. These Exercise CMR experiments demonstrated a fundamental 
synergy between RV and LV function in the biventricular heart that optimizes efficiency of 
SV delivery during exercise. RV systolic function has a pivotal role in this synergetic 
mechanism. By regulating LV filling it optimizes efficiency of LV SV augmentation. This 
work illustrates the pivotal interdependency of the two ventricles in optimizing cardiac 
function. This is a significant contribution to the current understanding of cardiac physiology.   
Demonstrated the impact of absence of a sub-pulmonary ventricle in the 
Fontan circulation during exercise and showed the benefit of acute HR 
reduction therapy on ventricular function and cardiac output in patients with 
Fontan circulation. The mechanism behind development of exercise intolerance and heart 
failure in patients with Fontan circulation has not been well understood. Inefficient 
haemodynamics potentially contribute to the constantly progressive decline in cardiac 
performance in these patients. Using Exercise CMR, exercise haemodynamics were 
investigated in patients with a Fontan circulation (type: total cavo-pulmonary connection). 
This work showed that the absence of a sub-pulmonary ventricle significantly deteriorates 
cardiac function during exercise, as ventricular filling cannot be maintained with increasing 
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HR, resulting in a drop in SV and CO. Acute selective heart rate inhibition significantly 
improved exercise haemodynamics in our group of Fontan, resulting in an improved cardiac 
output and a higher energetic efficiency of the single ventricle during exercise. These 
experiments illustrate the key role of HR in Fontan physiology, hereby improving 
understanding of the Fontan haemodynamics. This might imply a potential beneficial role of 
for selective heart rate modulation in  optimization of cardiac function in patients with Fontan 
circulation. Whether this benefit remains beyond this acute study in larger trails and for 
patients with other variants of Fontan circulation, needs to be further investigated.  
Evaluated the use of a computational modelling framework to aid patient-
specific CMR assessment of exercise intolerance in patients with Fontan 
circulation. Causes of exercise intolerance and failure of Fontan circulation are often hard 
to assess even when highly detailed examinations are used, such as combined cardiac 
catheterisation and CMR (XMR) during dobutamine stress. In this thesis, the potential value 
of computational modelling in improving diagnostic capacity of the XMR dobutamine stress 
exam was evaluated. A framework was developed to utilize the data obtained during the 
XMR exam to inform and calibrate patient-specific biomechanical models of the single 
ventricle coupled with the circulation. It was shown that the proposed modelling framework 
allows identification of patient-specific pathophysiological mechanisms underlying the 
exercise intolerance, thereby improving the diagnostic value of the XMR exam. 
1.3  Outline 
The thesis is organised in 6 further Chapters. Chapter 2 provides a background to the topics 
fundamental to this thesis. Chapters 2, 3, 4, 5 and 6 will describe the original contributions of 
the PhD. Chapter 7 provides a summary of the contributions and focuses on future directions. 
 
Chapter 2  Background 
In this Chapter, a review of the literature and background relevant to the studies performed 
during the PhD is given. In the first section, an overview of cardiovascular exercise dynamics 
is given. After this, the Fontan circulation is discussed, including Fontan haemodynamics at 
rest and during exercise. Finally, Section 2.3 will provide a background of cardiac magnetic 
resonance imaging.     
2.1  Healthy Heart during Exercise 
Together, the two ventricles of the heart generate stroke volume (SV) and consequentially 
provide cardiac output (CO) to the body. One of the main topics of this thesis is the 
investigation of the mechanism underlying SV preservation and augmentation during 
exercise. In this chapter a basic introduction is given to cardiac physiology including the 
cardiac response during exercise to put the original contributions of this thesis in context. 
Most information is inspired by textbooks of medical physiology and cardiology [2, 25].     
2.1.1  Basic concepts of biventricular cardiac function 
In the healthy heart, the right and left ventricles (RV and LV, respectively) are connected in 
series with the pulmonary circulation and systemic circulation. As a consequence, both 
ventricles are forced to generate a similar SV. However, the two ventricles have very distinct 
geometrical, structural and functional differences. These differences originate from early 
development. The two ventricles have a separate embryological origin; the LV develops from 
the primary heart field, while the RV originates from the secondary heart field [26].  
2.1.2  Anatomy of LV and RV 
This fundamental difference in development is reflected in the macro- and micro-anatomical 
structure of RV and LV. The RV is thin walled, highly trabeculated and has a triangular and 
crescent shape. On the other hand, the LV has a thick muscular wall, which is mostly smooth 
and has a bullet-like, ellipsoid shape. The myofibre architecture is also different between the 
two ventricles. In the RV, the superficial outer myofibres are oriented circumferentially, 
parallel to the atrio-ventricular valve plane, and point obliquely towards the apex. The deeper 
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RV myofibres are arranged longitudinally. The LV, the superficial (inner and outer) myofibre 
structure are obliquely and helically oriented, with a fibre angle of ~60°, while in the middle 
layer the fibres are oriented circumferentially. These macro- and micro-anatomical 
differences between the two ventricles are reflected in their contraction patterns. The RV 
contraction is peristaltic, starting at the inlet and propagating towards the outlet, with a 
mostly longitudinal motion. While in the LV, contraction of the muscle is predominantly 
circumferential and radial, with additionally a prominent contribution of twisting motion. 
Compared to the LV, the RV has a larger myocardium-blood surface to volume ratio. 
Therefore, a smaller inward motion of the ventricular wall is needed to eject a similar SV 
[27]. 
The two ventricles are supplied by three main coronary arteries: the left anterior descending 
(LAD), the left circumflex (LCx) and the right coronary artery (RCA). In general, the LV 
anterior wall and anterior parts of the septum are supplied by the LAD, while the lateral wall 
is supplied by the LCx and the inferior wall and inferior septum by the RCx. In a right 
dominant coronary system (~80% of the population) the RCA supplies most of the RV, with 
the branches of the LAD supplying the anterior wall and the antero-septal region. The 
infundibulum is supplied by the conal artery, which in ~30% of the population has a separate 
ostial origin.  
2.1.2.1  Myocardial perfusion 
In the LV, coronary blood flow largely occurs during diastole, with complete to near 
cessation of flow during systole (due to the high pressure in the LV muscle). However in the 
healthy RV, coronary blood flow occurs both in systole and diastole. Interestingly, while 
having a lower oxygen demand, the RV has a more extensive system for collateral perfusion 
than the LV, which has almost none. This is mostly due to the presence of the moderator 
band artery, a branch of one of the septal perforator arteries originating for the LAD. 
Coronary artery flow consists of approximately 5% of total cardiac output. The LV oxygen 
extraction is large, even at rest it extracts ~75-80% of all the supplied oxygen. Therefore, 
increasing oxygen supply to the LV is dependent on increasing perfusion. The RV, typically 
only extracts 50% of oxygen [28]. This reflects its lower work but also means that the RV has 
a significant myocardial perfusion reserve. Indeed, during exercise, the RV can first increases 
its oxygen extraction, before having to rely on vasodilation, whereas the LV is purely 
dependent vasodilation from the start [29]. Altogether, this suggests that the RV has a much 
larger reserve capacity to increase myocardial perfusion than the LV. While at rest, this might 
seem contradictory, during exercise this reserve is utilized by the RV. While LV afterload 
only rises by a factor 1.5, RV afterload can rise significantly more (100-150%), resulting in a 
disproportionate increase of RV systolic wall stress [10].  
2.1.2.2  Sarcomere Contraction 
The heart contracts due to shortening of the muscle cells. The sarcomeres, contained within 
myofibrils, deliver the actual shortening of the muscle cell that allows the heart (and other 
muscles) to contract with force, see Figure 2.1. This shortening is based on an interaction 
between the thick and thin myofilaments of the sarcomere. Actin fibres combined with 
regulatory proteins such as tropomyosin and troponin form the thin myofilaments. The thick 
myofilaments consist of a myosin protein. Repeated cycles of cross-bridge formation between 
the myosin heads and the binding sites of actin causes a sliding motion of the myosin 
myofilament along the actin fibrils, leading to shortening.  
Under resting conditions, the binding sites on the actin fibres are blocked by troponin-
tropomyosin complexes. However, the presence of Calcium ions (Ca2+) causes a change in 
conformation of the troponin-tropomyosin complexes, which uncovers the actin binding sites. 
ATP-activated (elongated) myosin heads bind with high affinity to the actin myofilaments 
and forms a cross-bridge under tension. Formation of the cross bridge is then followed by a 
passive re-conformation of the myosin head into a non-elongated state. This shifts the myosin 
myofilament along the actin myofilament. Renewed binding of ATP to the myosin head 
activates it again, causing it to release the binding site and elongate. It will then form a new 
cross bridge with the next available binding site on the actin myofilament and the cycle of 
cross bridge formation and sliding is repeated. This process of passive myosin-actin binding 
and active myosin elongation is repeated as long as the actin binding sites are uncovered (i.e. 
as long as the Ca2+ concentration is high). In order to relax, Ca2+ must be actively removed 
from the cytosol.  
Muscle cells have well developed sarcoplasmatic reticulum (SR). SR stores Ca2+ and 
transporter channels on its surface regulate the influx and active removal Ca2+ from the 
cytosol. After generation of the membrane action potential, electrically activated slow 
reacting Ca2+ channels, so called dihydropyridine receptors (L-Ca2+ channel), that are located 
in the T-tubules, release Ca2+ into the cell. After an initial 10-20% increase in Ca2+ 
concentration via these cells, a second Ca2+ channel (called the ryanodine receptor) is 
activated. This channel rapidly releases a large amount of Ca2+ ions from the SR into the 
cytosol. Ca2+ re-uptake is an active process in which several active transporter channels are 




Figure 2.1 Sarcomere and its components. A) Schematic representation of the sarcomere, B) sarcomere in 
relaxed and fully contracted state, C) actin and myosin filaments, interactions in the sarcomere and D) actin 
myofilament with the troponin-tropomyosin complexes. From [25]. 
 
2.1.2.3  Ventricular Function and Loading conditions 
The individual anatomical and functional features of the LV and RV seem to fit their 
individual loading conditions. At rest, the RV operates with a relative low preload, while it 
ejects against a highly complaint, low-pressure pulmonary circulation. Filling of the RV is 
mostly dependent on systemic venous return flow, which in turn is dependent on cardiac 
output, systemic venous tone and propagation of flow through, for example active muscle 
contractions. The thin wall, large volume-surface area and relative high compliance of the 
ventricle support is beneficial in this environment, as it minimizes the resistance to filling of 
the ventricle [30]. However, due to the low afterload, wall stress remains relatively low. A 
second benefit of the low RV afterload is that iso-volumetric contraction and relaxation times 
are relatively short in the RV. Therefore, duration of filling is longer [31]. This compensates 
for the lower filling velocities in the RV compared to the LV.   
In the LV, systemic afterload is ~5-6 times higher than the RV. Therefore, the LV needs to 
generate a significantly larger stroke work to eject blood, see Figure 2.2. As a result, oxygen 
consumption of the LV at rest is nearly 5 imes as much as that of the RV at rest. The LV 
geometry supports its task of overcoming the high afterload; the LV has a thick muscular 
wall and an ellipsoid shape that keeps its volume-surface ratio low. This minimizes wall 
stress. Furthermore, its radial and circumferential contraction pattern optimally utilizes the 
generated wall stress to rapidly increase intra-ventricular pressure.  
The distinct different contractions in the ventricles can be well observed using pressure-
volume (PV) loops; while the LV has a squared shape PV-loop (fast pressure generation to 
overcome afterload) the RV has a more trapezoid shaped pressure volume loop, in which 
pressure is still build up during ejection and increases while the ventricle is still ejecting, see 
Figure 2.2. While aiding ejection, the structure of the LV makes it less compliant compared 
to filling than the RV. In order to maintain similar filling, the LV thus needs a higher preload. 
Indeed, left atrial pressures are significantly larger than right atrial pressures (LA pressure: 6-
12 mmHg, RA pressure: 3-8 mmHg). As a result, the LV is less influenced by factors such as 
filling time and heart rate compared to the RV, despite having a lower compliance [32]. 
 
 
Figure 2.2 Right and left ventricular function and work. A) Pressure-volume (PV) loops of RV and LV. Note the 
trapezoid shape of RV compared to LV, with minimal isovolumetric contraction. Also note the larger RV size.  
B) Left and right ventricular stroke work (= area within the PV loop in A) function plot shows significant larger 
work in LV compared to RV throughout a range of atrial pressures. See Section 3.2.2 for explanation of function 
plot. A adapted from [33], B from [25]. 
 
2.1.3  The healthy heart during exercise 
The hearts’ behaviour during exercise has been of interest of researchers since more than a 
decennium. However, the inevitable body motion and exertion that accompany exercise have 
made detailed assessment of the heart difficult; see Chapter 2.3.4 for more details. Imaging 
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studies of the heart have so far been limited and sometimes resulted in variable results due to 
inaccuracies in methods of measurement. In this section, the most consistent findings are 
presented to give an overview of the cardiac behaviour during exercise. Most exercise studies 
so far have only analysed LV behaviour. Therefore, most of this section will cover the 
behaviour of the LV, with a more cautious description of RV dynamics during exercise, as 
evidence of RV behaviour during exercise is scarce.  
2.1.3.1  Regulation of cardiac function during exercise 
Cardiac output is the product of the frequency of cardiac contraction, heart rate (HR) and the 
volume ejected per beat, stroke volume (SV): CO = HR times SV. At rest, cardiac output in 
healthy adults is ~5-6 L/min, but this can increase 5- to 6-fold during exercise. Cardiac output 
in the body is tightly regulated by oxygen demand of the peripheral tissues. Higher metabolic 
needs in the tissue causes a direct effect of increased perfusion thanks to auto-regulation 
mechanisms within the tissues themselves. The response of the heart to the increased 
metabolic demand of the body is regulated through a direct heterotropic regulation based on 
the Frank-Starling mechanism and indirect regulation of inotropy (contractility), chronotropy 
(heart rate), dromotropy (increase in conductivity in the conducting system of the heart) and 
lusitropy (an increased rate of relaxation), mostly, but not exclusively, through sympathetic 
activation. All these factors contribute to acute regulation of CO. In the longer term (months-
years), the heart’s ability to increase CO can be regulated further by growth of the ventricles 
(myocardial hypertrophy and ventricular dilatation) combined with down-regulation of 
resting heart rate. 
2.1.3.1.1  Heterotropic regulation (Frank-Starling Law) 
In the end of the 19th and beginning of 20th century, Otto Frank and Ernst Starling described a 
phenomenon of a ‘spontaneous’ increase in stroke volume of the left ventricle after 
increasing end-diastolic volume [34]. This effect was found independent of inotropic, 
chronotropic and lusitropic regulations and has become known as the Frank-Starling law. It 
describes the relationship between end-diastolic myocardial fibre length and its force of 
contraction, see Figure 2.3A. Initially, the effect of increased force with length was explained 
by a better overlap between actin and myosin molecules when the myocardial fibre is 
stretched, which would result in a higher number of cross-bridge formations. Nowadays, an 
increased Ca2+ sensitivity due to stretch and passive tension of the sarcomeres is believed to be 
the major component increasing contractile force [35].  
Stretch of the ventricle (e.g. end-diastolic fibre length) is determined by end-diastolic 
volume.  End-diastolic volume in turn is dependent on end-diastolic pressure. For an 
individual muscle fibre, preload is defined as the passive force that establishes muscle fibre 
length before contraction. In the heart, preload can therefore be best defined as end-diastolic 
pressure, as this determines maximal volume of the ventricle and therefore is the main 
determinant of end-diastolic fibre length. Most physiological experiments demonstrating the 
Frank-starling mechanism have been performed in ex-vivo isolated heart-lung preparates. In 
these preparates, the pericardium is often not present allowing for an unlimited, regulated 
increase end-diastolic pressure. Figure 2.3B shows typical cardiac output curves (so called 
Starling or ventricular function curves). As illustrated in this figure, CO can markedly 
increase just by stretch alone (up to 12-13 L/min). In vivo, such effects are less pronounced, 
as the heart is constrained by the pericardium and thoracic cage, but this illustrates the 
important potential contribution of the Frank Starling mechanism in CO generation. The 
Frank Starling mechanism is believed to be especially important in maintaining equilibrium 
between right and left ventricular output. As the circulation is a closed-loop in which the two 
ventricles are coupled in series, a mismatch in ventricular output would lead to a shift of 
blood to one of the two circulations. Due to the presence of the Frank-Starling mechanism, an 
unequal increase in output of one ventricle, resulting in a larger preload of the other, would 
automatically increase in adaption of output of the second through increased stretch and vice-
versa. As previously discussed, the RV operates under lower preloads than the LV. This is 
reflected in the Frank-Starling curves of the two ventricles, in which the RV curve is shifted 
to the right compared to the LV curve, see Figure 2.3B. 
 
 
   
Figure 2.3 A) Force-tension relationship in the sarcomere. Note the increase in tension during stretch of the 
sarcomere (A, B) up to a maximal distance (C) before overstretching results in a decrease in tension (D). B) 
Frank-Starling curves of LV and RV show the relationship between atrial pressure and LV and RV ventricular 




2.1.3.2  Heart Rate Response during Exercise 
Heart rate is often regarded as the main mechanism contributing to the acute increase in CO 
during exercise or other causes of increased metabolic demand of the body. However, it is 
noteworthy that this HR response is only effective when SV can be preserved. When HR 
increases cause a drop in SV due to impaired filling, these HR increases become less 
efficient. 
At initiation of exercise, a coordinated autonomic response is triggered in the medulla that 
withdrawals parasympathetic activation to the heart. This withdrawal of vagal function 
contributes to the initial 15-20% of HR increase. Following with the parasympathetic 
withdrawal, sympathetic activation starts, resulting in a further stimulus of the sinusnode to 
increase frequency. Muscle motion and metabolism than further stimulate the sympathetic 
system local chemo- and mechanoreceptors that identify muscle contractions. Additionally to 
this direct sympathetic effect, catecholamine’s are released from the adrenal medulla 
resulting in a further reinforce the increasing HR. Altogether, these mechanisms can increase 
HR from resting values of 60-80 beats per minute (bpm) up to as high as ~200 bpm. The 
increase in HR results in a significant change in systolic and, especially, diastolic time-
intervals (reference time intervals). Systolic time reduces mildly due to fast ejection by 
approximately 30% (from ~320 millisecond to 230 milliseconds). Changes in diastolic time, 
however, are significantly larger. Diastole falls more than 50-60% (from ~500-600 
milliseconds to ~200-220 milliseconds) [36]. 
2.1.3.3  Inotropic and lusitropic regulation 
The force of contraction is not only regulated by fibre length, but also by frequency of 
contraction (force-frequency relationship) and the sympathetic nerve activity. These stimuli 
increase alter the contractile properties of the myocardium, e.g. the strength of the 
contractions after activation. This is defined as an increase in inotropy. Inotropic stimulation 
increases contractility by several mechanisms, such as increased sensitivity of the ryanodine 
receptors, resulting in a larger concentration of Ca2+ in the cytosol, increased myosin ATPase 
activity or direct increase of the rate of cross-bridge formation. Lusitropy (the force of 
relaxation) is enhanced by an increased re-uptake rate of Ca2+ ions from the cytosol into the 
SR. Both inotropy and lusitropy are controlled by sympathetic activation. As shown by 
Janssen et al. the kinetics of relaxation and contraction in the heart muscle are tightly linked 
and do not vary independently [37].  
The sympathetic nerve system is central in regulation of chronotropy, inotropy, lusitropy and 
dromotropy of the heart. It additionally plays an important role in regulation of the peripheral 
vascular responses. See Figure 2.4 for a schematic of the sympathetic nerve system’s 
influence on stress haemodynamics.  
 
Figure 2.4 Impact of sympathetic activation on cardiac output curve (A) and function (B). From [25]. 
 
2.1.3.4  RV during exercise 
As noted before, only few studies have investigated the RV response to exercise due to the 
challenges in imaging the RV during exercise using the currently available methods. Invasive 
studies are available, however imaging studies are scarce lacking. Even if available, data 
needs to be reviewed cautiously as the complex shape of the RV is likely to make quantitative 
assessment challenging. Recently, some research groups have used dobutamine stress as a 
pharmacological surrogate to exercise to investigate RV behaviour using CMR. 
Pharmacological stress does not mimic all the complex physiological responses during 
exercise. However, the findings of these studies give some idea about the behaviour of the 
RV during exercise.  
Based on previous invasive studies, it is clear that RV preload does not significantly increase 
up to near maximal levels of exercise [38, 39]. In the human cardiovascular system, RV 
preload is governed by systemic venous return, which in turn is determined by factors outside 
the heart (the muscle pump, venous capacitance and venous return). This implies that RV 
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filling is only mildly augmented during exercise, despite a significant reduction in diastolic 
filling time. This is in keeping with the observation in dobutamine stress CMR studies that 
RV end-diastolic volume (EDV) falls with increasing HR’s [40–42]. Although the muscle 
pump is not active during dobutamine stress, the only available physiological exercise CMR 
investigations, from La Gerche et al., shows a similar fall in RV EDV [9].  
The fall in EDV in the RV with increasing HR seems to imply that during exercise RV SV is 
maintained by a constant increase in contractility, in order to lower ESV. However, this is 
currently not well established.  
2.1.3.5  Pulmonary Circulation during Exercise 
The pulmonary circulation is a highly distensible high flow, low-pressure circulation. 
Whereas the relative volume of the pulmonary vascular bed is small, it accommodates total 
CO. Especially during exercise, this means that blood flow through the lungs increases up to 
5 times its resting values. At rest, pulmonary vascular resistance is low (1-2 Woods unitsm2) 
and the vasculature is close to maximally dilated. Only in hypoxic conditions or lung 
diseases, PVR is increased. As a result, PVR decreases only minimally during exercise at sea 
level in healthy individuals. Pulmonary vasodilation (PVD) has shown to not impact 
pulmonary blood flow at sea level in healthy individuals, even during exercise.  
Main pulmonary arterial pressure (Ppa) is low at rest (< 20 mmHg mean pressure) resulting 
in a low RV afterload. However, as PVR decreases only minimally during exercise, 
augmentation of CO leads to a nearly linear increase in Ppa [43, 44]. Therefore, during 
exercise Ppa pressures increase significantly, resulting in a large increase in afterload and 
myocardial wall stress in the RV [45]. Based on invasive measurements during supine 
exercise in 63 healthy subjects (including 21 women) regression models showed an average 
increase of 1±0.91 mmHg mean Ppa for each liter increase in Q in healthy young adults [46]. 
However, it must be noted that there was a large individual variety in linear regression slopes 
(SD of 0.91 mmHg) making individual estimates based on these regression lines not feasible.    
The size of the pulmonary circulation is small. Therefore, pressure generated by the RV is 
propagated through the pulmonary circulation towards the left atrium (LA). As a result LA 
pressures increase significantly during exercise [15, 45, 47].  The relationship between LA 
pressure and Ppa relates nearly linearly during exercise, suggesting that preload of the LV is 
significantly increased with increasing HR [44].   
2.1.3.6  LV during exercise 
2D echocardiographic exercise studies and cardiopulmonary exercise tests in healthy trained 
and untrained volunteers suggests that LV SV, after an initially increase of 15-30% at onset, 
remains constant during all stages of exercise [48–50]. This preservation of SV is vital for 
CO augmentation; it allows the heart to linearly increase CO with increasing HR (as CO = 
SV x HR). 
Both echocardiographic [51, 52] and CMR [53, 54] exercise studies have reported that LV 
EDV is maintained during exercise. This is keeping with the previous discussed enhancement 
of LV preload, which supports LV filling during the increase in HR. The initial increase in 
SV during exercise is caused by a fall in LV ESV. This fall seems to be the consequence of a 
decrease is systemic vascular resistance (SVR) and an increased contractility [55, 56]. After a 
heart rate of 130-135, ESV does not change any further.  From that moment, SV is 
maintained [14, 57], likely as a result of the preload enhancement in the LV. This 
preservation of EDV in the face of the striking decreased diastolic filling rate implies that 
filling needs to be augmented to 4 to 5 times the resting values during peak exercise. In 
trained athletes, LV EDV even seems to increase during exercise [58–60]. This is in keeping 
with reports that show that endurance trained athletes increase pulmonary artery pressures to 
a larger extend during all levels of exercise than non-athletic controls [45, 61]. 
2.1.3.7  Systemic Circulation during Exercise 
During exercise, the systemic circulation undergoes a range of changes to accommodate the 
increased CO of the heart and transport it to the metabolically active tissues. In order to 
distribute the blood effectively to the exercising muscles, a complex neural, hormonal and 
mechanical response mechanism affects the systemic circulation. Blood is redistributed to the 
specific vascular beds (exercising muscles, skin), while blood flow to other regions (e.g. the 
visceral organs) is decreased. A review of all of these mechanisms is beyond the scope of this 
thesis. While the sympathetic drive during exercise initially leads to general in arterial 
vasoconstriction, this drives is locally suppressed in metabolic active tissues and muscles, 
resulting in hyperemia. This mechanism allows the body to distribute blood to the most 
metabolic active regions, while non-active regions do not experience overperfusion. This 
way, the peripheral vasodilation, and the resulting drop in systemic vascular resistance 
(SVR), is proportional to the amount of muscles used and their activity.  
SVR is significantly larger than PVR (25-30 Woods unitsm2). Due to the extensive 
vasodilation during exercise, SVR can drop up to 50-60%. However, even after the more 
pronounced fall in SVR during exercise, SVR remains significantly higher than PVR.   
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2.1.3.8  Atrial function during exercise 
The atria contribute to filling by being a reservoir for blood during ventricular systole and a 
conduit for venous blood during diastole. Towards the end of ventricular diastole, the atria 
contract actively, hereby supporting filling. In the healthy heart, this atrial contraction 
attributes to about 15% of ventricular filling.  Studies on atrial function during exercise in 
healthy individuals are scarce. Using echocardiography, it was shown that left atrial strain is 
significantly increased during [62] and directly after cessation of exercise [63]. Schnell et al. 
recently published the only available study on atrial volume and ejection during exercise [64]. 
This study showed that both right and left atrial function increases during exercise. Their 
work also showed that maximal right atrial size decreases with exercise, while maximal left 
atrial size does not. This is in keeping with the changes in RV vs. LV preload during exercise 
and suggests that the LA is (and thus LV) filling is better maintained during exercise than RA 
and RV filling. 
In athletes, atrial function is not significantly different from healthy during exercise [62, 64]. 
Atrial volumes at rest are larger compared to sedentary healthy volunteers, but the changes 
during exercise are similar in the two groups. This suggests that the larger atria especially 
function as reservoir for early ventricular filling.  
2.1.4  Ventricular interdependence in the biventricular heart 
Based on [30, 31] 
Due to their inherent structural connection and shared ventricular septum, the two ventricles 
impact each-others behaviour. This interdependence is called mechanical ventriculo-
ventricular interaction. In-vivo and ex-vivo animal experiments have shown that 
approximately 20-40% of RV ejection is dependent on contraction of the LV (including the 
septum). On the other hand, pressure or volume loading of the RV can result in inward 
bulging of the septum towards the LV (septal shift) that impairs LV inflow or can result in 
decreased LV elastance. As RV pressure is lower than LV pressure, the shared septum 
implies that the RV can utilize the firm contracted LV as a wall to contract towards. This 
decreases its contractile costs and makes RV function less to RV myocardial scarring or 
damage, as long as the LV function remains intact.  
 
Researching ventricular interdependence in this thesis 
The clear differences in structure, loading and contraction between the RV and LV suggest 
that the two ventricles are likely to have distinct functional roles in the process of CO 
generation. The heart is a single organ with two pumping chambers and it seems likely that 
these chambers both play an individual role to optimize the total function of the heart. This 
notion is supported by the observation that the RV seems to have an important impact on 
prognosis and treatment efficacy of typical LV diseases [11, 12]. Also, the fact that the 
single-ventricle circulation is burdened by progressive decline of cardiac function, see 2.2, 
seems to point towards an interdependency between the two ventricles. Understanding of this 
mechanism of ventricular interdependency can provide a fundamental physiological 
understanding of cardiac function and might help to better understand the impact of absence 
of the RV on cardiac function in patients Fontan circulation. Therefore, one of the main 
focuses of this PhD was to investigate this mechanism. 

2.2  The Fontan Circulation 
The Fontan circulation is a surgically established palliation for complex congenital heart 
diseases in which one of the ventricles is functionally unable to support the circulation, a 
group also commonly referred to as ‘univentricular hearts’. Although exact figures are 
unknown, the incidence of univentricular hearts is estimated at 3/10,000 live births [18]. 
Every year, over 200 of these patients undergo Fontan completion in the UK [65]. This 
surgery can be regarded as a major success in the treatment of this otherwise lethal disease. 
However, the unusual circulation in these patients results in a high incidence of morbidity 
and progressive deterioration of cardiac performance over the years, leading to a significantly 
reduced life expectancy. The mechanisms behind this deterioration are poorly understood. As 
a result, treatment options remain scarce and prognostic parameters are largely absent in this 
disease.  
2.2.1  The Fontan Procedure 
The Fontan procedure was originally developed by Dr. Fontan and Dr. Baudet as a palliation 
strategy for tricuspid atresia [17]. During the initial procedure, the right atrium was connected 
to the main pulmonary artery to allow blood flow to the lungs, while bypassing the ventricle. 
The Fontan operation was soon extended to the treatment of other forms of univentricular 
hearts and in 1987 Leval et al. proposed to functionally bypass the right heart completely by 
anastomosing the superior vena cava (SVC) directly to the right pulmonary artery (RPA) and 
creating an intra-atrial tunnel from the inferior vena cava (IVC) to the RPA [66]. An extra-
atrial variant of this so-called total cavopulmonary connection (TCPC) followed soon and 
connected the IVC to the RPA via an extra cardiac tunnel, anatomically bypassing the heart 
completely. The intra- and extra-atrial TCPC have become standard treatment options for 
univentricular hearts over the years, and the original Fontan procedure is largely abandoned.  
To minimize volume loading and acute changes in ventricular mass / volume ratio in these patients, Fontan 
palliation nowadays typically consists of three staged surgeries, of which the TCPC is the last one [18].  During 
the first stage, systemic blood flow from the single ventricle is secured and a temporary systemic-pulmonary 
shunt is constructed to allow blood-supply to the lungs (see  
 
Figure 2.55). The second stage surgery unloads the heart partially by redirecting SVC flow 
towards the pulmonary arteries [67]. The third procedure, the Fontan procedure, finally 
completes the Fontan circulation by connecting the IVC to the RPA. Surgical mortality rates 
of the Fontan procedure has decreased markedly over the last decades; from 39% before 1982 
to <2% between 2000-2010 [18, 68]. The overall mortality from birth to Fontan completion 
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remains high, with reported mortality rates ranging from 25-40% depending on the institution 














Figure 2.5 Variations of Fontan surgery. A the ‘classic’ Fontan, in which the RA is anastomosed to the 
pulmonary artery. B: total cavopulmonary connection (TCPC); intra-cardiac lateral tunnel with the IVC 
anastomosed to the RPA. C: extra-cardiac TCPC. Note the Blalock Taussig-shunt in A (original blood supply to 
the lung) that is taken down and over sewn. Note in C epicardial pacemaker leads. From [18] 
 
2.2.2  Fontan Haemodynamics 
In the Fontan circulation, systemic and pulmonary circulations are coupled in series without a 
ventricle supporting the pulmonary circulation. Pulmonary blood flow (PBF), and 
consequently preload of the heart, are therefore reliant on passive flow of systemic venous 
blood through the pulmonary arteries (PAs), and requires a degree of systemic venous 
congestion. The result is a paradoxical physiology in which caval hypertension and 
pulmonary vascular hypotension coexist and preload of the heart is restricted by the 
pulmonary vascular bed [71]. This anatomy has important implications for physiology of 
Fontan circulation and consequently the mechanisms behind failure of the circulation.  
In Fontan patients, cardiac output (CO) at rest is typically decreased to about 70% of normal 
for body surface area [72].  During exercise, this difference becomes even more visible. 
Morphologically normal hearts can produce up to a five-fold increase in CO in response to 
exercise [73], whereas Fontan patients typically only achieve 50-60% of predicted exercise 
capacity [74]. In acquired heart diseases, ventricular dysfunction is most of the time the 
reason for an impaired CO response to stress. In Fontan patients, the heart seems to be less 
determining factor of CO.  
2.2.2.1  Preload in the Fontan Circulation 
Over the last two decades, it has become increasingly clear that preload of the systemic 
ventricle is an essential determinant of CO [19]. Already in 1982, Shachar et al. observed that 
CO at rest and during stress was not associated with ventricular ejection indices, but relied on 
unobstructed venous flow through the cavo-pulmonary connection and pulmonary arteries 
[75]. This observation was later supported by multiple studies that showed increases in 
resistance in the cavo-pulmonary connection or the pulmonary vascular system, such as small 
pulmonary arteries, elevated PVR and positive pressure ventilation, significantly decrease 
cardiac output [76–80]. The importance of preload for the Fontan heart has also clinically 
been recognized. Creation of a fenestration, and hereby creating a ‘right to left shunt’ 
improving preload, is now a well known intervention to increase cardiac output in Fontan 
patients in the early stages of accommodation after surgical completion of the Fontan 
circulation [81–84].  
In order to maintain circulatory flow and thus preload, the Fontan circulation is critically 
dependent on maintaining systemic venous hypertension. Krishan et al. have shown that the 
vascular circulation in asymptomatic Fontan patients has adapted to facilitate this by 
increasing vascular resistance, reducing venous compliance and decreased microfiltration 
[85]. While supporting the venous pressure gradient, reducing venous pooling (and thus 
congestion of oedema in important venous compartments such as the splanchnic bed) and 
improving blood flow through the Fontan circulation, these changes have a negative impact 
on organ perfusion and afterload of the heart. Interestingly, the study of Krishan et al. showed 
that the changes in vasculature are largest in the lower extremities. This is likely the effect of 
the larger pressure needed to propel venous return from the legs in upright position of the 
body.  
2.2.2.2  Cardiac function in the Fontan circulation 
The Fontan circulation has become a palliative treatment option for a range of congenital 
heart defects in which one of the two ventricles is unable to support the circulation [18]. As a 
result, there is a wide variety of morphological and geometrical differences between single 
42 Background 
 
ventricles. Some single ventricles are purely of right or left ventricular origin (patients with 
hypoplastic left or right heart syndromes), whereas others are a mixture of the two (complex 
AVSD’s with a hypoplastic component of the RV for example). These differences make 
investigation of cardiac function difficult. The origin and geometry is likely to play a 
significant part in the role of cardiac function in Fontan haemodynamics, in particular in 
chronic adaption. Patients with a single ventricle of LV origin seem, for example, to have a 
better long-term preservation of cardiac function and exercise capacity than patients with a 
ventricle of RV origin [86]. Ideally, cardiac morphology is taken into account when 
investigating ventricular function. However, due to the relative rarity of the disease and 
therefore small patient numbers, this is not always possible. 
Conventionally, systolic and diastolic function of the heart is measured using global 
ventricular parameters, especially cardiac volumes and ejection fraction (EF), that are easy 
estimated or directly measured from widely available diagnostic examinations at rest such as 
echocardiography and cardiac MRI. However, such measures are load dependent. Loading 
conditions of the Fontan circulation are severely abnormal. Furthermore, univentricular hearts 
are often severely dilated. These factors decrease the sensitivity of conventional markers of 
cardiac function for myocardial status and can lead to erroneous conclusions. Diastolic 
dysfunction has, for example, been reported in over 70% of all Fontan patients of the 
paediatric heart network cohort based on echocardiographic measures [87]. However, 
Senzaki et al. elegantly showed that the clues of diastolic dysfunction seen on 
echocardiography are consequence of loading conditions of the Fontan circulation, and that 
during invasive assessment such diastolic dysfunction was not present [88].  Similarly, EF is 
often reported as impaired or low normal. However, multiple invasive and non-invasive 
studies investigating load-independent parameters of systolic function have shown that in 
asymptomatic Fontan patients, contractile function is often normal [88–90].  Overall, this 
suggests that ventricular function is not the main problem in Fontan circulation. However, 
even asymptomatic patients experience exercise intolerance and have lower CO than healthy 
volunteers. This realization has over recent years led to an increasing focus on vascular 
factors of the circulation as the main ‘problem’ of CO in the Fontan circulation. As 
previously described, vascular adaptions to the single ventricular circulation result in a 
significant increase in afterload. This results in larger costs of cardiac contraction, and thus 
creation of CO. Indeed, in modelling, as well as clinical studies it has been shown that 
ventricular efficiency of the Fontan ventricle is lower than in the biventricular heart at rest 
[77, 91]. In addition, Saiki et al. showed that at rest HR adversely effects efficiency of the 
ventricular contraction more than in the healthy heart [89]. This was the result of the higher-
than-normal afterload, necessitation high contractility, and relative under filling, resulting in 
ventricular-arterial uncoupling. Whereas the systolic and diastolic function of the ventricle in 
asymptomatic Fontan patients seems to be good, the inefficiency of the circulation has a 
significant impact on its function and has been hypothyzed to attribute to the long-term 
deterioration seen in Fontan patients [19].    
2.2.2.3  Exercise/stress haemodynamics of Fontan circulation. 
As described in the previous section, assessment of cardiac (and vascular) function of the 
Fontan circulation has remained challenging using measurements at rest. In cardiology, it has 
widely been recognized that exercise testing is a sensitive measure of cardiovascular status, 
as CO, the result of total cardiovascular function, is one of the main determinants of exercise 
capacity. Also in Fontan patients, exercise intolerance is a sensitive predictor of morbidity 
and mortality [92, 93]. Therefore, investigation of cardiac (and vascular) function during 
exercise potentially can lead to valuable insight into the Fontan physiology and can 
potentially improve identification of targets for treatment in individual patients.  Over the 
recent years, several research groups have investigated the haemodynamic response to 
exercise or pharmacological stress, a surrogate for physiological exercise, in Fontan patients. 
These studies have given some important clues regarding the physiology of the Fontan 
circulation.  
Both cardiopulmonary exercise test (CPET) [94, 95] and dobutamine stress CMR [96, 97] 
studies have shown that the ability to augment CO in exercise is impaired in Fontan patients. 
Whereas the HR response is lower in Fontan patients than healthy volunteers, the lower CO 
in Fontan patients compared to healthy volunteers is largely unexplained by HR alone [72].  
In their CMR study, Robbers-Vissers et al. found that, in contrast to healthy individuals, SV 
did not increase during low dose dobutamine stress (7.5mcg/kg/min) in adult Fontan patients, 
but remained constant [97]. This was the result of a fall in EDV, while HR increased. A 
similar report from Pushparajah et al. showed that higher doses of dobutamine stress 
(10mcg/kg/min and 20 mcg/kg/min) result in a further fall of EDV and consequently a 
decline in SV in a cohort of children with Fontan circulation. This decline in SV caused CO 
to plateau at moderate levels of stress, as every further increase in HR is accompanied by a 
similar fall in SV [98].  These results were in keeping with an exercise echocardiography 
study executed by Gewillig et al. [79].  
Senzaki et al. [88] investigated the origin of this fall in SV during stress, using both atrial 
pacing and dobutamine stress in adult Fontan patients. This invasive study showed that end-
diastolic pressure (EDP) fell 25% at increasing HRs in Fontan patients, whereas there was no 
change in healthy volunteers. Using pressure area curves, they derived that the impaired CO 
response was caused by a fall in EDV due to an inadequate preload reserve, while the 
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contractile response to dobutamine was normal. Wong et al. [99] showed a similar 
mechanism of reduced preload leading to a fall in SV in children with Fontan circulation 
during CMR dobutamine stress. These results seem to suggest a lack in preload in the Fontan 
circulation. However, the studies were performed using dobutamine stress or atrial pacing. 
The lack of active muscular contractions, which augment preload, could therefore potentially 
explain these results. Therefore, comprehensive assessment of the heart during physiological 
exercise should be performed in order to find out the exact mechanism of reduced SV during 
exercise.  
The observed fall of SV during increasing HRs could potentially have important 
consequences for the efficiency of the single-ventricular heart. As described in Chapter 2, SV 
preservation is essential part of the HR response in healthy subjects, as it results in a linear 
increase in CO during HR augmentation. Fontan patients are unable to preserve SV, and 
reach maximum CO at moderate levels of exercise. Between moderate and high levels of 
stress, the increase in HR results in a significant increase in energy demand of the heart. 
Although the internal work (IW) increases [25, 100], it does not yield extra CO.  Hence, 
cardiac efficiency (stroke work / total work) decreases progressively. The lower increase in 
HR in Fontan patients compared to healthy volunteers seen during stress / exercise might 
very well be a compensation mechanism of the body to prevent further deterioration of 
cardiac function [74]. However, as illustrated in Figure 2.6 this compensation is only partially 
effective compensation, as EDV still falls and results in a decrease in SV during stress.  
 
Figure 2.6 Pilot data. Changes in ventricular volumes during dobutamine stress in Fontan patients (HLHS) 
and healthy volunteers. Figure 1: SV decreases in Fontan patients. Figure 2: more prominent fall in ESV in 
Fontan patients. Figure 3: CO plateau’s at moderate dobutamine (10 mcg/kg/min). With Permission K. 
Pushparajah, 2014 
 
The above described investigations into Fontan physiology during exercise seem to suggest 
that the exercise and stress response in the single ventricular circulation is inherently 
impaired due to a fall in SV during exercise, that results a significant increase in inefficiency 
of the ventricle, which already at rest was impaired. Whether these observations hold during 
physiological exercise remains to be seen. Therefore, investigation of this exercise response 
in Fontan patients, and the impact of the missing RV, is the main objective of this PhD.  
2.2.2.4  Failure of the Fontan circulation 
Fontan palliation is a valuable option in otherwise lethal complex congenital heart defects. 
However, the abnormal circulation brings a burden of hemodynamic sequelae and 
complications to initial survivors, resulting in a poor life expectancy [101]. Fontan patients 
experience a slow but constant progressive deterioration of cardiac function and exercise 
capacity and a high incidence heart failure, arrhythmia’s and thromboembolic events [87]. 
This results in Fontan failure (death or transplantation) in up to 40% of the patients after 25 
years of follow up [102, 103]. The mechanisms behind the decline in exercise capacity and 
development of heart failure are not completely understood. Complaints of exercise 
intolerance often occur without obvious cardiac dysfunction at examination and reliable 
markers that predict morbidity and mortality after Fontan palliation are currently absent. 
Based on recent cohort studies, two modes of Fontan failure can be identified: failure with 
impaired systolic function (IVF) and failure with preserved systolic function (PVF) [104–
106]. In patients with end-organ dysfunction, listed for transplantation, IVF is present in 
about ~40-50%, with the remainder having PVF [106].  
The phenotype of IVF can be directly related to impaired systolic function, with reduced 
ejection fraction, a low CO and high SVR, resulting poor exercise tolerance. In these cases, 
medical treatment has largely focused on reducing cardiac work (beta-blockage) and reducing 
afterload (ACE-inhibition). Both such treatments lack scientific backing and have so far not 
proven to be very successful. Therefore, many patients ultimately are evaluated for 
transplantation.  
In PVF group, the cause of failure is less obvious. Ejection fraction is normal and CO is often 
normal. Patients often have vascular complications such as protein losing enteropathy (PLE) 
or plastic bronchitis. The cause of these complications remains unclear, but both are 
associated with high mortality rates [104]. The pathway of PVF is often suggested to be 
related to high systemic venous pressures with elevated post-sinusoidal pressures in the liver. 
It is thought that chronic liver damage due to these high pressures results in liver mediated 
widespread disregulation of autonomic vascular function, with a fall in SVR. The drop in 
SVR subsequently leads to low perfusion pressures and shunting of blood away from non-
vital organs, such as the splanchnic bed and kidney [106]. This seems to be supported by the 
increased resistance in the splanchnic bed observed in PLE [107]. Ozawa et al., who studied 
ventricular-arterial coupling in patients with PLE, suggested an increased afterload, and 
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resulting mismatch in VA coupling as the cause of PLE. Whereas this at first seems to 
contradict the previous work, a close inspection of their data shows that their interpretation of 
increase afterload was based on an increase in vascular elastance (Ea). Ea is measured as end-
systolic blood pressure / stroke volume. Whereas in normal loading conditions this measure is 
mostly influenced by systemic vascular factors and contractility, filling of the ventricle also 
plays a role. If EDV and therefore SV decreases (as often observed in Fontan patients, see 
above), Ea increases. Therefore, the measured increase in Ea in the PLE patients by Ozawa et 
al. is potentially a reflection of lower ventricular filling, a factor previously reported in 
Fontan patients with PLE and PVF. Although their study does not give sufficient information 
to investigate whether SV was indeed decreased due to a fall in EDV, the results are not 
directly contradictory to the hypothesis of reduced SVR.   
Treatment has remained difficult in patients with PVF. Both medical and surgical treatments 
have shown to be suboptimal, with only partial reduction of symptoms in most cases and 
rarely complete remission. For PLE, a recent suggestion of embolization of the involved 
lymphatic branches has shown promising short-term results, with evidence of total remission 
of leakage of lymph to the gut [108]. Whether such interventions also result in long-term 
remission, or are only a temporary solution, remains to be seen. In PVF, heart transplantation 
has shown good results, with even remission of vascular symptoms. However, mortality-rates 
of transplantation in PVF have been shown to be significantly higher than in IVF [105],  
although recently survival rates in this groups seems to have improved due to better post-
transplantation care [109].  
Whereas the results of heart transplantation improved for Fontan patients, bringing them 
closer to transplantation results for patients with other underlying diseases, the need for 
transplantation reflects the poor efficacy of alternative treatment options [110]. 
So far, no successful treatment regimes have been identified to prevent or even slow down 
the progressive functional decline in heart failure. Scientific basis for treatment is only 
limitedly available, and if available has yielded unsatisfying or sometimes contrasting results. 
ACE-inhibition, often used in acquired heart diseases to reduce afterload of the heart, has 
shown not to provide evident benefit and might even lead to reduced functional capacity 
[111]. Bearing in mind the suggestion that the increased SVR in Fontan patients is a 
functional adaption to provide perfusion pressure and blood flow through the circulation in 
the face of low CO, the use of ACE-inhibition might indeed be contra-productive [19].   
Over the recent years, more attention has been given to the improvement of blood flow 
through the pulmonary circulation using pulmonary vasodilation (PVD). The rationale of this 
treatment is based on the highly deteriorating effect of increased pulmonary vascular 
resistance on Fontan haemodynamics and is supported by the observation that PVR with 
increased age seems to increase over time due to the lack of pulsatile flow in the pulmonary 
arteries. Short term studies have indeed shown a beneficial short-term effect of pulmonary 
vasodilators (Sildenafil, Bosentan and Iloprost) on pulmonary blood flow [112, 113] and 
exercise capacity [114–116]. However, a 6 months follow up did not show a sustained benefit 
[117]. Furthermore, an exercise CMR study done by Van den Brueane et al. showed that the 
improved CO during exercise after Sildenafil was mainly caused by a reduction of SVR, most 
likely a side effect of the drug, but not by improved flow through the pulmonary circulation 
into the single ventricle [96].  The long-term effects of the PVD remain to be seen. 
Further investigation into potential treatment, PVD’s, and other options, is highly needed. In 
particular, the mechanisms of impact of potential treatment options need to be carefully 
assessed, as the Fontan circulation functions so distinctively different to the normal 
circulation.  
In this thesis, we will address the challenges in treatment of Fontan patients by aiming to 
better understand Fontan physiology using exercise CMR. More over, a potential new 
treatment target, selective HR inhibition, will be evaluated to identify its impact on Fontan 
haemodynamics and energetic efficiency of the circulation. 

2.3  Cardiac Magnetic Resonance Imaging 
In order to investigate the primary questions of this thesis, an imaging technique that allows 
evaluation of biventricular cardiac function during exercise needed to be developed. As 
discussed in Chapter 1, CMR is the most desired method for imaging during exercise. 
However, adaption of conventional CMR techniques in order to allow imaging during 
exercise is however non-trivial. Therefore, a thorough understanding of CMR techniques is 
needed. In this chapter, the basis of MRI physics, current standard CMR techniques and 
potential strategies for CMR during exercise are reviewed. Most of this information is based 
on a textbook for cardiovascular MRI by Plein et al. [1] and a Cardiovascular MRI course 
given by Dr. Gerald Greil at King’s College London. 
2.3.1  Introduction 
Since its commercial introduction in 1980’s, nuclear magnetic resonance imaging (MRI) has 
had a significant impact on cardiovascular imaging. It allows for imaging of cardiovascular 
structures without geometric restrictions, such as acoustic windows in echocardiography, and 
encompasses a wide array of techniques for 2 dimensional (2D) and 3-dimensional (3D) 
assessment of cardiac and vascular anatomy, function, blood flow and tissue characterization. 
MRI manipulates the magnetic moment of protons to create a signal that can be used to 
generate images. Although many different elements have nuclei with magnetic resonance 
properties, hydrogen (H+) nuclei are exploited during conventional MRI imaging, as their 
intrinsic sensitivity to magnetic resonance imaging is high and their occurrence in our body, 
in the form of water and fat, is abundant. 
2.3.2  MRI Physics 
2.3.2.1  Proton Spins and Magnetization 
Hydrogen nuclei possess a positive charge and spin around their axis. Hereby, they generate 
their own magnetic field, also called magnetic moment [1]. Normally, the magnetic moments 
of individual hydrogen atoms are randomly orientated, but when a strong external magnetic 
field (B 0) is present, the spin states of these atoms align with (parallel) or against 
(antiparallel) with the external field (see Figure 2.7). As aligning parallel to the magnetic 
field is a more favourable position for the atoms, the application of the external magnetic 
field results in a net-magnetization M 0 of the tissue along the axis of B 0. The ratio of the spins 
in the parallel vs. antiparallel configuration determines the size of net-magnetization and this 




Figure 2.7 Spin alignment parallel or anti-parallel to B0. From [1] 
 
2.3.2.2  Signal generation 
Although aligned by the magnetic field, the spin axis of a proton rotates around the vertical 
axis. This motion is similar to the motion of a child’s spinning top, that slows down and starts 
to spin no longer completely vertical and is called precessional motion.  This phase of the 
precession motion is random and hence, the transverse component of M 0 is zero. 
The frequency of the precession motion of the spins, the Larmour frequency (𝓌L) is given by 
their gyromagnetic ration y and the strength of B 0. When a radio-frequent (RF) pulse is given 
to protons at a frequency identical to their frequency of precession the system of spins is able 
to absorb the energy from this pulse. The absorption of energy will cause all spins to precess 
in phase while also flipping the parallel spins into the anti-parallel configuration. As the full 
spin system precesses in phase, the net magnetization will rotate around the vertical-axis, 
hence creating two components of M 0; the vertical component of the net magnetization (M z) 
and the transverse component of the net magnetization of (M xy).  Whereas vertical 
magnetization is undetectable, the rotating transverse component of the net magnetization 
produces an oscillating magnetic field that can be detected by a receiver coil in the MRI 
scanner. This receiver coil detects a sinusoid signal that slowly decreases in amplitude: due to 
the relaxation process that brings the net magnetization back to its original state. This slowly 
decaying signal is known as the Free Induction Decay (FID) (see Figure 2.8). The signal 
decay, or relaxation, consist of two independent relaxation processes: a recovery of the 
longitudinal magnetization, called T1 relaxation, and a decay of the transverse magnetization, 
with the resultant decay of the MR signal, called T2 relaxation. In human tissues, T2 
relaxation is usually faster than T1 relaxation and therefore the signal decays away before the 
spin system returns to the original M z. 
 
Figure 2.8 Dephasing of the spins results in a gradual decline in transverse magnetization; also called free 
induction decay  (FID). 
2.3.2.3  T1 relaxation 
The recovery of the longitudinal component of the net magnetization is caused by a transfer 
of energy from the proton spin system to its surrounding molecular system. This recovery is 
an exponential process with a time constant T1 and is dependent on the size of the molecules 
and their motion (tumbling rate).  As a result, T1 relaxation times differ for different 
structures: Fat has a relative fast relaxation rate, while water, which has an unfavourable 
tumbling rate, has a much slower relaxation rate (= longer T1 relation time). 
2.3.2.4  T2 relaxation 
After application of the RF pulse, all spins move in phase, resulting in transverse 
magnetization. However, over time the pins dephase. This dephasing has two causes: 1) 
interactions between neighbouring protons (spin-spin interactions) and 2) local 
inhomogeneity’s in the applied magnetic field. 
Spin-spin interactions represent the ‘true’ T2 relaxation. Due to random interactions between 
protons in a molecule, their individual magnetic field is slightly modified, resulting in de-
phasing of their spins. This dephasing is irreversible, due to its randomness and independent 
of the strength of B o. The resulting relaxation is exponential with a time constant (T2). 
However, the M xy signal decay is always faster than the true T2 relaxation rate, due to 
inhomogeneity’s in the applied magnetic field. These small differences in the magnetic field 
observed by individual protons, result in additional dephasing of the spins. And therefore, the 




Figure 2.9 Spin echo sequence (left) and gradient echo sequence (right): the 180° refocusing pulse of the spin 
echo flips the spin momentum, hereby reverting the effect of field inhomogenities on the spins.  The recovered 
signal is therefore only dependent on T2 relaxation, and results in good signal. The two opposite gradients in a 
gradient echo sequences (right) result in rapid dephasing and rephasing of spins. However, result in lower signal 
as the transverse magnetization decays with T2* relaxation. From [1] 
 
2.3.2.5  MR echoes for signal acquisition 
Although the FID could potentially be read as an MR signal, this signal is mostly ignored as 
it is disrupted by additional magnetic field gradients that are applied to spatially localize and 
encode the MRI signal. Therefore, instead of sampling the FID directly, echoes are used to be 
able to measure FID. The two most common types of echoes are gradient echoes and spin 
echoes.  
2.3.2.5.1  Spin Echoes 
A shown before, the FID is influenced by both T2 relaxation and local field inhomogeneity’s. 
Whereas signal decay from T2 relaxation is irreversible due to the randomness of the spin-
spin interactions, the signal decay of local field inhomogeneity’s is potentially reversible, as 
these are constant: The degree of dephasing (‘faster’ or ‘slower’ precession) is dependent on 
the local magnetic field. The spin echo sequence exploits these fixed local field 
inhomogeneity’s. After an initial 90° RF pulse, a 180° refocusing pulse is applied that the 
spins flip by 180°. As a result, the local field inhomogeneity’s become exactly opposite to the 
first initial experienced local field inhomogeneity’s. The precessions that initially ‘slowed 
down’ compared to average because of the local field inhomogeneity’s now speed up again, 
whereas the ‘accelerated’ precessions now slow down. Hereby, the spins will come back in-
phase. This pulse is therefore called the refocusing pulse. The signal will grow until all spins 
are in phase, before decaying again. This peak signal is called the spin echo and as local field 
inhomogeneity’s are cancelled out, it lies on the T2 relaxation curve. The time from the RF 
pulse to this echo is called Echo Time (TE). As a consequence of the 180° flip, the refocusing 
pulse is exactly at TE/2.  
The use of both a 90° RF pulse and the 180° refocusing pulse gives the largest possible signal 
that can be obtained in MRI. Hence spin echo sequences are ideal for imaging quality 
imaging with reduced sensitivity to image artefacts due to magnetic field inhomogeneity’s. 
This characteristic can be exploited, for example when imaging cardiac patients with a 
pacemaker: the relative low susceptibility for artefacts when using spin echo sequences will 
optimize the image quality obtained during CMR.  
2.3.2.5.2  Gradient Echoes 
Gradient magnetic fields are used to produce a linear variation of the external magnetic field 
B 0. These gradient fields can be used to accelerate the normal dephasing of spins after an 
initial RF pulse. Switching on a gradient will diphase the spins quickly, resulting in rapid 
decrease of FID to zero. By subsequently applying a second gradient field along the same 
direction with a similar slope but opposite polarity, the spins will rephrase, causing an 
increase in FID, which peaks at maximal rephrasing. This peak lies on the T2* relaxation 
curve, as the gradient echo sequence ignores field inhomogeneity’s. The peak signal is called 
gradient echo. If another pair of gradients with opposite polarities is turned on, another echo 
can be obtained. Gradient echo sequences use an RF pulse with a variable flip angle, which is 
normally less than 90°. Although this reduces the amount of transverse magnetization, and 
thus signal, of an individual echo, it allows for much faster repetition of the pulse sequence 
(repetition time; TR).  
In CMR, most gradient echo sequences use a very short TR (<10 ms). The static tissue in the 
image slice is saturated, as there is little time for recovery of the z-magnetization, due to the 
fast repetition of RF pulses. However, as blood flows it comes into the image plain without 
having received any of the earlier pulses. All the spins can be fully magnetized, resulting in a 
relative high signal compared to the static tissue. Hence, these fast gradient echo sequences 
are referred to as bright blood sequences. 
2.3.3  Cardiac Magnetic Resonance 
MRI acquisitions of the heart have to take into account three important factors: motion of the 
heart, breathing motion and blood flow in the heart and vessels. Depending on the indication, 
these factors need to be compensated (for still imaging) or are part of the image that needs to 
be obtained. Over the last decades, a multitude of sequences have been developed for 
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individual imaging purposes. These range from still imaging of the heart to comprehensive 
assessment of three dimensional motion and blood flow.  
2.3.3.1  Cine imaging    
Cine imaging refers to dynamic imaging in which the motion of the heart is displayed over 
time and is used for the assessment of wall motion and volumetrics of the heart. ‘Bright 
blood’ cine gradient echo sequences are used for this purpose. In the King’s College London 
Cardiovascular Imaging Department, balanced steady state free precession sequence is most 
commonly used for cine imaging (see Figure 2.11 right plane) 
Acceleration of image acquisition can be achieved by simply repeating the gradient echo 
sequence rapidly, acquiring multiple lines of k-space within a cardiac phase. Increasing the 
number of lines recorded per cardiac phase decreases the scan time, but it increases the 
window of acquisition per cardiac phase, thus decreasing temporal resolution of the scan.  
When the full k-space is sampled within a single cardiac phase, the sequence is called ‘real 
time’. 
For the assessment of ventricular volumes, a complete stack of cine images is acquired that 
covers the whole heart (mostly commonly acquired in short axis orientation). Acquisition is 
mostly done during breath holds to avoid motion artefacts. Imaging without a breath hold can 
be achieved, but requires correction of breathing motion. Typically, 20-30 phases are 
acquired during cine CMR to allow assessment of cardiac motion as well as end-diastolic and 
end-systolic volumes.  
2.3.3.2  Flow Imaging 
2.3.3.2.1  2D phase contrast flow imaging 
Phase contrast (PC) flow MRI was first introduced in the 1980’s and since then, has gained a 
major role in daily clinical CMR assessment, especially in valvular and congenital heart 
diseases[118].  It allows for the measurement of blood flow at any location in the body and 
has flexible spatial and temporal resolution.  
PC flow imaging makes use of the direct relationship between blood flow velocity and the 
phase shift observed during MRI acquisition. During a cine gradient echo pulse sequence, the 
application of a magnetic gradient field results in dephasing of magnetization along the 
gradient. By applying two gradients along the same direction with opposite signs, a so-called 
bipolar gradient pulse pair, a phase shift due to movement of the spins can be measured. In 
static tissue, the de-phasing caused by the first gradient is reversed by the second gradient. 
However, as spins in the blood pool move between the two gradients, de-phasing is 
incomplete, leaving a phase shift in the pixels of the blood pool that is proportional to the 
velocity of the blood.  
By measuring this phase shift, an image can be created that is depended on the phase of the 
transverse magnetization, a so-called phase map. This phase map, however, not only holds 
information on phase changes due to blood flow, but also changes due to magnetic field 
inhomogeneity’s, eddy currents and motion along more than one gradient direction. To 
correct for these phase errors, two consecutive acquisitions of each phase encoding step are 
usually acquired (a ‘reference’ and a ‘velocity encoded’ scan). During the first acquisition, a 
signal s1 is obtained, containing both static and moving spins ss and sm, respectively. During the 
second acquisition, the gradient in the flow direction is altered, hence resulting in a phase 
shift of the spins (Sm+ phase shift) moving in this direction. Thus, 
 S1 = ss + sm 
 S2 = Ss + Sm + phase shift 
By subtracting the phase maps of the two scans, the phase changes due to causes other than 
velocity in the flow-encoded direction are removed, creating a phase contrast velocity map 




Figure 2.10 2D PC flow imaging with phase encoding in one direction. A) For every cardiac frame, a reference 
image and a flow-sensitive image is generated. Note the bipolar gradient applied in the flow-sensitive image 
From these images a phase difference map and a magnitude image are created. B) For every flow-image, an 
adequate velocity encoding (VENC) needs to be selected. Phase differences in an angle from +VENC (highest 
velocity) to –VENC (lowest velocity) are encoded as velocity. Velocities higher than the set VENC result in 
aliasing. From [1] 
  
In order to obtain a strong signal from fast moving blood, turbo gradient echo sequences with 
a short echo-time (TE) are needed during a cine acquisition with reduced flip angle.  During 
turbo gradient echo imaging, the gradient echo pulse is repeated several times, using different 
amplitudes of the phase encoding gradient. Hereby, multiple gradient echoes can be 
generated during one cardiac phase and hence, multiple lines of k-space can be acquired. The 
acquisition is repeated for every cardiac phase over multiple heartbeats until all lines of k-
space are filled. Although this decreases scanning time, it increases the acquisition window 
for each cardiac phase and hence results in a higher temporal resolution. As for every heart 
beat a segment of k-space is acquired for each phase, turbo gradient flow imaging is also 
called multiple shot imaging or segmented k-space gradient echo imaging.  
 
Figure 2.11 Magnitude image (left) and phase image (middle) acquired during 2D PC flow imaging of the aorta. 
Right: typical cine imaging (4 chamber) of a univentricular heart. 
 
During the flow sequence, data is obtained from different heartbeats. The synchronization of 
data collection over the different heartbeats is achieved by either prospective or retrospective 
gating of the patient’s electrocardiography (ECG) signal. During prospective gating, a trigger 
signal from the ECG starts the acquisition of the images and data is acquired over a 
predefined time during the heart beat, based on a pre-set duration of the heart beat. When 
heart rate varies from the pre-set heart rate during the scan, inaccuracies in acquisition timing 
arise with prospective triggering, which may lead to exclusion of late diastolic flow in the 
flow assessment. With retrospective gating, data collection is continuous while the ECG is 
recorded. As variations in heart rate during retrospective gating result in differences in the 
number of data points per heartbeats an average heart beat interval is calculated and the data 
from the different heartbeats are adapted (stretched or compressed) to fit the average heart 
beat interval. Hereby, an average flow data set is created that contains data from the full 
cardiac cycle. 
2.3.3.2.2  4D phase contrast flow imaging 
During the last decade time resolved three dimensional (3D) phase contrast flow imaging, 
also called ‘4D flow’, has been introduced [119]. By encoding velocity in three spatial 
dimensions in a 3D volume, a complete picture of flow in three dimensions could be acquired 
in the heart and the great vessels. This enables more thorough investigation of the flow 
patterns inside the heart and their role in cardiac diseases. 
Acquisition of this data is achieved in a similar way to 2D PC flow imaging, however instead 
of having a reference image for every velocity direction, three dimensional velocity 
information is efficiently achieved by acquiring three velocity encoded images along three 
orthogonal axes (x, y, z) and subtracting them from one reference image [120]. Data 
collection for every phase is segmented over multiple heartbeats; hence ECG gating and 




Figure 2.12 4-D flow image of a healthy heart. Time resolved path-lines are plotted over the cardiac cycle, blue 
is flow from the RA to the pulmonary artery, red is flow from the LA to aorta. From [121] 
 
After reconstruction of the data, a 3D magnitude and three 3D velocity datasets are generated 
for an average heart beat (see Figure 2.12). Long acquisition times of a 4D flow dataset have 
prevented its use in daily clinical practice [122]. Therefore, speed-up techniques are essential 
to acquire 4D flow images within a reasonable time frame. These techniques rely on reducing 
the amount of data acquired for each image (e.g. under-sampling), while still being able to 
reconstruct an accurate image. This reconstruction can be achieved by exploiting the fact that 
images series contain a high degree of correlations in space and time.  
Three different strategies can be used to exploit correlations between data-points [123];  
correlation in k-space, in time and in both k-space and time (k-t techniques). The first 
technique reconstructs the image using other data-points from the same image, while the 
second reconstructs a missing point with data-points from images in its vicinity in time. K-t 
techniques use both data-points from the image itself and images closely related in time to 
reconstruct the missing data, hereby improving the accuracy of the reconstruction.   
Using the latter strategy, Giese et al. have shown to be able to achieve a net acceleration 
factor of 8, using a strategy called compartment based k-t principal component analysis (k-t 
PCA+) [124]. Using the latter technique together with real time respiratory self gating [125], 
gross scan times between 10 and 15 minutes can be achieved. 
2.3.4  CMR during Exercise 
2.3.4.1  Cardiac assessment during Exercise 
Cardiac function is a major factor influencing exercise performance. In many heart diseases, 
symptoms of early stages of disease are present during exercise before pathological changes 
occur at rest [126]. During exercise or other stress, the heart uses its reserve to improve 
oxygen supply to the body by augmenting cardiac output (CO). Investigation of this cardiac 
reserve can therefore improve the understanding of (patho-)physiological mechanisms in the 
heart, and potentially even improve early detection and treatment evaluation in patients with 
heart diseases.  
Investigation of the heart during exercise is challenging as bodily motion and high heart rates 
complicate both non-invasive imaging techniques and invasive pressure measurements. 
Cardiopulmonary exercise testing (CPET) is the most used techniques to assess exercise 
capacity [127]. By measuring pulmonary gas-exchange, while monitoring ventilation, heart 
rate and electrocardiograms during ergometer or running exercise, CPET allows assessment 
of the functional capacity to perform exercise. As CO is indirectly related to exercise 
performance; CPET allows to indirectly infer cardiac performance. However as direct 
information about the cardiac contractions is lacking during CPET, cardiac function, and 
especially the mechanisms of cardiac dysfunction underlying a pathological CPET result, 
cannot be completely assessed.  
Two techniques that allow direct assessment of cardiac function during exercise are radio-
nucleotide ventriculography and echocardiography. However, both these techniques have 
significant limitations in quantification of cardiac volumes and therefore function, as exercise 
motion and geometrical assumptions result in inaccuracies in volumetric assessment [16]. 
This has led to a great heterogeneity between studies investigating cardiac behaviour during 
exercise [2, 4].  As a result, investigations into cardiac response to exercise have so far been 
limited and, when performed, results are often interpreted cautiously due to the known 
variability in measurements.  
CMR is the current gold standard for the non-invasive quantification of ventricular volumes 
and blood flow in the great arteries, outperforming both echocardiography and radio 
nucleotide ventriculography [118, 128]. Especially as cardiac volumes of both ventricles can 
be reliably assessed, CMR is regarded superior to echocardiography [129].  This makes its 
use for exercise imaging appealing. However, motion artefacts and unreliable ECG-signals 
are inevitable during exercise and result in poor image quality when conventional CMR is 
used [4]. As a result, most researchers have avoided direct imaging during exercise, and 
instead used pharmacological stress as a surrogate [76, 97, 99, 130], or only obtained imaging 
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after cessation of exercise [53, 54].  For pharmacological stress, most authors so far have 
used a dobutamine infusion. Dobutamine (DL-3-4-dihydroxy-N-(3-(4-hydroxyphenyl)-1- 
methyl-n-propyl), is a synthetic catecholamine that increases cardiac output by increasing 
contractility via stimulation of the beta-1 receptors in the heart. At high doses, it also 
increases heart rate and systemic vasodilatation, without a notable effect on the pulmonary 
vasculature [131, 132]. These effects are similar to the HR and inotropic changes seen during 
exercise. However, the question is whether pharmacological stress mimics the complete 
physiological exercise response. The bodily response to exercise encompasses a system of 
physiological factors that impact cardiac function: sympathetic stimuli directly impact cardiac 
contraction, heart rate and arterial vascular tone, and skeletal muscular contractions and 
heavy breathing impact venous return and pulmonary blood flow.  The absence of a total 
systemic exercise response during infusion of dobutamine might therefore result in a stress-
state that is not comparable to normal physiology, leading to erroneous conclusions. Only one 
study so far reported on this issue [133]. This study showed similar SV and HR responses 
during exercise and high dose dobutamine infusion (20mcg/kg/min), but reported differences 
in contractility (more pronounced during dobutamine stress) and EDV (a slight fall during 
dobutamine stress) between the two groups. Unfortunately, the scientific value of this study 
was poor, as they used two small groups (one undergoing exercise, the other one undergoing 
dobutamine stress) and, therefore, could not rule out the impact of differences between the 
two groups on the observed results. 
2.3.4.2  Current Exercise CMR Techniques 
As explained in the previous sections, CMR provides imaging that allows reliable assessment 
and quantification of myocardial function and blood flow in a non-invasive manner. To 
obtain the high quality of CMR imaging, images are not taken in real time, but constructed 
from k-space data obtained over a multitude of heartbeats, during a state of minimal extra-
cardiac motion. Consequently, the subject undergoing CMR needs to be completely still 
during imaging, and often hold their breath, as any bodily motion significantly distorts the 
acquired images. 
To overcome the difficulties with motion and ECG acquisitions, several groups have diverted 
to measuring cardiac function before, during short breaks and / or immediately after cessation 
of exercise using conventional or accelerated image acquisition [7, 134, 135]. However, due 
to changes in heart rate, muscle activity and fast recovery in healthy individuals after 
exercise, such methods might not provide a true reflection of exercise physiology.  
Other groups have used highly accelerated phase contrast flow acquisitions during exercise 
[8, 136–138]. Mostly in order to obtain a measure of cardiac output during in-MRI cardio-
pulmonary exercise tests. Unfortunately validation of these methods during exercise often 
lacks. Furthermore, they only allow flow assessment and therefore cannot explain the 
underlying changes in cardiac function.   
Recent developments in acceleration techniques now allow imaging at very high temporal 
resolution (35-50 milliseconds), allowing near ‘real time’ dynamic imaging. Imaging at these 
such speed means that motion does not significantly blurry the images, as the displacement 
during image-acquisition is only minimal. Whereas image quality suffers due to the high 
acceleration factors needed for real time imaging, these sequences potentially allow imaging 
during exercise. Two research groups have been developing strategies for exercise CMR 
using real time imaging in the last 5 years: Lurz et al. [139] and La Greche et al. [4]. Both 
groups use real-time, free-breathing, ungated steady state free-precession (SSFP) cine 
imaging to assess ventricular volumetrics and have shown to be able to quantify cardiac 
volumes during moderate (Lurz et al.) up to sub-maximal (La Greche et al.) exercise 
intensities. Lurz et al. developed a customized real time imaging sequence, that utilized a 
radial sampling pattern and unfolded-SENSE acceleration to achieve high temporal resolution 
(~30milliseconds) [139]. They acquired a stack of real time images in a short temporal 
window (2-3 heart beats) in short axis orientation and quantified cardiac volumes without 
taking into account respiratory motion. La Gerche et al. have a different approach [4]. They 
modified a routinely available un-gated cartesian sampled SSFP sequence using routine 
acceleration techniques (half-Fourier transform, half-scan, and SENSE under-sampling) to 
achieve a temporal resolution of (~35 milliseconds). Furthermore, they developed a dedicated 
exercise CMR analysis software (RightVol, KU Leuven, Belgium) that allows manual 
correction of respiratory motion [4]. By acquiring images over at least one respiratory cycle 
per slice, they were able to identify target end-diastolic and end-systolic images at end-
expiration. This way, they avoided a bias in volumetric assessment that results from through 
plane motion of the heart during respiration. 
Both groups also differ in their mode of exercise during CMR. Lurz et al. used an ergometer 
in which patients move their straight legs up and down. This form of exercise uses only a 
small part of the leg muscles, which is reflected by a maximal workload (< 22.5 Watts) 
during the scans that was significantly lower than the maximal workloads that were achieved 
by La Gerche et al. using a supine bicycle ergometer (218±52 Watts) [4] and upright CPET 
(225-600 Watts) [140, 141].  
The exercise CMR methods discussed above demonstrate the potential feasibility of exercise 
CMR. Real-time CMR seems to be a good solution to obtain CMR images that are not, or 
minimally, affected by motion. However, a downside of real time imaging is the large 
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amounts of images acquired. This results significant variation in quantified volume as instead 
of a single averaged beat in conventional cine CMR, operators choose new ED and ES target 
images for each slice out of multiple beats. Furthermore, manual respiratory correction leads 
to significantly longer processing times for exercise CMR compared to normal cine CMR. 
These issues demonstrate a clear scope for further development of Exercise CMR imaging 
and processing techniques in order to facilitate its use in routine clinical research studies. 
Part II:  Original Contributions

Chapter 3  Exercise CMR set-up 
3.1  Introduction 
In order to successfully perform Exercise CMR, several adaptions had to be made to the 
scanner set-up and the image acquisition process. In this chapter, the development of the 
exercise CMR protocol is described. Firstly, the bicycle ergometer equipment and adaptions 
to the MRI scanner will be discussed in Section 3.2. Next, a method for acquisition of blood 
pressure waveforms during exercise CMR is introduced in Section 3.3. Finally, the 
development of the exercise CMR imaging protocol is described in Section 3.4. Different 
imaging strategies can potentially be used for exercise imaging. Here the different in-vitro 
and in-vivo experiments executed to assess CMR and bicycle adaptions for Exercise CMR 
are described. 
3.2  CMR bicycle set-up 
In order to allow strenuous physiological exercise during CMR scanning, a bicycle ergometer 
must first be integrated with the MRI scanner. Several MRI-compatible bicycles have been 
developed. Whereas these bicycle ergometers could technically be used during MRI-
scanning, their use is often restricted to out-of-bore cycling for CMR [142]. The reason for 
this is the fact that during CMR scanning, with the chest in the iso-centre of the MRI scanner, 
the knees hit the bore while cycling due to the small size of most MRI bores (60 cm) 
combined with a relative high position of the bicycle, which is mounted with a frame onto the 
top of the table, resulting in a relative large angle of the knees. To allow exercise inside the 
bore, several groups have developed a customized bicycle or adapted existing systems [4, 7, 
143].  
In King’s College London, a Lode MRI compatible bicycle ergometer was available. 
However, this ergometer could only be used to exercise subjects outside the bore prior to 
imaging, due to physical restraints when cycling inside the bore (knees hitting the bore) 
[142]. This system was therefore taken apart and adapted for in-bore exercise. Firstly, the 
ergometer was migrated from an Achieva 1.5T MRI scanner to an Ingenia 1.5T MRI Scanner 
(both from Philips, The Netherlands). The Ingenia MRI scanner has a larger bore than the 
Achieva system, 70 instead of 60 cm. As is illustrated in Figure 3.1, this difference in size 
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results in a significant larger space at the top of the bore, making more room for the knees 
during cycling.  
Next, adaptions to the bicycle and the mechanism that attaches it to the table were made to 
further improve the ability to cycle while scanning. In order to lower the bicycle as far as 
possible, the mounting frame (6 cm high) was disposed and the bicycle was directly attached 
to a new CMR table, resulting in a dedicated ergometer bed for Exercise CMR. Additionally, 
the length of the cranks of the bicycle was adapted to decrease the radius of the rotations 
made during cycling. Altogether, these adaptions resulted in a decrease of maximal knee-
height during cycling of 5-12 cm, dependent on the subject’s posture.  
 
Figure 3.1 Illustration of the effect of increased bore size. A greater bore size significantly improves vertical 
available space inside the bore, hereby increasing the maximal angle of the legs inside the bore and enabling 
supine bicycle ergometer exercise. 
 
After the above-described adaptions, the bicycle ergometer system allowed in-bore cycling 
with the chest in the iso-centre of the scanner in subjects ranging in height from 160 cm to 
200 cm. However, strenuous cycling inside the MRI bore was still restricted as the power 
related to cycling resulted in upward shift of the body, ultimately pushing the participants 
away from the bicycle. This shift of the body did not only restrict the intensity of cycling, but 
also resulted in errors in image acquisition as the subject’s movement changed the position of 
predefined target geometries. To restrict the body motion during cycling, a handgrip system 
was designed. This plastic system was build to fit onto the MRI bed and allowed exercising 
subjects to hold themselves in place while cycling at high power. Additionally, the imaging 
protocol was adapted to include a rapid check of geometries prior to imaging at each exercise 
level. This check was performed using the ‘interactive’ b-SSFP sequence (a dynamic scan 
sequence routinely available on Philips MRI scanners to facilitate planning of geometries).  
Finally, the coil set-up was changed to reduce image-artefacts. The Ingenia scanner (Philips, 
the Netherlands) utilizes a large body-coil for CMR. This coil is placed directly on the chest 
of the subject during CMR. However, cycling movements resulted in significant motion of 
the coil during exercise, leading to a decreased image quality.  In order to stabilize the coil, 
two plastic coil bridges were designed to hold the coil away from the body. This resulted in a 
significant improvement of image quality.  
 
Figure 3.2 Exercise CMR set-up. Upper left: bicycle ergometer customization. Upper Right: Custom-build 
handgrip system that decreased body motion. Below: Exercise CMR set-up with coil bridges and handles. 
 
3 .3  Measuring blood pressure during exercise CMR 
Afterload of the heart is an important factor influencing cardiac function, especially during 
exercise [2]. Direct assessment of afterload requires invasive central aortic pressures. 
However, as such measurements are challenging to obtain, non-invasive brachial blood 
pressures are often obtained as a surrogate measure for the assessment afterload [144]. In this 
section, the development and validation of Exercise CMR blood pressure assessment is 
described. 
3.3.1  Introduction 
Automated blood pressure cuff measurements allow accurate assessment of mean, systolic 
and diastolic pressure. In some cases, such as the Centron, a pressure waveform over a full 
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cardiac beat can be obtained [145].  Unfortunately, automated blood pressure devices often 
rely on oscillation waves for the measurement of blood pressure. As significant muscle and 
body motion occurs during exercise these oscillation waves are disturbed. As a result, 
automated blood pressure devices are notoriously inaccurate during exercise. To overcome 
this problem, manual assessment of blood pressure using auscultation is often performed 
during routine clinical exercise tests.  
Manual blood pressure measurements are not feasible during exercise CMR, as the subject is 
positioned inside the MRI bore and there is not enough physical space to measure brachial 
blood pressures. Furthermore, manual measurements only allow determination of systolic and 
diastolic pressures, whereas assessment of the full waveform was desired in order to support 
future work in the development of computational algorithms that allow determination of the 
central aortic waveform based on peripheral pressure waves [146]. Finapress (FMS, the 
Netherlands) allows continuous non-invasive radial blood pressure waveform assessment. It 
uses the so-called volume-clamp technique to determine blood pressure based on the changes 
in arterial dimensions [147]. The Finapress measurements are less disturbed by bodily 
movements and therefore allow measurement during exercise [148].  The only downside to 
this system is that it needs intermittent calibration (using conventional brachial oscillometry) 
in order to prevent a drift in pressure measurements. As oscillometry has proven not to work 
during exercise, we aimed to develop a novel method for acquisition and calibration of blood 
pressure waveforms, based on the Finapress system, that was suitable for use during supine 
physiological exercise inside the MRI bore. 
3.3.2  Developed blood pressure system 
In order to obtain adequate calibration of the Finapress blood pressure waveforms, a system 
was build utilizing the cessation of pulsatile flow in the radial artery during total occlusion of 
the ipsilateral brachial artery. This total occlusion of the brachial artery was obtained using an 
inflation oscillometer (Omron IM, the Netherlands), which was reprogrammed to inflate the 
brachial blood pressure cuff at a continuous rate from 50 – 200 mmHg (ramp: 14 mmHg / 
second). By simultaneous analysis the Finapress signals and the Omron inflation, the moment 
of cessation of pulsatility in the Finapress signals could be related to the pressure in the 
brachial cuff. This allowed calibration of the Finapress signal to a systolic blood pressure. 
In order to obtain this point, pressure signals of both the Omron device and the Finapress 
waveform were transmitted to a desktop computer using a PowerLab analog and digital 
receiver (AD Instruments, United Kingdom).  Brachial cuff pressure was measured directly 
from the cuff using a pressure transducer, while the Finapress pressure waveform signal was 
sourced electronically from the Finapress device. Both signals were displayed simultaneously 
using LabChart (AD Instruments, United Kingdom). After acquisition, the Finapress 
waveforms were exported to Matlab (MathWorks, USA) and rescaled based on the obtained 
systolic measurement. See Figure 3.3A a schematic of the set-up (Fina-method) and Figure 
3.3B for an example of the systolic blood pressure assessment.  
 
Figure 3.3 Measuring blood pressure during exercise CMR using Finapress (FMS, The Netherlands) combined 
with a ramped inflation of a brachial blood pressure cuff. A) Schematic of the acquisitions and their integration 
into one system. B) Using the two aligned signals, the systolic blood pressure can be determined as the pressure 
in the brachial cuff at which pulsatility is lost in the Finapress waveform.  
 
3.3.3  Validation 
The developed set-up was validated against manual blood pressure measurements in 10 
subjects during a supine exercise using the set-up of the Exercise CMR. The aim was to 
investigate how accurate the developed system could identify the systolic blood pressure 
value, in comparison to the standard manual auscultation. Systolic pressures were measured 
during low, moderate and sub-maximal exercise, corresponding to a heart rate of 80-90, 100-
115 and 140-155 respectively. Blant-Altman analysis of systolic and diastolic blood pressure 
was performed. The results showed excellent agreement between the two methods, with a 
mean difference of 0.5±3.87 mmHg. As shown by the Blant Altman plots in Figure 3.4, 
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individual measurements have some variability, however the limits of agreement of ±7.4 
mmHg (±6%) are satisfactory for blood pressure measurements.  
 
Figure 3.4 Blant Altman Analysis of difference in mean systolic pressure measurement using Fina-method 
compared to manual auscultation during supine bicycle ergometer exercise. Middle (grey) line represents mean 
diference, upper and lower thick lines represent limits of agreement. 
 
Subsequently the diastolic pressures obtained from the rescaled Finapress waveforms were 
compared to the diastolic pressure obtained manually. As shown in Figure 3.5, there is a 
larger variability in diastolic pressures obtained with the two methods compared to the 
variability in systolic pressures, with a mean difference of 1.96±4.2 mmHg and limits of 
agreement of ±8.4 mmHg (±14%). This larger variability in diastolic blood pressures 
obtained with the two methods could be the result of inaccurate rescaling of the Finapress 
waveform. However, it can also be due to inaccurate measurements during manual 
auscultation, which is known to be inherent to the method, and is likely to be exaggerated due 
to difficult assessment of the diastolic Korotkoff sounds during exercise [149].  
Based on these results, it can be concluded that the developed system for blood pressure 
assessment allows for accurate measurement of systolic blood pressure during supine 
physiological exercise from low up to sub-maximal exercise intensity levels. Diastolic 
pressures were potentially less reliable, but are still within acceptable window of agreement 
for exercise CMR.   
 
Figure 3.5 Blant Altman Analysis of difference in mean diastolic pressure measurement using Fina-method 
compared to manual auscultation during supine bicycle ergometer exercise. Middle (grey) line represents mean 
diference, upper and lower thick lines represent limits of agreement. 
 
3 .4  Development of exercise imaging protocol 
Part of this work (CASPR-TIGER cine evaluation experiments) was done in collaboration 
with Dr. M. Usman. Part of the experimental work was publish in [150]. 
As previously described, the lack of a good ECG signal, the inability to breath hold and 
bodily motion severely limit the use of conventional imaging during exercise. Real-time 
imaging can overcome these problems, as these sequences are not ECG gated and can be used 
during motion without significant distortion of the images. Whereas several real-time 
imaging protocols have been described, they are not standardly available on each MRI 
scanner. Furthermore, their performance during exercise has only limitedly been investigated. 
In order to develop a robust imaging protocol for Exercise CMR, several imaging strategies 
were tested for their suitability for exercise CMR.  
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3.4.1  Evaluation of real t ime imaging 
In order to analyse cardiac volumes during exercise, a stack of cine CMR covering the full 
heart needs to be acquired. As explained previously, real-time imaging is the most suitable 
option to do this during exercise, as it yields high quality imaging independent of an ECG 
signal and with limited motion distortion. La Gerche et al. have previously demonstrated the 
use of a SENSE accelerated balanced steady state free precession (b-SSFP) sequence for 
exercise imaging [4]. This sequence appeared to be robust, but has reduced image quality 
compared to conventional b-SSFP cine imaging. Furthermore, this sequence is acquired in 
real-time without motion correction. As a result, target images need to be manually selected 
at a fixed point in the breathing cycle from a large series of images per slice (typically >100 
frames / slice). This process is time and labour intensive and limits the frequent use of 
exercise CMR in clinical research.  
Recently several more complex acceleration and image-reconstruction techniques have 
become available that can potentially improve real-time imaging for Exercise CMR. An 
example of such an acceleration technique is K-T BLAST. K-T BLAST is an adaption to the 
conventional SENSE sparse sampling of k-space [123]. K-T BLAST takes into account not 
only sparse sampling in the k-space of one image (the ‘K’ factor), but also sparse sampling of 
data over multiple images (the ‘T’ factor). By utilizing the similarity between two subsequent 
images, K-T acceleration needs less ‘K’ data per image, and therefore higher acceleration 
factors can be achieved than using normal ‘K’ only SENSE acceleration. Alternatively, 
similar acceleration can be achieved with better image quality compared to SENSE alone. K-
T BLAST is currently available on all Philips CMR scanners and might potentially improve 
real-time cine imaging for Exercise CMR by providing better image quality in similar highly 
accelerated acquisitions.  
Although K-T BLAST can improve quality of the real-time imaging, the large amount of 
images and labour intensive analysis of images remains a drawback for Exercise CMR. Self-
navigated acquisitions, acquisitions in which the images are gated before reconstruction 
based on the k-space samples, can potentially solve this problem. Recently, Usman et al. 
proposed a technique for self-gated, free breathing, ECG-free cine CMR at rest [150, 151]. 
This technique is based on a golden angle radial k-space acquisition and uses a variant of 
radial / spiral golden angle k-space image acquisitions; CArtesian trajectory with Spiral 
PRofile ordering and TIny Golden angle step for Eddy current Reduction (CASPR-TIGER). 
The advantage of using a ‘golden angle’, 111.25°, or one of its variants, is that k-space is 
homogeneously sampled through time. This means that theoretically, even with as little as 3-
4 k-space lines, an image can be reconstructed, as information is homogeneously present in 
all parts of k-space. This feature was used during motion correction. Initially, two image sets 
are reconstructing from the acquired data (one high temporal resolution and one low temporal 
resolution image). Based on these images, motion is estimated using image-processing 
algorithms to estimate cardiac and respiratory motion [151]. Based on these motion signals, 
k-space data is reordered and binned into cardiac phases at a desired respiratory state (end-
expiration) and the final cine image sequence is reconstructed from the original k-space 
acquisitions without the need of breath holding or an ECG signal. Whereas this sequence is 
not widely available, its ability to allow real time gating with automated gating can be a 
significant benefit for the acquisition and analysis of cine CMR during exercise. 
3.4.2  Methods 
Three different real-time cine acquisition strategies were sequentially tested for their 
suitability in Exercise CMR in order to find an optimal imaging strategy: 1) a free-breathing 
self-gating (‘CASPR-TIGER’) cine imaging, 2) a K-T blast accelerated b-SSFP cine 
sequence (‘K-T BLAST’) and 3) the SENSE-accelerated b-SSFP approach of La Gerche et 
al. [4] (‘rt-SENSE’). The imaging parameters for each acquisition, including a conventional 
ECG gated, breath held cine acquisition for reference, are shown in Table 3-1. In short, all 
imaging sequences were accelerated to obtain a temporal resolution / frame of ~35-40 
milliseconds. The rt-SENSE acquisition had the lowest spatial resolution, while CASPR-
TIGER had the highest. All imaging was evaluated in a sequential process: 1) Image quality 
was assessed at rest using the Exercise CMR set-up (including bike and coil n coil bridges), 
2) If image quality at rest was sufficient, rest volumes were compared to a conventional ECG 
gated and breath held cine acquisition (‘REFcine’). 3) All acquisitions that scored sufficiently 
in step two were then assessed of robustness and quality of the images during exercise. Based 
on these experiments, the ‘best acquisition’ for exercise CMR was chosen. 
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Table 3-1 Image parameters of the investigated real time sequences and a ECG gated, breath hold reference 
sequence (REFcine). Rec. represents reconstructed. 
 
3.4.3  Results 
3.4.3.1  Image quality at rest 
All three imaging sequences were tested at rest using the bicycle set-up. The presence of the 
bicycle ergometer was important as potential artefacts on the images caused by the exercise 
equipment can be anticipated. See Figure 3.6 for an illustration of the images acquired during 
the different acquisitions. There is a clear loss of image quality in real-time imaging. The 
CASPR-TIGER sequence came closest to the original imaging quality, despite several 
streaking effects that are inherent to the acceleration technique used. There was also a mild 
degree of temporal blurring present in the images. The K-T BLAST suffered significant 
artefacts. Further investigation showed that these artefacts reduced significantly when the 
bicycle was turned off, and even more if the bicycle was taken out of the room. The quality of 
K-T BLAST limited analysis of cardiac volumes. As the artefacts were related to the bicycle, 
and even at rest imaging was already insufficient, the K-T BLAST sequence was ignored for 
further assessment. The rt-SENSE acquisition had mildly decreased image quality, but was 
sufficient for cardiac analysis. 
 
Figure 3.6 Image Quality of the different real-time acquisitions for Exercise CMR. Acquisitions were all made 
at rest. Most left image is the current standard ECG-gated, breath hold cine acquisition for comparison. Note 
significant artefacts in K-T BLAST acquisition. 
3.4.3.2  Volumetric Analysis at rest  
The CASPR-TIGER acquisition showed the best results in the initial image quality screening. 
Therefore this sequence was tested first for use during real-time imaging. The sequence was 
evaluated in 8 healthy volunteers. Total acquisition time of a short-axis stack was 1 minute 
and 10 seconds. Due to the complexity of reconstruction, the images could not be directly 
viewed on the scanner. After downloading the raw data, a 4,5 hour offline reconstruction was 
needed before obtaining images. As a result, it was not possible assess planning or potential 
errors in the acquisition until after the CMR exam had finished. The comparison of cardiac 
volumes obtained using the CASPR-TIGER and REFcine scans is shown in the Blant Altman 
analysis in Figure 3.7. As shown, there is a relative large error in end-systolic volumes (limit 
of agreement: ± 9.4 ml). Inspection of the data showed that this difference was mainly caused 
by errors in the cardiac gating during reconstruction, resulting in allocation of image data to 
wrong cardiac phases, combined with the temporal blurring present in the images. The 
CASPR-TIGER method did perform suboptimal during the imaging trail at rest: the image-
processing time was long and did not allow direct quality control during imaging. 
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Figure 3.7 Blant-Altman Analysis of cardiac volumes with CASPR-TIGER (A) and rt-SENSE (B) 
acquisitions versus reference standard acquisition (REFcine). Upper and lower lines are limits of agreement 
(+2SD and -2SD lines) of the acquisitions with respect to REFcine. Middle line is mean difference from 
REFcine. 
 
Additionally there were some inaccuracies in volume quantification. Therefore, the rt-SENSE 
acquisition was evaluated as a potential strategy. Despite the mildly lower image quality, rt-
SENSE acquisitions yielded good results for volume quantification with high correlation in 
obtained cardiac volumes between rt-SENSE and REFcine, see the Blant-Altman analysis. 
Note that the limits of agreement suggest a smaller error between rt-SENSE and REFcine 
than between CASPR-TIGER and REFcine. An additional benefit of rt-SENSE was that 
images were readily available during acquisition, allowing correction of potential errors in 
planning of images and identification of artefacts. 
3.4.3.3  Image quality during exercise   
In order to make a final decision which acquisition to use for volumetric assessment during 
Exercise CMR, the CASPR-TIGER and rt-SENSE acquisitions were assessed for quality 
during exercise, see examples in Figure 3.8. Note the significant blurring of the CASPR-
TIGER acquisition. In-depth analysis of the origin of this blurring showed that the motion-
estimation algorithm in the reconstruction framework, used to detect breathing motion and 
cardiac beating, failed to accurately detect the cardiac phases during high heart rates. As a 
result, data was misallocated to the wrong cardiac phases, which led to the observed temporal 
blurring. The rt-SENSE acquisition is reconstructed frame by frame, each consisting of a 
complete k-space acquisition in 35 milliseconds. Therefore, this acquisition was not sensitive 
to such problems. rt-SENSE was robust, without significant artefacts and only mild blurring 
at heart rates >130 bpm. 
 
Figure 3.8 Quality of images during supine bicycle ergometer exercise. Note the significant blurrying in the 
CASPR-TIGER acquisition. There is notably less blurring seen in the rt-SENSE acquisition.  
 
 
3.4.4   Discussion 
In this section, three different real-time (ungated, free-breathing) MRI sequences were 
evaluated for their potential use for cardiac volume assessment during exercise. In order to 
capture information at a high enough resolution, all sequences were accelerated to obtain a 
frame-rate of <40 milliseconds. The first sequence, CASPR-TIGER, used a recently 
developed golden angle radial k-space sampling trajectory combined with compressed sense 
imaging. This sequence previously showed to allow very high acceleration factors while 
retaining image quality at rest [150]. Furthermore, during reconstruction of the images, 
breathing and cardiac motion are automatically corrected, which could have benefited 
quantitative analysis of Exercise CMR. The second (KT-BLAST) and third (rt-SENSE) 
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sequences did not have this retrospective motion correction, resulting in a long series of real-
time images of the heart over multiple heartbeats and respiratory cycles. 
First image quality at rest was evaluated. This test that the KT-BLAST sequence was 
susceptible for artefacts of the exercise bicycle, resulting in severe distortion of the 
reconstructed images. Therefore, this technique was abandoned and not included in further 
analysis. The two remaining sequences, CASPR-TIGER and rt-SENSE showed both to allow 
reliable quantification of cardiac volumes at rest, agreeing well with a standard (reference) 
ECG-gated breath hold short-axis cine acquisition. The error in volume assessment in the 
CASPR-TIGER acquisition was larger than the error of the rt-SENSE acquisition. This was 
the result of small misallocations of k-space data in the cardiac phases, leading to blurring of 
the images.  
After the tests at rest, the CASPR-TIGER and rt-SENSE acquisition were evaluated for their 
performance during exercise. It was not possible to acquire the reference standard (REFcine) 
during exercise (due to bodily motion and a lack of ECG). Therefore, only image quality was 
assessed in this experiment. As expected based on previous work from La Gerche et al. [4], 
the rt-SENSE acquisition performed well, with nearly no blurring of the images and no 
significant artefacts. The CASPR-TIGER acquisition, however performed significantly 
worse. The reconstructed images of the CASPR-TIGER acquisition were significantly 
blurred. This was caused by a significant increase in misallocation of data in cardiac phases 
due to the high heart rate and was further worsened, as the algorithm was unable to correct 
the significant bodily motion during exercise.  
Based on these experiments rt-SENSE was therefore chosen as the most optimal image 
sequence for quantitative assessment for cardiac volumes during Exercise CMR. rt-SENSE 
allowed robust imaging, even during high exercise intensities. Unfortunately, the downside of 
this technique is that the acquisition does not include motion correction. This makes analysis 
of cardiac volumes prone to errors and labour intensive.  
3.5  Conclusion 
In this chapter, several acquisition methods were evaluated for their suitability for use during 
exercise CMR. It was demonstrated that rt-SENSE acquisition was the best performing 
acquisition for cardiac volumes during exercise. Therefore, this sequence was chosen for 
further development in the Exercise CMR protocol. A downside of the rt-SENSE acquisition 
is that this acquisition results in a large series of real time images over multiple heartbeats, 
without respiratory or cardiac motion compensation. In the next Chapter, this problem is 
addressed by developing a reconstruction pipeline to yield a conventional cardiac and 
respiratory-gated cine stack from the rt-SENSE acquisition. 

Chapter 4  Retrospectively gated Exercise 
CMR 
This Chapter was adapted from the following publication: Ruijsink et al. LCNS 2017 [152] 
4.1  Introduction 
As explained in Chapter 1, assessment of cardiac volumes, function and wall motion using 
cardiac magnetic resonance imaging (CMR) during physiological stress (exercise) has a great 
potential to improve early diagnosis, treatment evaluation and prognostic stratification in 
patients with heart disease. In the previous chapter, the initial set-up of Exercise CMR and 
development of a highly accelerated, near real-time, imaging protocol was explained. The 
resulting exercise CMR protocol allows imaging during exercise without motion corruption 
of the images. However, the obtained images are not cardiac nor respiratory gated. As a 
result, through-plane motion of the heart during respiration and bodily movements during 
exercise can lead to significant errors in quantification of cardiac volumes and function from 
the real-time images [9]. The lack of cardiac gating also leads to inconsistent timing of 
cardiac phases between slices, as imaging is started at each slice in a random point in the 
cardiac cycle. This further complicates comprehensive analysis of myocardial function, as it 
does not allow 3-dimensional assessment of myocardial wall motion abnormalities. Finally, 
instead of reconstructing a single heartbeat, the real time image sequence results in an image 
sequence of multiple heartbeats. This increases analysis time, as the operator needs to search 
for a representative beat, and leads to further errors in volumetric analysis as the variation in 
target images chosen by operators increases inter- and intra observer variability. Altogether, 
these factors introduce significant challenges to the use of real-time exercise imaging for 
clinical research applications. 
To account for respiratory motion during free-breathing CMR, a navigator echo is typically 
added to CMR sequences [153]. While valid for CMR at rest, this method reduces temporal 
resolution of dynamic imaging. This makes it unsuitable for imaging during exercise, as high 
heart rates require a very high temporal resolution (<40 ms / frame). Several self-navigating 
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(SG) sequences have recently been developed to account for respiratory and cardiac motion 
during CMR. In SG, target motion is estimated directly from the acquired data. As a result, 
most SG techniques do not increase scan-time or reduce temporal resolution. SG techniques 
can be divided in image-based, k-space based, and model-based approaches.  
Image-based SG relies on registration of high quality dynamic images based on motion 
signals derived from lower temporal or spatial dimensional images reconstructed from the 
same dataset [151, 154–156]. K-space based methods derive the respiratory signal from 
central k-space lines [157–159]. Finally, model-based approaches have been proposed for 
motion detection in CMR. An example of such an approach is described by Yoon et al. [160] 
who use a low-rank method that separates the background of the image mathematically from 
the dynamic portions. Although the above described SG techniques have great potential for 
imaging during exercise, the proposed methods rely on complex k-space trajectories, such as 
radial [154, 155] or golden angle radial [151, 156, 158] acquisition schemes, and 
computationally intensive reconstruction frameworks. Such techniques are currently not 
widely available in a clinical CMR environment, limiting their use for clinical exercise CMR. 
An exception to this is the method proposed by Hansen et al. [161]. Their image-based 
method for respiratory gating of cardiac images obtained at rest utilized a real-time CMR 
sequence that is standardly available on commercial MRI systems. However, proposed 
technique requires ECG waveforms for cardiac gating; a strategy that is not feasible for 
imaging during exercise as ECG signals are significantly disturbed due to body motion. 
The aim of this chapter is to develop an image-processing framework that reconstructs a 
respiratory and cardiac gated cine CMR stack from real time CMR data obtained during 
exercise. Obtaining such a gated cine stack, similar to the ones normally used during rest 
CMR, would significantly improve the assessment of cardiac volumes, function and wall 
motion during strenuous physical exercise. To maximise the application of the developed 
technique in a clinical CMR environment, several criteria were determined prior to 
development: 1) the method needed to have minimal user interaction, 2) the processing time 
of the reconstruction framework needed to be minimized to be within clinical standards and 
3) the method needed to be able to be flexibly applied to images from all imaging platforms 
without the need for advanced sequence programming or the use of intensive computing 
power. 
The developed framework is described in 4.2, followed by a validation of the technique in 4.3 
and finally a discussion of the technique in 4.4. This chapter shows that the developed 
technique is able to reconstruct gated cine images with improved image quality and lower 
inter-and intra-observer variability compared with non-gated RT imaging. Further, this 
section demonstrates that the proposed solution allows detection of a pathological cardiac 
response to exercise in patients with a complex congenital heart disease. 
4.2  Methods 
The proposed strategy involves (i) acquisition of highly accelerated dynamic (real-time) MRI, 
as described in Chapter 3 followed by (ii) image-based cardiac synchronisation, (iii) image-
based respiratory gating and (iv) motion correction and reconstruction of a 24-30 phase 
cardiac cine image stack.  The main novelty of the proposed method lies in the clinical 
applicability of our semi-automatic, image-based reconstruction framework that creates 
respiratory and cardiac gated cine images of the heart during exercise without the need for 
intensive computing power or advanced cMRI pulse-sequences.  The proposed framework is 
illustrated in Figure 4.1. The reconstruction pipeline was implemented in MATLAB R2015b 
(MathWorks, Natick, USA) utilizing the signal processing, image processing and statistics 
toolboxes. This study has been approved by the regional ethics board (REC: 15/LO/522, 
Bloomsbury London, UK) and informed consent was obtained from all participants. 
4.2.1  Highly Accelerated Dynamic CMR 
The reconstruction pipeline relies on near real-time (temporal resolution of < 40 ms) dynamic 
imaging. Such temporal resolution can currently be achieved on all major commercially 
available MRI scanners using vendor supplied acceleration techniques without the need of 
advanced user settings. In this work, images were acquired on a 1.5T MRI scanner (Ingenia, 
Philips Medical, Best, The Netherlands).  The real time image sequence used was explained 
in detail in Chapter 3. In short, steady-state free precession imaging was performed without 
cardiac gating. 80-100 consecutive frames were acquired per slice in a short axis orientation, 
with a slice thickness of 8 millimetres. Imaging parameters were: field of view, 300 x 260 
mm (approx.); flip angle 50°; SENSE factor 3 (Cartesian k-space undersampling); partial 
Fourier factor 0.5, repetition time 1.8 milliseconds, echo time 0.9 milliseconds and 
reconstruction-matrix, 128 x 112, resulting in a reconstructed voxel size of 2.3 x 2.3 x 8 
millimetres and a frame rate of ~35 milliseconds. Total acquisition time for a short axis stack 
was ~55 seconds. After the acquisition, images were automatically loaded into Matlab and a 
region of interest around the heart (cROI) and a centre point for the LV were manually 
selected on an average of all images to facilitate the reconstruction process. This is the only 
manual step of the reconstruction pipeline. 
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4.2.2  Cardiac Synchronisation 
ECG signals, routinely used for cardiac gating in CMR, are significantly distorted during 
physical exercise. However, the high temporal resolution of the real-time acquisition allows 
for direct estimation of the cardiac periodicity from the images, as was previously 
demonstrated by Van Amerom et al. [162]. This proposed technique was integrated in the 
developed framework in collaboration with Dr Josh van Amerom. In order to obtain cardiac 
gating, the cardiac periodicity was estimated by detecting the changes in blood pool contrast 
during ventricular contraction. From the cROI, the mean contrast signals were calculated for 
each frame and the Fourier transformation was applied to examine the signals in frequency 
domain. By plotting the frequency spectrum of the signal, the periodic changes in contrast of 
the blood pool (caused by beating), appear as peaks (local maxima). The local maxima were 
subsequently detected, as shown in Figure 4.2A, and the heart rate was calculated. A filter 
was applied to detect only maxima in a range of fundamental frequencies (0.8-2.8 Hz), 
corresponding to heart rates of 45 to 170 beats per minute (bpm). Subsequently, each frame 
was binned to an associated cardiac phase based on the cardiac time interval. For HRs < 130 
bpm, the cardiac time interval was divided in 30 equally spaced cardiac phase bins, whereas 
for higher HRs the frames were divided into 24 cardiac phase bins. In both cases, the 
temporal resolution (in cardiac phases) of the cine reconstructions was in keeping with 
routine CMR cine imaging [163]. 
4.2.3  Respiratory Gating 
In order to resolve high quality gated cine imaging of the heart, respiratory motion needs to 
be corrected. We therefore applied Laplacian Eigenmaps, a Manifold Learning (ML) 
technique, in order to automatically estimate the respiratory motion in each slice in the 
imaging stack based on image intensity [151]. ML projects a higher dimensional manifold 
(e.g., an image of large dimensions) to a corresponding low dimensional representation. By 
assessing such lower dimensional representation over time, bulk changes in the image states 
can be assessed. Theoretically, this means that large changes in the images, such as breathing 
effects, can be identified in the lower dimensional representation of the total image, without 
the need of locating a navigator signal over the diaphragm, and with little impact of potential 
local image artefacts resulting from high acceleration factors. Indeed, previous work has 
shown that the ML technique is able to accurately estimate a 1D representation of respiratory 
motion from cardiac imaging at rest [151]. The ML respiratory motion estimation was 
implemented from the previous work in collaboration with Dr Mohammed Usman and 
adapted for use in highly accelerated dynamic imaging during exercise. As the ML estimated 
respiratory signal might have cardiac component due to high temporal resolution of real-time 
images, the acquired ML signal was filtered in the frequency range of 0.1 - 0.5 Hz in order to 
retain the respiratory component only. The resulting respiratory signal was plotted and a 
predefined respiratory gating window was used to select the images at end-expiration (20% 
of respiratory movement from maximal expiration) for further reconstruction, see Figure 4.1. 
This gating window is equivalent to a ~6-8 mm gating window using respiratory navigator 
conventionally applied during CMR at rest. Figure 4.2B shows an example of the ML 
estimated respiratory signal overlaid on a spatio-temporal intensity profile of the real time 
image acquisition through diaphragm, demonstrating the accuracy of the obtained respiratory 
signal. 
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Figure 4.2 (A) Range of fundamental frequencies (0.8 - 2.7 Hz) of the temporal frequency domain, estimated 
cardiac rate on the ROI appeared as the maxima (red arrows). (B) Estimated respiratory signal (red line) overlay 
to a spatio-temporal intensity profile through diaphragm. 
 
4.2.4  Cine Reconstruction 
The previous cardiac and respiratory gating steps resulted in selection and binning of images 
into cardiac phases. Within each of these cardiac phase bins, the most representative image 
was subsequently selected by computing the mean-square error between all image pairs in 
that bin. The image with lowest error with respect to all other images was selected as the 
reference image. Subsequently, a Demons non-rigid registration algorithm [164] was used to 
estimate the set of displacement fields that aligns each image to this reference image. All 
images were registered and averaged to form a unique image per bin, resulting in a single 
image per cardiac phase. In order to assure temporal alignment of the cardiac phases between 
all slices, the LV blood pool was segmented using an automatic segmentation algorithm 
based on Otsu's method that was guided by the cROI and LV centre point. The smallest 
segmentation of each slice was selected as the end-systolic frame. Based on this reference 
frame all slices were temporally aligned so that, for each slice, the first frame of the 
reconstructed image sequence started at end-diastole. Finally, a rigid body in-plane image 
registration was performed to register the position of the heart over time and reduce inter-
frame exercise motion. This facilitates the interpretation of ventricular contraction and wall 
motion abnormalities in three dimensions. 
4.3  Experiments and Results 
4.3.1  Experiments for Evaluation 
The developed reconstruction method was evaluated in 10 healthy volunteers and 6 patients 
with congenital heart diseases (CHD) and exercise intolerance. Dynamic imaging datasets 
were acquired at moderate and high intensity supine bicycle ergometer exercise 
corresponding to a heart rate (HR) ~100-110 bpm and ~135-150 bpm, respectively. Image 
quality was rated using a 5-point Image Quality Score (IQS; 1 = unsuitable for diagnostic 
use, 5 = similar to conventional cine imaging at rest) by two blinded cardiologists specialized 
in CMR comparing conventional gated cine sequence, the non-gated RT sequence and our 
reconstructed exGated cine. As routinely used clinical cine CMR (conventional cine) is 
significantly distorted during exercise and does not yield enough image quality for analysis, 
the reconstructed cine exercise CMR images were compared to a previously validated, non-
gated real-time imaging protocol (non-gated RT) that uses manual selection of respiratory 
state using a dedicated cardiac analysis software package (RightVol, KU Leuven) [4]. 
Agreement between the two methods was compared using Pearson's correlation. Inter- and 
intra-observer variability in 16 acquisitions of healthy controls (8 moderate, 8 high) were 
assessed with Bland Altman plots and the difference in inter- and intra-observer variance 
between the two methods was assessed using the F-ratio. Finally, systolic function was 
compared between healthy volunteers and patients with CHD during exercise using repeated 
measures ANOVA with exercise intensity as the within-subject effect. A p-value of <.05 was 
considered statistically significant.  
4.3.2  Results 
All datasets were successfully reconstructed to exGated cine stacks that allowed volumetric 
analysis. Figure 4.3 shows an example of conventional cine, non-gated RT MRI and our gated 
cine approach. Quality of the reconstructed images was significantly better compared to 
conventional CINE during exercise and non-gated exercise RT cine, with a mean IQS of 
1.1±.3 for conventional cine, 3.1±.6 for non-gated RT and 3.9±.5 for exGated cine (cine vs. 
exGated p-value <.01, non-gated vs. exGated p-value = 0.02), see Figure 4.4. 
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Figure 4.3 Reconstructed MRI images during exercise: (a) conventional cine MRI, (b) non-gated real-time cine 
MRI, (c) proposed approach – exGated cine MRI. Arrows denote better delineation of pericardium and RV wall 
of the proposed method. 
These images reflect the improved image quality of the proposed exGated cine method with 
good delineation of pericardial fat and RV-wall obtained by our proposed method. 
There was good agreement in ventricular stroke volume (SV) between exGated cine and non-
gated RT imaging (R = 0.82). Figure 4.5 shows the Blant Altman comparison between the 
two methods. This shows that there is a mild degree of underestimation of SV using ExGated 
cine in comparison to non-gated RT imaging. Next, inter- and intra-observer variability for 
SV was compared between the two methods. As can be appreciated in Figure 4.6, both the in 
inter- and intra-observer variability was larger in RT imaging compared to the exGated cine, 
with larger limits of agreement for RT imaging (intra-observer: ±14.8 mL, inter-observer 
±22.6 mL) compared to exGated cine (intra-observer: ±8.8 mL inter-observer ±13.2 mL). 
Also statistically, the inter- and intra-observer variance of SV was significantly lower in 
exGated cine compared to RT imaging (intra-observer: F = 2.75, p<.01 and inter-observer: F = 
3.01, p<.01).  
 
Figure 4.4 Image quality score between 
conventional cine (white bar), non-gated RT 
(gray bar) and our proposed approach – 
exGated cine CMR (black bar) y-values are 
times score a certain level. 
 
Figure 4.5 Bland Altman plot of agreement in stroke 
volume (mL) between exGated cine and non-gated RT. 
 
 
Figure 4.6 Bland Altman plots of inter- and intra-observer variability of stroke volume (mL) of the two 
methods. Note the smaller limits of agreement and variance in exGated Cine. 
Next, intra-observer variability between the two methods was assessed for EDV and ESV. As 
expected based on the SV results, Blant Altman analysis showed that intra-variability for both 
EDV and ESV was lower in exGated cine compared to non-gated RT, see Figure 4.7. Limits 
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±8.8 mL. Analysis of variance using the F-test showed variance in exGated cine was not 
statistically different from RT imaging, although there was a strong trend towards a lower 
variance (F = 3.2, p= 0.06). For ESV, intra-observer limits of agreement were for RT imaging 
were ±10.8 mL than for exGated cine ±5.5 mL. For ESV, analysis of variance using the F-
ratio showed a statistically lower variance in exGated cine than RT imaging (F 4.2 p = 0.04). 
Lastly, interrogation of the change in LV global systolic function during exercise using 
exGated cine showed that the increase in LV global systolic function (measured by ejection 
fraction) was lower in patients with congenital heart disease and exercise intolerance 
compared to healthy volunteers (p<.01 for both moderate and high exercise), see Figure 4.8 
 
 
Figure 4.7 Bland Altman plots of inter- and intra-observer variability of EDV (upper two plots) and ESV (lower 







Figure 4.8  Ejection Fraction during exercise for patients with complex congenital heart disease (CHD) and 
healthy voluneers using the exGated cine MRI. * represents a p-value <.05. 
4 .4  Discussion  
In this chapter, a reconstruction pipeline for cardiac and respiratory-gated cine CMR was 
presented. Our method utilizes standard available imaging sequence for highly accelerated 
dynamic imaging and computational inexpensive image-processing techniques to obtain a 
cardiac and respiratory gated cine stack during physiological exercise, without the need for 
breath holding or ECG triggering. As a result, our proposed framework can be readily applied 
in most clinical CMR environments using a simple personal laptop computer, independent of 
MRI vendor MRI.  
In the proposed pipeline, the high temporal resolution of these images is exploited for 
estimation of cardiac and respiratory motion. By applying motion estimation techniques to 
the reconstructed non-gated real time images, the need for complex k-space based 
reconstruction techniques is avoided. Computational expenses were further reduced by 
utilizing dimensional reduction of the images in the applied motion estimation techniques. As 
a result, the proposed framework is able to reconstruct a cine stack of the heart in a clinically 
acceptable total reconstruction time of ~30-40 minutes using a standard laptop computer.  
Manifold Learning was used to estimate motion from the acquired stack of dynamic images. 
This method has previously been used in combination with complex acquisition schemes for 
CMR at rest and shown to be both robust and fast in estimating motion from images [151].  
By using the entire image as an input to the ML algorithm, it was found that the respiratory 
motion was accurately estimated, as demonstrated in Figure 4.2. In some cases, ML did also 
detect a cardiac signal. However, the cardiac periodicity estimation based on this signal 
proved to be not precise enough for cardiac gating, due to significant shifts in image 
intensities as a result of through-plane motion of the heart and surrounding fat. Estimation in 
the temporal frequency domain proved more accurate, but unfortunately only when a cROI 
was introduced to avoid detection of other (exercise) motion. As a result, the pipeline requires 
a single manual step: the identification of a cROI and a LV centre point at the onset of 
processing, just after the images are loaded. Future work might be able to address this single 
manual step, by implementing recently developed, fully automated deep neural networks for 
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ventricular segmentation. In collaboration with Dr Puyol-Anton such an algorithm is 
currently under development, and the preliminary results will be presented at the IEEE 
International Symposium for Biomedial Imaging 2018 [167].  
After development, the proposed framework was implemented in a workflow for exercise 
CMR in our clinical research CMR facility. Tests of the performance of exGated cine in 
healthy volunteers and patients with a complex congenital heart disease showed that exGated 
cine is in acceptable agreement with the only currently available validated standard for non-
gated RT imaging in quantification of SV.  There is some variability in quantification of SV 
noted between the two methods. This variability can be a result of underperformance of our 
technique, or could be part of the inherent variability of the non-gated RT imaging. As 
previously discussed, non-gated RT imaging suffers from inaccuracies as target images for 
analysis are manually selected out of a large real time dataset and, despite manual respiratory 
correction, inconsistencies in respiratory states per slice are hard to avoid [168]. The 
technique proposed in this chapter utilizes information from multiple heartbeats to 
reconstruct a single averaged beat, much like conventional cine CMR, reducing the target 
images for analysis. Furthermore, the automated respiratory correction results in consistent 
motion states throughout the image stack, both in cardiac phases as well as slices. These 
advantages were reflected in the superior inter- and intra-observer variability of exGated cine 
compared to non-gated RT imaging. These results suggest that the observed variability 
between exGated cine and non-gated RT cine can potentially be a result of inaccurate 
quantification in the non-gated RT reference standard. Unfortunately, no other standards for 
quantification of exercise SV are available, except for highly invasive measurements, such as 
deriving CO using the Fick method, which in themselves have known inaccuracies [169]. The 
improved accuracy of analysis of cardiac function is an important gain of our technique, as it 
facilitates implementation of exercise CMR for clinical studies for investigation of cardiac 
exercise performance. The usefulness of the proposed technique is demonstrated in the 
subsequent chapters in which the (patho)physiology of the healthy heart and the Fontan 
circulation are investigated.  
4.5  Conclusion 
Based on the results presented in this chapter, it can be concluded that the proposed 
retrospective cardiac and respiratory gating reconstruction framework for non-gated RT 
imaging improves clinical applicability of Exercise CMR, ensuring better accuracy of volume 
quantification, while being user-friendly and widely applicable. In the subsequent chapters, 
the developed technique will be utilized to investigate the cardiac response to exercise in 
healthy volunteers and patients with Fontan Circulation. 

Chapter 5  Role of the Right Ventricle in SV 
Augmentation during Exercise 
In the previous two chapters, the development, implementation and subsequent validation of 
Exercise CMR imaging and image-analysis framework was discussed. The following parts of 
the thesis describe how this framework is utilized to investigate the primary questions of this 
PhD: What is the role of the right ventricle in the heart during exercise? and How does the 
absence of the RV impact the (patho-)physiology in the Fontan Circulation?  The present 
chapter presents the experiments that were executed in order to investigate the role of the RV 
in cardiac function during exercise, in particular its role in maintaining and augmenting 
stroke volume (SV). Firstly, in Section 5.1 the rationale behind this work is discussed, 
especially the importance of SV regulation in cardiac function. Next, in Section 5.2 the used 
methods are discussed, including the description of the Exercise CMR tests executed and 
definitions of the biomechanical model used to examine the observed exercise behaviour. In 
Section 5.3 the results of the executed experiments is discussed. Finally, Section 5.4 
discusses the implications of the observations, which show a key role of that the RV in LV 
function and total cardiac performance during exercise, and concludes this chapter.   
5.1  Introduction 
In Chapter 2, the cardiac physiological response to exercise was described. As noted there, 
the healthy human heart increases cardiac output (CO) during exercise by increasing HR 
while simultaneously sustaining SV. Despite a dramatic reduction in ventricular filling- and 
ejection-times due to the HR response, SV is maintained or marginally increased up to 
maximal exercise levels [5, 14, 15, 49]. This allows the heart to effectively increase CO up to 
5-fold its resting values, as CO = HR x SV. Although fundamental in cardiac performance, 
the mechanism of SV preservation (i.e. SV regulation) is not well understood. Anatomical 
and mechanical differences between the LV and RV [30], and contrasting changes in 
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ventricular volumes observed during exercise [7, 40] suggest distinct roles for the two 
ventricles in SV regulation, but too date these roles remain unclear [13]. 
Traditionally, evaluation of cardiac function in clinical cardiology and physiology has 
focused on the left ventricle (LV), while the role of the right ventricle (RV) is often 
neglected. However, advances in medical imaging have improved our ability to assess RV 
function. Aided by these improvements, new evidence has emerged showing that the RV is 
not merely a sub-pulmonary pump, but has an important impact on overall cardiac 
performance. In athletes, RV dysfunction is seen after high intensity endurance exercise 
[170], while in patients with heart failure, outcomes are poorer if the RV is also effected [11, 
12]. Similarly, the absence of a sub-pulmonary pump, as in patients with a single ventricle 
circulation, results in profound exercise intolerance and pre-mature heart failure [18]. These 
facts suggest that the RV plays an important role in biventricular pump function for effective 
cardiac performance. 
The impact of the RV on the effective performance of the biventricular heart could 
potentially be explained by a cooperative, or codependent, mechanism between RV and LV 
function in SV regulation. Mechanical interaction through the shared ventricular septum is 
well established. However, this interaction alone cannot explain the impact of RV on LV 
function and ultimately total cardiac performance. Understanding SV regulation, and in 
particular the interaction between RV and LV function, is therefore critical for characterizing 
fundamental cardiac physiology and helps to explain the importance of the RV in the 
optimization of total cardiac function. 
5.2  Methods 
In order to investigate the role of the RV in SV augmentation, three Exercise CMR 
experiments and a biomechanical modeling study were executed. During each Exercise CMR 
test, the biventricular response to physiological exercise was investigated, by obtaining 
cardiac volumes at rest and during exercise. In particular, the changes in RV and LV volumes 
during exercise that determine the SV response were assessed.   
First, an Exercise CMR test was performed under normal physiological circumstances in 17 
normally active (<4 hrs training per week) healthy volunteers (9 males and 8 females) to 
evaluate the normal physiological biventricular response to exercise. Next, the same group of 
volunteers underwent an identical second Exercise CMR test (HR-inhibited test), after 
pharmacologically induced negative chronotropy (indirect positive inotropy).  
CO is closely regulated by oxygen demand of the body. On its turn, oxygen demand is 
closely related to exercise intensity and load. Exercise levels, exercise time, imaging time, 
cycle rotations per minute, room temperature and humidity were kept constant between the 
two Exercise CMR tests. Therefore, selective inhibition of chronotropic response was 
expected to result in an indirect inotropic drive to increase SV during exercise. This allowed 
investigation of the changes in LV and RV behavior occurring between the two Exercise 
CMR tests that underlie augmentation of SV. 
Pharmacological inhibition of chronotropy in the HR-inhibited test was obtained by 
administration of 7.5mg ivabradine orally. This was expected to reduce HR by ~10-15% 
during exercise [171]. Ivabradine is a selective inhibitor of the If current in the sinusnode. 
This results in an increased repolarization period, leading to inhibition of the pacemaker 
frequency of the sinusnode. While decreasing HR, it has no systemic vascular effect, nor any 
direct pharmacological impact on cardiac inotropy or lusitropy [172]. Ivabradine was 
administrated directly after the physiological Exercise CMR tests. A three-hour wait was 
observed between the two Exercise CMR tests in order to allow full recovery and obtain the 
desired HR-inhibition effect.  
Next, the physiological biventricular volume response to exercise was evaluated in a group of 
8 competitive endurance-trained athletes (>10 hours of training per week for more than 5 
years). All athletes underwent a single Exercise CMR under normal physiological 
circumstances. Finally, a personalized anatomically correct biventricular biomechanical 
model of the heart was introduced in order to explain the observed ventricular behavior 
underlying SV augmentation during exercise and explore its impact on cardiac performance. 
98 Role of the Right Ventricle in SV Augmentation during Exercise 
 
 
Figure 5.1 Exercise CMR setup and flowchart of Exercise CMR experiments. A) Wide bore 1.5T MRI scanner 
with a supine bicycle ergometer mounted on a dedicated exercise CMR bed. Wires coming out of the bore are a 
Finapress continues finger pressure waveform lead and an oscillometry brachial blood pressure cuff used for 
calibration. B) Flowchart of the exercise CMR experiments. 
 
5.2.1  Exercise CMR’s 
The set-up of Exercise CMR and a flowchart of the exercise experiments is shown in Figure 
5.1. At the start of the study, a supine cardiopulmonary exercise test (CPET) was performed 
in all participants in order to obtain personalized exercise levels (exercise load in Watts) for 
the exercise CMR experiments. A week after the CPET, participants underwent the Exercise 
CMR tests. Imaging was obtained at rest and at two levels of exercise: moderate and sub-
maximal exercise. The exercise levels were determined as follows: ‘moderate exercise’ was 
defined as the workload corresponding to a HR of 110-120 beats per minute (bpm) during the 
CPET, and ‘sub-maximal exercise’ was defined as the workload corresponding to a HR of 
145-155 bpm during the CPET. Prior to the CPET and each exercise CMR, a 10-minute 
training ride was executed in order to avoid training bias between the tests. 
During the exercise CMR, a short and long axis image stack were acquired at each exercise 
level using highly accelerated real time exercise imaging protocol described in Chapter 3 and 
Chapter 4. End-diastolic volume (EDV), end systolic volume (ESV) and SV were measured 
in both RV and LV at rest and during moderate and sub-maximal exercise. Real-time 2D 
phase contrast flows were also recorded in the aorta and, in selected patients, also in the main 
and branch pulmonary arteries, and the descending aorta using the real-time flow protocol 
described in Chapter 3. Furthermore, blood pressure measurements were obtained at each 
level of exercise using Finapress (FMS, the Netherlands) continuous blood pressure 
waveform analysis, with calibration of the waveform prior to each measurement using a 
brachial blood pressure cuff as explained in Chapter 3. 
  
5.2.2  Definition of the biomechanical model 
To study the mechanical behavior of the biventricular heart, a biomechanical model was 
constructed based on previous works by Dr. Nordsletten et al. [173, 174]. The model 
reference anatomy was personalized based on MRI imaging data collected at end systole 
from a 30 year old female [21]. While model anatomy was patient-specific, the model was 
personalized based on values obtained in previous literature [21].  The reduced Holzapfel-
Ogden model [173, 174] was used to represent the myocardium, with stiffness parameters (a, 
af) scaled to ensure that model pressure / volume matched predictions based on Klotz et al. 
[175] (e.g. ensuring Vref = VED (0.6 – 0.006 PED), with PED set to 8 mmHg).  Idealized fibers 
were introduced into the myocardium as described previously [174], with fiber angles 
varying transmurally epi to endo +/- 60° in the LV and +/-40°  in the RV free wall. Passive 
stiffness was increased by an order of magnitude around the valve rings to emulate the more 
collagenous tissue.  A length-dependent active tension model [173] was used to enable tissue 
contraction, with separate activation parameters introduced for LV / septum and RV free 
wall.  To examine the influence of activation and work in the myocardium during sub-
maximal exercise, the model was inflated to typical LV / RV exercise afterloads (LVP = 
158mmHg (obtained from the data), RVP = 40 mmHg obtained from [15]) and active tension 
was subsequently introduced into both heart chambers.  In the model, aortic and pulmonary 
valves were fixed, the mitral valve was held in plane but allowed to slide, LV / RV 
endocardial pressures were set to ramp up and subsequently sustained at estimated sub-
maximal exercise afterload, and epicardial boundaries employed zero traction.  Active 
tension was increased in LV / RV at the same rate, with little variance in pressure / volume 
observed when varying the LV activation or RV activation due to the prescribed model 
afterload.  Increasing contraction parameters, the model exhibited a rapid drop in volume that 
eventually stagnated.  This was a consequence of length-dependence of active tension that 
reduced the active tension exerted on the model.  This result also was a consequence of the 
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passive / active stiffness interaction at fixed afterloads (Figure 5.6).  At zero LV / RV active 
tension, the load was held entirely by the passive elasticity of the tissue.  Contraction 
subsequently begins to carry the afterload and relieve the passive stretch.  However, as the 
chamber volumes reduced in size passing the reference volume of the heart, the internal wall 
shear eventually began to resist the activation of the muscle, limiting volume reduction.  
Reflecting the exponential stress-strain response of the passive myocardium [176], this 
resulted in an exponential growth in the activation stress / volume curve, therefore requiring 
increasing amounts of active tension in order to achieve similar volume changes achieved at 
larger chamber volumes. See Figure 5.6 for an illustration of the impact of these properties on 
the active tension curves.   
5.2.3  Statistics 
Data were analysed using IBM SPSS statistics for Mac (version 22, Chicago, IL, USA). 
Descriptive data for continuous variables are presented as means ± standard deviation. 
Descriptive statistics for discrete variables are presented as frequencies and percentages. 
Two-way repeated measures ANOVA was used to compare the biventricular response from 
rest to sub-maximal exercise between physiological and HR-inhibited tests in healthy 
volunteers, with exercise intensity and HR inhibition both as within-subject effects. The same 
test was used to compare athletes versus healthy volunteers, with exercise level as within-
subject effect, and athlete vs. volunteer as between-subjects factor. Differences in ventricular 
volume responses during exercise between groups were expressed as mean effects or mean 
differences ± standard deviation (SD). Bonferroni post-hoc tests for multiple comparisons 
were performed. Significance levels are reported after Bonferroni adjustment. A p-value 
<0.05 was considered statistically significant. 
5.3  Results 
Exercise CMR’s were successfully performed in all included participants. No participant 
reported discomfort or adverse events from the study. 
5.3.1  SV response to physiological exercise  
All exercise CMR test results are shown in Table 5-1. During the physiological Exercise 
CMR, SV increased in healthy volunteers from rest to moderate exercise in both ventricles 
(+3±3 ml/m2 p=.04) and was subsequently maintained during sub-maximal exercise (Figure 
5.2A). The behavior underlying the increase in SV was different between RV and LV, see 
Figure 5.2B,C and Figure 5.3A.  
EDV fell in both ventricles during exercise, resulting in a negative impact of EDV on SV 
compared to resting values. However, the fall in LV EDV was less than RV EDV (mean 
difference: 5.86±1 ml/m2, p<.01) with RV EDV falling nearly twice as fast from rest – sub-
maximal exercise (RV EDV-19±6 ml/m2 vs. LV EDV -10±4 ml/m2, p<.01). ESV also fell 
less in the LV compared to the RV (mean difference: 5.92±1 ml/m2, p<.01), with a total 
change of ESV from rest – sub-maximal exercise of -20±6 ml/m2 and -13±5 ml/m2 for RV 
and LV respectively (p<.01). These observations are consistent with other studies 
investigating RV and LV volumes during moderate intensity supine exercise in healthy 
volunteers [41, 168, 177], and are in keeping with a larger group of studies that have 
investigated LV behavior during exercise up to sub-maximal intensity levels [7, 40, 135, 
168].  
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Figure 5.2 RV and LV volumetric changes during exercise. A) Change in Stroke Volume (SV) from rest during 
physiological (blue) exercise CMR and HR inhibited exercise CMR (red) and in athletes during physiological 
exercise CMR (green). B) Change in EDV during physiological exercise in the RV (solid blue line) and LV 
(dotted  blue line)during physiological exercise in healthy volunteers. C) Change in EDV during physiological 
exercise in the RV (solid blue line) and LV (dotted blue line) during physiological exercise in healthy 
volunteers. Mean±SEM. *denotes a significant mean difference in volume response during exercise with p<.05 
after Bonferroni correction. 
 
The different behavior of LV and RV EDV during exercise is likely to be a reflection of the 
different preload conditions in the two ventricles. In the human circulation, RV preload is 
governed by systemic venous return, which in turn is largely determined by factors outside 
the heart (such as blood flow propagation by active muscle contractions and arterial and 
venous tone) [178]. Although venous return is enhanced during physiological exercise, the 
increase in RV preload is not sufficient to compensate for the reduced filling time, resulting 
in the observed fall in RV EDV [38, 39, 179]. In contrast, the heart is able to manipulate 
preload conditions of the LV. The relatively small volume and low resistance of the lung 
circulation allows increased RV systolic contraction, and the resulting increase in pulmonary 
artery (PA) flow and pressure, to be transmitted through the pulmonary vascular bed, 
translating into higher left atrium (LA) pressures during exercise [10, 61]. This fits our 
observation that LV EDV is better preserved during exercise than RV EDV and that the RV 
is more dependent on a drop in ESV to augment SV during exercise compared to the LV. 
 
 
Table 5-1 Changes in heart rate, cardiac output and indexed cardiac volumes during exercise CMR. Exercise CMR 
test results for healthy volunteers during physiological supine exercise and after HR inhibition and exercise CMR 
test results for athletes during physiological supine exercise.  er physiological Native test versus HR-inhibited test. 
Expressed are means±SD. Colored boxes refer to a significant mean difference in exercise response between right 
and left ventricle (blue), physiological and HR inhibited exercise test (red) and healthy volunteers and athletes 
during physiological exercise using repeated ANOVA, with a significance level of p<.05 after Bonferroni 
correction. 
 
5.3.2  SV response to exercise after negative chronotropy 
To gain insight into SV regulation at higher levels of inotropic drive, ivabradine an If current 
inhibitor was given to the healthy volunteers after the physiological exercise CMR to induce 
selective negative chronotropy (indirect positive inotropy). After a 3hr wait, the exercise 
CMR study was repeated using identical workloads and exercise times.  
Exercise HR decreased significantly between the physiological and HRi-test (mean effect: -
7.5±0.8%, p<.01) and forced a significant SV response (mean effect: +7.5±1.0%, p<.01) 
while CO was maintained (mean effect: +1.0±1.5% p=.43), see Figure 5.2A. The changes 
between the physiological exercise and HRi tests are shown in Table 5-1 and Figure 5.3A.  
In the RV, the increase in SV was obtained primarily by increasing contractility, resulting in 
a lower RV ESV (mean effect: -9.5±1.6% p<.01).  The RV EDV response during exercise did 
Healthy(Volunteers: Athletes
Physiological(exercise HR7inhibited(exercise
Exercise(Level Rest Moderate Sub5maximal Rest Moderate High Rest Moderate Sub5maximal
Exercise(Load((Watts) 0 65±5 121±4.5 0 65±5 121±4.5 0 90±5 174±15
Heart(Rate((beats(per(minute) 68±10 114±14 148±15 65±10 108±12 133±13 52±7 109±9 140±8
Cardiac(Output((L/min/m2) 3.5±0.6 6.2±1.1 7.9±1.0 3.2±0.6 6.5±0.9 8.0±1.0 3.37±0.5 8.1±1.3 11.0±1.5
Stroke(Volume((ml/m2) 50±7 54±6 53±6 49±6 60±6 60±6 65±8 76±11 79±11
Left(Ventricle
End(Diastolic(Volume((ml/m2) 81±12 77±12 71±11 80±11 83±12 79±10 108±13 112±13 111±13
End(Systolic(Volume((ml/m2) 31±7 24±8 18±6 31±7 23±9 19±5 43±9 35±5 31±5
Ejection(Fraction((%) 62±4 70±6 75±6 62±4 73±6 77±4 62±4 69±4 71±4
Right(Ventricle
End(Diastolic(Volume((ml/m2) 91±14 82±11 74±9 90±13 84±10 76±8 125±15 116±13 111±13
End(Systolic(Volume((ml/m2) 40±10 28±6 22±5 41±9 24±6 16±4 59±8 39±7 32±6
Ejection(Fraction((%) 56±6 67±5 71±5 55±5 72±4 78±4 52±4 65±6 71±4
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not change between the two tests (mean effect: +1.0±1.0%, p=0.8). In contrast, SV 
augmentation in the LV stemmed principally from an increase in LV EDV (mean effect 
+5.3±0.7% p<.01), as the LV diastolic filling rate was significantly increased compare to the 
physiological test (mean effect: +13±6% p<.01). Whereas the LV ESV response exhibited no 
change (mean effect: 0.2±2%, p=.91). Interestingly, even during moderate exercise (when the 
LV still exhibited the ability to decrease ESV), the additional increase in SV seen in the Hr-
inhibited test was driven by an increase in LV EDV and not a decrease in ESV. 
These findings, combined with the results of the physiological exercise CMR test, highlight 
that the mechanism of SV augmentation differs between the two ventricles. In the face of a 
lack of sufficient preload, the RV can only augment SV by contracting down to a lower ESV. 
The LV is able to augment SV through regulation of EDV and ESV as a consequence of 
RV’s ability to regulate LV preload. However, as shown here, LV SV augmentation during 
exercise is largely achieved through improved EDV. 
The observed improved LV filling could originate either from an enhanced active LV 
relaxation (‘LV pull’) or increased support of LV filling through the RV systolic ejection 
(‘RV push’) or some combination of these. We propose that the increased RV systolic 
ejection is the main driver of the observed LV EDV response. LV relaxation is not only a 
passive elastic recoil phenomenon, but also have an active component. However, as shown in 
experimental settings, the kinetics of contraction and relaxation are tightly coupled in the 
cardiac muscle [37] and, likely as a result of this, LV relaxation linearly related to changes in 
ESV during exercise [14]. This did not change during the HRi test and yet we saw substantial 
augmentation of LV preload as shown by improved LV diastolic filling rate. This implies that 
the LV pull is not likely to be a key driver of the observed SV augmentation. Also previous 
invasive studies show a marked increase in mean pulmonary, and LA pressures during 
exercise, suggesting that the RV push dominates the improved LV filling response [10, 61]. It 
therefore seems likely that the enhanced LV filling is mainly driven by the increased RV 
systolic contraction, which is propagated through the lungs to augment LV filling. 
 
 
Figure 5.3 Cardiac volume response and stroke volume augmentation during exercise. A) Right and left 
ventricular response to exercise from rest (grey dotted line) to sub-maximal exercise. Stroke Volume (SV) during 
physiological exercise is depicted (blue box) together with the augmented SV after HR-inhibited (red box). B) 
Change in ventricular volumes from rest during physiological in healthy volunteers and endurance trained 
athleters. The green box illustrates the mechanism of augmented SV response in athletes compared to healthy 
volunteers (blue box). Note that SV augmentation during HR inhibition as well as in athletes is achieved is 
achieved mainly by decreased ESV in the RV whereas in the LV an increase in EDV is the main contributor. 
Represented are Mean±SEM. *denotes a significant mean difference in volume response during exercise with 
p<.05 after Bonferroni correction. 
 
5.3.3  SV response to exercise in Athletes 
In addition to the observations in healthy volunteers under physiological and indirect 
inotropic conditions, SV augmentation during exercise in endurance trained athletes was 
evaluated. To determine what underlying LV and RV behavior leads to better SV 
augmentation in athletes compared to untrained healthy volunteers, the exercise CMR results 
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of athletes were compared to the physiological exercise CMR test in the healthy volunteers. 
Because most athletes have very low resting heart rates (between 35 and 50 beats per minute 
in our cohort), no HR-inhibited test was performed, as this was contra-indicated. Effectively, 
athletes have due to training remodeled to an augmented SV response similar to the indirect 
chronotropic response obtained in the healthy volunteers.  
As expected, CO increased significantly more in athletes compared to healthy volunteers 
during exercise (mean difference +1.8±1.5 L/min/m2, p<.01). This was the result of a larger 
increase in SV (mean difference: +6.7±1.5 ml/m2, p<.01), see Figure 5.2A. 
In the LV, the larger SV increase was achieved mainly through an enhanced EDV response 
from rest compared to healthy volunteers (mean difference: +7.3±1.6 ml/m2, p<.01), whereas 
the ESV response was not different between the two groups (mean difference: -0.5±1.8 
ml/m2, p=0.7). This behavior is similar to the LV response seen after negative chronotropy in 
untrained healthy volunteers, as is clearly seen in Figure 5.3. 
In the RV, the augmented SV response seemed to be driven mainly by a trend towards a 
larger decrease in ESV from rest in athletes (mean difference: -3.9±2.1 ml/m2, p =.06), in 
combination with a slightly lower fall in RV EDV (mean difference: +2.4±1.98 ml/m2, 
p=.15), as also illustrated in Figure 5.3, that is likely caused by improved venous return due to 
the larger CO in athletes. 
The ventricular behavior observed in athletes echo earlier studies that showed that the better 
LV SV exercise response in athletes compared to sedentary individuals stemmed primarily 
from an enhanced LV EDV [7, 58, 60],  with no, or minimal changes in LV ESV [7, 58, 60] 
and LV relaxation [180, 181]. Also, previous invasive pressure studies showed even larger 
augmentations PA and LA pressures during exercise in athletes compared to untrained 
individuals [10, 61], again suggesting a central role of the RV systolic push in LV SV 
regulation.  
5.3.4  Energetic advantage of biventricular SV augmentation  
A core question arising from the results of the exercise CMR experiments is: What drives the 
heart to improve LV SV by relying on RV supported filling instead of augmenting the LV 
ESV response? Using a personalised biomechanical model of the biventricular heart, it is 
possible to investigate this question by examining the active stress required to generate 
physiological pulmonary and systemic systolic exercise pressures over a range of different 
volumes in the RV and LV, respectively. This way, the costs of activation (sum of active 
stress from EDV - ESV) can be estimated for each ventricle and changes in the energetic cost 
for increased SV – through some combination of increasing EDV and decreasing ESV – 
could be explored.  These modelling experiments illustrate that the LV has a significant 
benefit of maintaining an optimal volume state and that maintaining this state during exercise 
by through RV supported augmentation of LV filling minimizes the costs of biventricular 
contraction in the heart. 
Disregarding overinflated states, where a significant increase in passive stretch diminishes the 
active tension needed to maintain sub-maximal exercise afterloads, LV active tension is large 
at sub-maximal LV volumes and decreases with falling volumes, following Laplace’s law 
(see Figure 5.4). At very low volumes, however, costs of activation increase steeply as 
internal shear deformation of the LV myocardium becomes mechanically limiting. Based on 
the shape of the LV active tension curve, the LV should ideally work with an ESV close to 
the active tension minimum in order to optimize costs of contraction. The results of the 
individualized model show that during exercise the LV operates in this volume range (see the 
two markers in Figure 5.4A). Albeit minimizing costs of contraction, this volume state of the 
LV restricts its ESV reserve, as further decreases of ESV result in an exponential increase in 
contractile costs. As a consequence, the LV becomes increasingly dependent on external 
sources to enhance EDV in order to maintain or adapt SV during exercise (see insert in 
Figure 5.4A). On its turn, LV EDV, unable to profit from a further boost in relaxation by 
augmented elastic recoil from a lower ESV, becomes reliant on effective RV systolic function 
during increasing exercise intensities.  
In the RV, the costs of contraction are significantly lower than the LV (see Figure 5.4 and 
Figure 5.5), reflecting the reduced stroke work required to overcome the relatively low 
afterload of the RV. As described above, the RV is limited to decreasing ESV to augment 
SV. However, the low costs of contraction make increasing contraction to a lower ESV 
significantly less expensive in the RV compared to the LV.  This means that the heart is able 
to utilize augmentation of SV through contraction to lower ESV in the RV (working against 
the ‘low pressure circulation) to improve filling of the LV, hereby allowing the LV (working 
against the ‘high pressure circulation’) to minimize costs of contraction by maintaining an 
optimal volume state.  The costs of RV contraction inevitably increase exponentially at very 
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low ESV’s due to mechanical constraints. However, as shown by the less pronounced 
changes of the active tension curve in Figure 5.4, RV active tension does not vary as much 
with volume compared to the LV. As a result, the RV costs of contraction are less dependent 
on its volume status. This allows larger RV volumes, and thus a larger RV ESV reserve, that 
improve the ability to augment SV and LV filling. This could explain why the RV is 
generally larger than the LV in the human heart and why the heart adapts to larger ventricular 
volumes in endurance athletes [182]. Adjusting the model by increasing rest volumes in both 
chambers by 10%, we observed that the work required to drive SV indeed improved. With a 
similar costs of contraction, a ~10% increase in SV was achieved, leading to greater 
efficiency in pump function. Altogether, these modelling experiments show that the heart, in 
an attempt to minimize total costs of contraction, operates via a mechanism of RV and LV 
cooperation that results in a clear dependence of LV SV on RV systolic function during 
exercise 
 
Figure 5.4 RV and LV costs of contraction. RV and LV active tension curves (active stress required to 
overcome afterload at each volume) in a personalized biomechanical model of a healthy volunteer. In grey 
volume state during submaximal exercise in a representative volunteer. White Dotted line; volume state at 
moderate exercise. Grey dotted lines represent a 10% SV increase through decrease in ESV versus an increase 
in EDV. Insert represents the increase in costs of a SV increase (5%, 10%, 15%) using different strategies with 
left end of the curves representing SV increase through ESV solely. 
 
 
Figure 5.5 Illustration of the personalized biventricular biomechanical model and colour map of active tension 
needed to overcome exercise-afterload in the ventricles. Note the larger tension needed in the LV compared to 
the RV.   
 
5 .4  Discussion 
In this Chapter, the cooperativity between LV and RV in SV regulation during exercise was 
investigated. The results showed that RV systolic function is pivotal in LV SV augmentation 
and optimization of total cost of contraction of the heart during exercise. This explains the 
previously observed, but so far not well understood, impact of the RV on cardiac 
performance in heart disease and competitive endurance exercise. Furthermore, it means that 
the RV can be a potential target for optimizing cardiac function in disease and exercise 
training that should not be ignored during assessment of the heart.    
To date, appreciation of ventricular interdependence has largely focused on mechanical inter-
ventricular interaction through the septum. While this is a core element of ventricular 
interaction, the results of this chapter demonstrate that ventricular interaction through SV 
regulation and preload presents another functional interaction pivotal to cardiac performance 
during exercise. The importance of this interaction for optimization of cost the cardiac 
contraction seems to explain the key role of RV function observed during exercise 
performance and cardiac disease. The described results show that the RV systolic function is 
exploited to optimize LV SV augmentation during exercise. This explains why transient 
myocardial injury is observed in the RV after intense endurance exercise, while the LV is not, 
or to a lesser extend, affected [170]. Furthermore, it helps to understand the mechanism 
underlying the adverse effects of high intensity training often reported in the RV but not the 
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LV, such adverse RV re-modeling [170] and its associated RV originating ventricular 
arrhythmia’s [170]. In cardiac disease, the observed importance of RV function in optimizing 
cardiac performance sheds a new light on diseases typically associated with LV dysfunction. 
In an already diseased heart, the inability of the RV to optimize LV function is likely to 
exacerbate the burden of cardiac disease. Whereas previously not well understood, the RV 
and LV interaction presented in this study seems to be a likely explanation for the reported 
adverse impact of RV dysfunction on prognosis of systolic and diastolic LV failure [11, 12] 
and dilated cardiomyopathy and efficacy of treatments, such as cardiac resynchronization 
therapy [183]. Similarly, our work helps to better understand the inevitable decline of cardiac 
function and resulting high burden of heart failure in patients with in the single-ventricle 
circulation, whom lack a sub-pulmonary pump. Heart failure in these patients, rather than 
originating from distinct events, was previously hypothysed to be the result of slowly 
progressive exhaustion of the ventricular pump [19]. Our results seem to support this idea, as 
chronic inability to optimize cost of contraction could have a significant chronic impact on 
cardiac function. The key role of the RV in optimization of cardiac performance seems to be 
further supported by the observation that habitual exercise did not improve functional 
exercise capacity in patients with single-ventricle circulation, while in patients with a 
biventricular circulation habitual exercise was associated with better exercise capacity [184]. 
In the light of this existing evidence, our work suggests that the optimization of RV function 
might provide a valuable new treatment target in cardiac diseases. Similarly, in patients with 
a single-ventricle circulation (who lack sub-pulmonary ventricle) partial substitution of this 
mechanism might be vital to maintain cardiac performance in the long-term. Already, some 
recently developed RV targeted treatments have shown promising results in (pre-)clinical 
studies. RV assist devices [185] and RV resynchronization therapy [186] have shown 
immediate improvement of systemic haemodynamics in RV failure. Similarly, implantation 
of pre-pulmonary impellors [187, 188] seem to improve systemic haemodynamics in the 
single-ventricle circulation in-vitro and in-vivo experiments. These therapies have focused on 
severe variants of RV disease. However, our work suggest that optimization of RV function 
might be a potential target for a much wider range of patients with less severe heart diseases. 
While monitoring of RV function might provide better prognostic assessment of cardiac 
diseases and could provide more insight into optimizing training regimes in athletes aiming 
for peak performances.  
5.4.1  Limitations 
The analysis presented in this study assumed that RV afterload did not change significantly 
enough to explain the RV behavioral changes between the related physiological and HR-
inhibited tests. We did not measure invasive pulmonary pressures. However, changes in 
properties of the pulmonary circulation between the native and HR-inhibited tests are 
unlikely. Pulmonary pressures and pulmonary capillary wedge pressures are highly correlated 
with CO [61], which remained unchanged. Furthermore, we recruited healthy non-smoking 
young adults, without lung or cardiovascular disease nor arrhythmic changes during exercise. 
At sea-level, maximal pulmonary vasodilatation is reached early in exercise in healthy 
volunteers and no significant changes in PVR are seen during increasing exercise levels [15, 
189]. This makes a sudden drop in PVR as the cause of RV ESV decrease after HR inhibition 
unlikely. Lastly, a decrease in PA pressures that would result in the observed changes in RV 
ESV would automatically be translated in lower left ventricular filling pressures, which is 
counterintuitive in the face of improved LV filling.  
HR inhibition itself could potentially result in changes of ventricular behavior during 
exercise. HR modulation was achieved in this study using ivabradine. Ivabradine is reported 
to cause no significant cardiac inotropic and lusitropic effects [172].  However, the decrease 
in HR results in a longer diastole and therefore will have impacted LV and RV EDV. Indeed 
we observed a trend towards a larger RV EDV, in which preload is largely independent of the 
heart’s actions. A similar effect can thus be expected in the LV.  However not only the 
duration of diastole was longer but also the trans-mitral inflow rate was significantly 
increased. This showed that HR-inhibition alone did not explain the observed changes in LV 
EDV.  
 
5.4.2  Conclusion 
In this chapter, the pivotal role of RV systolic function in LV SV augmentation during 
exercise was demonstrated. This role results in a biventricular cooperative mechanism that 
optimizes cost of contraction during SV augmentation in the biventricular heart. This synergy 
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in RV and LV function characterizes a fundamental mechanism in cardiac physiology, likely 
illustrating part of the rationale behind the biventricular design of the human heart. Moreover, 


















Figure 5.6 Explanation of Active Stress curve LV. The resulting curve is a combination of Laplace’s Law and 





Chapter 6  Impact of absence of the RV in the 
Fontan Circulation 
6.1  Introduction 
In the previous chapter, Chapter 5, it was demonstrated that the sub-pulmonary (right) 
ventricle is pivotal in SV augmentation during exercise in the healthy human heart. By 
supporting LV filling in the face of a striking fall in diastolic filling time in exercise, the RV 
optimizes total biventricular costs of cardiac contraction. In the Fontan circulation, the sub-
pulmonary pump is absent. As discussed in Section 2.2, patients with Fontan circulation 
experience a seemingly inevitable progressive decline in cardiac performance throughout life, 
ultimately leading to heart failure and premature death in most patients. The exact pathway of 
the exhaustion of cardiac performance is not well understood, but it seems clear that a single-
ventricular configuration of the circulation does not function as optimal as a biventricular 
system. 
Patients with Fontan circulation have an impaired exercise capacity, even when 
asymptomatic [190]. In healthy volunteers, CO increases linearly with HR and exercise 
intensity. In the Fontan circulation, however, the CO response is blunted, due to a fall in SV 
during increasing HR [88, 90, 191]. As a result, the single ventricle is unable to provide 
adequate CO to match metabolic demand of the body [192]. The findings in the previous 
chapter of this thesis may explain these observations; absence of a sub-pulmonary ventricle 
likely leads to a limit ability to augment systemic ventricular filling. This explains the low 
preload previously reported during exercise in the Fontan circulation [88, 191, 193]. 
Moreover, the lack of a sub-pulmonary might significantly alter the efficacy of the 
physiological HR response to exercise in Fontan patients. The effectiveness of the 
physiological heart rate response to exercise in the biventricular circulation is build upon the 
heart’s ability to maintain SV. This criterium is not met in patients with Fontan circulation, as 
SV falls progressively with increasing HR. Whereas there is some adaption of the body to the 
single ventricle circulation, with altered physiological exercise responses (including a lower 
peak exercise HR), the fall in SV during exercise seems suggest these adaptions are 
incomplete. This could mean that the physiological HR response to exercise and stress in 
Fontan patients is not optimally accommodating CO augmentation during exercise. 
Moreover, the sub-optimal filling of the systemic ventricle during exercise could potentially 
lead to an increase in energetic costs of contraction, see Chapter 5. 
In this chapter, the impact of HR on exercise haemodynamics in the Fontan circulation was 
investigated using exercise CMR. In particular, the ventricular response and its efficiency 
were evaluated under normal conditions and after selective inhibition of the HR response. 
Firstly, the cardiac response to exercise was assessed in Fontan patients compared to healthy 
volunteers under normal physiological conditions. Next, the impact of selective HR inhibition 
was evaluated in the group of Fontan patients. These experiments illustrated that the HR 
response during exercise is indeed sub-optimal in Fontan patients compared to healthy 
volunteers and that HR inhibition leads to a significant improvement in the energetic costs of 
delivering CO. 
6.2  Methods 
6.2.1  Subjects 
12 patients with Fontan circulation and 12 age- and gender matched healthy volunteers were 
included in this study.  
Patients were recruited from the outpatient clinics of our department of adult congenital heart 
diseases. All patients were clinically stable, with symptoms corresponding to a New York 
Heart Association (NYHA) class of <II.  Exclusion criteria were: significant AV or VA valve 
regurgitation, significant arrhythmia’s or rhythms other than sinus-rhythm, significant aorto-
pulmonary collateral flow or a patent fenestration and an inability to perform exercise during 
a supine CPET, performed prior to the study. 
Healthy volunteers had no history of cardiovascular or pulmonary disease and did not take 
any medication (except for contraceptives) and were normally active (participation in 
exercise up to 3 times a week). This study was approved by the London Bloomsbury’s 
regional ethics board (15/LO/522). All participants provided written informed consent. 
6.2.2  Data Acquisition Protocol 
Fontan patients underwent two exercise CMR exams; one during normal physiological 
exercise (physiological test) and one after selective HR-inhibition (HRi-test). Data from a 
normal physiological exercise CMR age and gender matched healthy volunteers was used for 
comparison.  
In this study, the Exercise CMR setup described in in Chapter 3 and Chapter 4 was used. The 
protocol of this study was similar to that described in Chapter 5. Briefly, imaging was 
performed at three stages during the Exercise CMR: at rest, during moderate and during sub-
maximal intensity exercise. End diastolic volume (EDV), end systolic volume (ESV), SV, 
CO and non-invasive brachial blood pressure were obtained at each stage. Additionally, mean 
diastolic ventricular filling (mDRF) rate was calculated as the ventricular inflow (mL) 
divided by the diastolic duration (seconds). Intensity levels for the moderate and high 
exercise levels were obtained from a CPET that was performed one week prior to the 
Exercise CMR’s. Moderate exercise was defined as the wattage level corresponding to a HR 
of 100-110 bpm, and sub-maximal exercise as the wattage corresponding to a HR of 135-145 
bpm during the supine CPET. 
After the physiological Exercise CMR, the group of Fontan patients received a single dose of 
7.5mg ivabradine (Procolaran, Servier, Suisse) orally. Ivabradine, an inhibitor of sinusnode 
repolariation, selectively inhibits HR without directly affecting inotropy or lusitropy [194]. 
After a 3 hour break, to wait for the HR-inhibiting effect and allowing sufficient recovery, a 
second Exercise CMR (HR-inhibited test) was performed in the Fontan group. Exercise 
levels, exercise time, imaging time, cycle rotations per minute, room temperature and 
humidity were kept constant between the two Exercise CMRs. Prior to all Exercise CMR’s 
and the CPET a 10 minute low intensity warm-up was performed to minimize training effect 
throughout the study. 
6.2.3  Data Analysis 
First, the difference in exercise response between Fontan patients and healthy volunteers was 
evaluated by examining the absolute change in HR, systemic ventricular volumes, CO and 
blood pressure from rest at each exercise level. Next, the impact of HR inhibition on exercise 
response in Fontan patients was investigated by comparing the change (%) in HR, systemic 
ventricular volumes, CO and blood pressure within each Fontan patient between the 
physiological and HRi-test. The use of absolute values for comparison between Fontan 
patients and healthy volunteers was based on the fact that baseline parameters might differ 
between individuals. In assessment of HR-inhibition (physiological vs. HR-inhibited test), the 
Fontan patients act as their own controls and therefore percentage change from their observed 
physiological exercise response was assessed. 
In addition to the changes in HR, cardiac volumes, CO and blood pressure responses after HR 
inhibition, the impact of HR inhibition on ventricular performance and ventricular efficiency 
was investigated in the Fontan patients. To do so, changes in ventricular end systolic 
elastance (Ees), arterial elastance (Ea), VA-coupling (Ea/Ees), ventricular mechanical 
efficiency (Meff), energetic efficiency (Eeff) and indexed total systemic vascular resistance 
(SVRi) were compared between the physiological test and HR-inhibited test, at rest and 
during sub-maximal exercise. These parameters were obtained based on the pressure-volume 
relationships. Key components of the pressure-volume relationships in the ventricle are EDV, 
ESV, end-systolic pressure (Pes), Ees (the linear slope between V0 and Pes at ESV), Ea (linear 
slope between EDV and Pes) and V0 (the x-intercept of Ees at zero pressure). See Figure 6.1 for 
an illustration of the pressure volume relationships. 
Ees and V0 (the x-intercept at zero pressure of Ees) can be estimated with the non-invasive 
single beat estimation method using cardiac volumes (and ejection fraction), brachial blood 
pressure readings as well as isovolumetric contraction (PEP) and systolic ejection times 
(SEP), as described by Chen et al. [144]. This method is based on physiological principle of 
consistent time-varying normalized elastance in the human heart [144, 195, 196] and has 
been used in a broad range of cardiac diseases, morphologies and loading conditions, 
including patients with Fontan circulation [88, 89, 112]. V0 is commonly regarded as a 
negligibly small number that does not change by chronotropic [197] or inotropic state [198, 
199]. Therefore, after calculating Ees and V0 at rest during the physiological test, we assumed 
V0 to be the fixed for each individual throughout the study. Using the fixed V0 we could then 
calculate Ees as the slope between V0 and Pes. This approach was taken to avoid the influence 
of errors in serial estimation of Ees and V0 on the analyses of cardiac performance between 
the tests. Pes was estimated as brachial systolic blood pressure (SBP) x 0.9 as described 
previously at rest and during exercise [144, 200].  Next, Ea (Pes divided by SV) and the VA 
coupling ratio were obtained and the PVA graph was constructed, as illustrated in Figure 6.1. 
 
Figure 6.1 Analytical model of the Pressure-Volume relations allow analysis of ventricular performance and 
ventricular-arterial coupling. A) Components of the pressure-volume area and coupling parameters. B) External 
Work Area, C) Pressure-Volume Area. Pes; end-systolic pressure, ESV; end-systolic volume, EDV; end-
diastolic volume, Ees; ventricular elastance, Ea; arterial elastance, EW; external work, PVA; pressure-volume 
area. 
  
From the obtained PVA, Meff, Eeff and myocardial oxygen consumption per beat (MvO2) 
can be calculated. Meff (%) is defined as follows [201, 202]:  
1   𝑀𝑒𝑓𝑓 =
𝐸𝑊
𝑃𝑉𝐴 
With external work (EW in mmHgml) and PVA (mmHgml) defined as:  
2  𝐸𝑊 =   𝑆𝑉 × 𝑃𝑒𝑠 
3   𝑃𝑉𝐴 =  
1
2  𝑃𝑒𝑠 × (𝐸𝑆𝑉 − 𝑉0) 
Eeff was subsequently calculated using the method of Burkhoff and Sawage [201] that 
demonstrated that MvO2 per beat is proportional related to PVA: 
4   𝑀𝑣𝑂2 (𝑚𝑙 𝑂2/𝑏𝑒𝑎𝑡)  = 𝛼 × 𝑃𝑉𝐴 +  𝛽 
Where 𝛼 is a coefficient of the PVA-MvO2 relationship that was fixed for each patient at 
1.9e-5 mL O2 mmHg-1ml-1 (as previously described by Burkhoff et al. [201] and used in a 
Fontan population by Saiki et al. [89]). And 𝛽 (mL O2/beat) was the intercept of the PVA-
MvO2 relationship which was dependent on Ees and obtained based on experimental 
measures as [201]: 
 
5   𝛽 = 0.0032 × 𝐸𝑒𝑠 + 0.104 
After expressing both EW and PVA in Joules (J), using the conversion 1 mmHgmL = 1.33e-4 
J and 1 ml O2 = 20 J, energetic efficiency was calculated as: 
6   𝐸𝑒𝑓𝑓 =
𝐸𝑊
𝑀𝑣𝑂2 
Finally, the efficiency of the cardiovascular system in delivering CO to the body (COeff) was 
evaluated by calculating the myocardial MvO2 consumption per Liter generated CO (ml O2 / 
L) using the obtained MvO2 per beat, the HR and CO:  
7    𝐶𝑂𝑒𝑓𝑓 =
𝑀𝑣𝑂2 × 𝐻𝑅
𝐶𝑂  
6.2.4  Statistics 
Data was analysed using SPSS (version 22, SPSS, Chicago, IL, USA). Continuous variables 
were tested for Gaussian distribution using a Kolmogorov-Smirnov test and presented as 
means±SD or medians (25% - 75%) as appropriate. Discrete variables are presented as 
frequencies or percentages. To investigate the difference in the cardiac volumetric response 
to exercise between Fontan patients and healthy volunteers, HR, CO and the change in 
cardiac volumes and diastolic inflow rate from rest was analysed using two way repeated 
measures ANOVA [203], with exercise level as the within-subject  effect and disease as the 
between-subject effect. An interaction p-value <.05 meant a statistical significant difference 
in exercise response between the two groups, while the mean effect expresses the mean 
difference between the groups during exercise.  
To evaluate the impact of HR inhibition in Fontan patients, two-way repeated measure 
ANOVA’s was executed for HR, cardiac volume and CO responses to exercise, with both 
exercise level and HR-inhibition as within-subject effects. In these ANOVA’s a significant 
mean effect (mean percentage change in the analysed parameter between the physiological 
and HRi-test) is interpreted as a significant difference in exercise response between the 
physiological and HRi-test. The mean difference in ventricular performance (Ees, Ea, VA-
coupling, Meff, Eeff and MvO2/CO) between the physiological and HR inhibited test at rest 
and sub-maximal exercise was measured using paired T tests.  Bonferroni post hoc tests were 
performed during all analysis to correct for multiple comparisons. A p-value of <.05 after 
Bonferroni correction was regarded as statistically significant.  
In the light of ethical considerations regarding the use of a drug intervention for the purpose 
of studying haemodynamics in patients, the study size was kept minimal. Therefore, this 
study was adequately powered to investigate the impact of HR inhibition on Fontan 
haemodynamics. The accuracy of Exercise MRI combined with the use of a crossover design, 
in which patients were their own controls, allowed us to evaluate core haemodynamic 
differences in this modest sized cohort. 
6.3  Results 
Baseline characteristics are shown in Table 6-1. Fontan patients were slightly smaller in 
height and weight compared to healthy volunteers, as expected. All Fontan patients had an 
intra-cardiac total cavo-pulmonary connection (TCPC). 5 (42%) of the Fontan patients had a 
systemic LV and 7 (58%) a systemic RV. Underlying cardiac defect, surgical history and age 
at Fontan completion of each individual Fontan patients is presented in Table 6-2.   
 
Table 6-1 Baseline characteristics of Fontan patients and healthy 
volunteers (Controls).  Expressed are means±SD and count (%). BSA body 
surface area.  
 
6.3.1  Exercise Response in Fontan versus Healthy controls 
HR increased during exercise in both Fontan patients and healthy volunteers with no 
significant difference in HR increase between the two groups (mean difference -10±14 bpm, 
interaction p=0.07), although there was a non-statistically significant trend towards lower HR 
increase in Fontan patients at each exercise stage (HR increase: moderate +43±8 vs. +32±25, 
sub-maximal +80±13 vs. +61±30 for controls and Fontan patients, respectively).  
Table.'Baseline'Characteristics''
Variable Fontan Controls p)value
Age,%y 26±5 27±4 0.54
Male%sex,%n%(%) 7%(58) 7%(58) 1
Height,%cm 173±6 178±11 0.05
Weight,%kg 64±8 75±16 0.01
BSA,%m2 1.76±0.12 1.92±0.25 0.01
Resting%HR%(bpm) 73±19 66±9 0.36
EDV%rest%(ml/m2) 88±13 80±12 0.16
ESV%rest%(ml/m2) 44±10 30±8 <.01
SV%rest%(ml/m2) 44±8 50±5 0.15
Ejection%Fraction%(%) 50±6 63±4 <.01
Resting%CO%(L/min.m2) 2.94±0.52 3.25±0.51 0.25
Systemic%RV,%n%(%) 7%(58) U U
In Fontan patients, the mean diastolic filling rate of the systemic ventricle was significantly 
reduced during exercise compared to the healthy volunteers (interaction p=.01). This slower 
filling resulted in a larger fall in EDV in Fontan patients (mean effect -3.7± ml/m2, interaction 
p<.01). There was no significant difference in change in ESV from rest between the two 
groups during exercise (interaction p=.12). Due to the fall in EDV, SV fell during exercise in 
Fontan patients whereas SV increased in healthy volunteers (interaction p<.01). Due to the 
fall in SV with during the increasing HR, CO increase during exercise was blunted in the 
Fontan patients, whereas it increased linearly with exercise intensity in healthy volunteers 
(interaction p<.01).  
 
Table 6-2 Surgical history, underlying cardiac defect and age at completion of Fontan for each patient included 
in the Fontan group. HLHS; hypoplastic left heart syndrome, HRHS; hypoplastic right heart syndrome, TA; 
tricuspid atresia, DILV; double inlet left ventricle, IAA; interrupted aortic arch, DORV; double outlet right 
ventricle, PS; severe pulmonary stenosis, MA; mitral atresia. TCPC; total cavopulmonary connection; BT; 
Blalock-Taussig, ASO; arterial switch operation AP; atriopulmonary, yr; year 
 
Figure 6.2 Heart rate and mean diastolic inflow rate at rest and during exercise in Fontan patients compared to 
healthy volunteers. * reflects significant difference in paired T test between the two group at the individual 
stage. Interaction was calculated using two-way ANOVA. 
 
Patient SV	morphology Underlying	defect Fontan-type Age	TCPC Surgical	History
1 RV HLHS	TA TCPC 4 BT-shunt,	Glenn	at	1yr
2 LV DILV TCPC 6 BT	shunt	<1yr,	Glen	at	1,5	yr
3 LV DILV TCPC 4 PA	banding	<1yr,	hemi-Fontan	at	1	yr
4 RV DORV TCPC 6 Septostomy,	Glenn	at	yr
5 LV DILV TCPC 18 atrial	switch	<1yr
6 RV DORV TCPC 7 BT-shunt,	Waterstone	shunt	at	5yrs
7 RV HLHS	TA TCPC 34 BT-shunt,	AP	Fontan	at	10yr	
8 RV DORV,	MA TCPC 6 BT-shunt,	Glenn	at	age	of	4
9 RV DORV TCPC 5 BT-shunt,	Glenn	at	1yr
10 LV DILV TCPC 4 not	available	(surgeries	completed	abroad)
11 RV HLHS TCPC 4 BT-shunt,	Glenn	at	1yr
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Figure 6.3 Changes in cardiac volumes and cardiac output from baseline rest in Fontan patients and healthy 
volunteers during exercise.* reflects significant difference in paired T test between the two group at the 
individual stage. Interaction was calculated using two-way ANOVA. 
6.3.2  Theoretical Rationale of HR inhibition 
Based on this comparison of exercise response between Fontan patients and healthy 
volunteers, combined with the existing literature regarding Fontan haemodynamics during 
exercise, the following observations can be made: 1) augmentation of ventricular filling is 
limited in the Fontan circulation, resulting in a fall in EDV during increases in HR. As a 
consequence, SV decreases with increasing HR resulting in a blunted CO response. 2) Due to 
the fall in SV and CO, Ea increases. This results in VA-uncoupling with increases in HR. 
Uncoupling of the VA relationship is known to decrease energetic efficiency of the heart 
[201]. Therefore, it could be hypothysed that HR inhibition, by increasing filling time, might 
improve SV and subsequently decrease Ea and improve VA coupling. This could lead to 
improved mechanical and energetic efficiency of the heart during exercise.   
6.3.3  Impact of HR inhibition on Fontan Haemodynamics 
HR inhibition significantly lowered the HR response during exercise in Fontan patients 
(mean effect -6±3%, p<.01), see Figure 6.4. The mean diastolic filling rate was unchanged 
between the two tests (mean effect +3±5%, p=0.13); however the diastolic period was longer 







































































































Interaction p<0.01 Interaction p=0.12 
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Rest ExLevel1 ExLevel2 Rest ExLevel1 ExLevel2 
* 
in a smaller fall in EDV (mean effect +5±1%, p<.01). The ESV response during exercise was 
not altered by HR-inhibition (mean effect +1±2%, p=.24). The larger EDV lead to a 
significant increase in SV during exercise in the HR-inhibited test (mean effect +6±2% 
p<.01). As the increase in SV was larger than the decrease in HR, CO was increased during 
exercise in the HR-inhibited test compared to the physiological test (mean effect: +4±3%, 
p=.04).  
 
Figure 6.4 Effect of HR inhibition on exercise heart rate and cardiac output in Fontan patients. Blue line 
represents physiological test. Red line is after administration of ivabradine (HR-inhibited test). All values are 
means±SD. An asterix means a significant difference before and after ivabradine. A dagger means a significant 
increase in baseline response from rest – high exercise.   
 
 
Figure 6.5 Effect of HR inhibition on diastolic filling rate and diastolic time in Fontan patients. Blue line 
represents physiological test. Red line is after administration of ivabradine (HR-inhibited test). All values are 
means±SD. An asterix means a significant difference before and after ivabradine. A dagger means a significant 
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6.3.4  Impact on VA-Coupling and Efficiency in Fontan 
The impact of HR-inhibition on VA coupling assessment in Fontan patients is presented in 
Table 6-3. Ees did not significantly change between the physiological and HRi tests. Not at 
rest (1.25±0.41 vs. 128±0.43, p=0.42), nor at sub-maximal exercise (1.96±0.90 vs. 2.04±1.05, 
p=0.22). This is not unexpected, as the change in loading due to improved filling should not 
impact a load-independent measure of contractility. Ea was unchanged at rest, however 
during sub-maximal exercise Ea was significantly lower in the HRi-test (1.49±0.24 vs. 
1.78±0.32 p<.01). Due to the lower Ea, VA coupling ratio improved at sub-maximal exercise 
in the HRi-test compared to the native test (1.36±0.66 vs. 1.12±0.50 p<.01). Furthermore, 
mechanical and energetic efficiency, whereas unchanged at rest, improved significantly at 
sub-maximal exercise from the physiological to the HRi-test (Meff: +6±3%, p<.01 and Eeff: 
+7±3%, p<.01), see Figure 6.7. The increased Eeff and lower number of heart beats needed to 
deliver the increased CO at sub-maximal exercise resulted in an improved efficiency of 
delivering CO, as COeff (the myocardial Mv02 consumption per Liter of generated CO) 
reduced by 9±4% (p<.01) from the physiological to the HRi-test. Systolic blood pressure at 
sub-maximal exercise was unchanged between the two tests, despite the higher CO in the 
HRi-test. This was the result of a fall in SVRi from the physiological to HRi-test (1309±324 
vs. 1374±346 dynescm-5m2) that made the vascular system more receptive for the increased 
CO. 
 
Figure 6.6 Effect of HR inhibition on cardiac function during exercise in Fontan patients. Blue line represents 
physiological test. Red line is after administration of ivabradine (HR-inhibited test). All values are means±SD. 
An asterix means a significant difference before and after ivabradine. A dagger means a significant increase in 








































































Mean Effect: +5±1%, p<0.01 
Interaction p<0.01 
Mean Effect: -1±2%, p=0.24 
Interaction p=0.65 
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Figure 6.7 Changes in mechanical and Energetic efficiency at rest and during submaximal exercise and after 
ivabradine (HR-inhibited test) from physiological rest. Means±SD.* denoted p-value <.05. 
 
 
Table 6-3 VA-coupling and ventricular efficiency at rest and during sub-maximal exercise before and after HR-
inhibition in patients with Fontan circulation. SVRi; indexed total systemic vascular resistance, VA; ventricular-
arterial. A Pink box indicates a significant difference between the physiological and HR-inhibited tests. 
6 .4  Discussion 
In this chapter the role of HR in the pathophysiological cardiac response to exercise was 
evaluated. The results show that the physiological HR response to exercise is 
disproportionately high in patients with a Fontan circulation. As the single ventricle 
circulation lacks an appropriate augmentation of ventricular filling, the HR response to 
exercise contributes to a fall in SV, resulting in a blunted CO augmentation. Selective 
inhibition of the HR response partially reverses this fall in SV and hereby improves CO, 
despite a lower HR. Furthermore, it improves mechanical and energetic efficiency of the 
ventricle and decreases the estimated oxygen consumption per Liter generated CO. These 
results present a new insight in physiology of the Fontan circulation and provide a potential 
novel treatment target for optimizing single-ventricular function.  
Fontan	Patients
Physiological	exercise HR-inhibited	exercise
Exercise	Level Rest ExLevel2 Rest ExLevel2
Systolic	Blood	Pressure,	mmHg 116±11 140±8 114±9 137±12
SVRi,	Dyne.s.cm-5.m2 2160±390 1374±346 2078±520 1309±324
End-systolic	Elastance	(Ees),		mmHg/mL 1.25±0.41 1.96±0.90 1.28±0.43 2.04±1.05
Effective	arterial	elastance	(Ea),	mmHg/mL 1.33±0.36 1.78±0.32 1.25±0.25 1.49±0.24
VA	coupling	ratio	(Ees/Ea) 0.95±0.21 1.12±0.50 1.02±0.24 1.36±0.66
External	Work,	mmHg.mL 7945±827 8744±1320 8290±861 10005±1538
Mechanical	efficiency	(EW/PVA),	% 0.64±0.05 0.65±0.10 0.65±0.07 0.70±0.10
Energetic	Efficiency,	% 20±1.6 20±3.0 21±1.9 22±3.0
COMvO2,		Joules	MvO2	/	Liter	CO 70±11 81±11 67±10 74±9
6.4.1  Abnormal exercise response in Fontan patients 
HR is key element of the human physiological response that augments CO in response to 
stress and exercise [2]. In the biventricular circulation, increasing HR is an effective way to 
augment CO, as SV is preserved despite a significant fall in diastolic filling time [7, 204]. As 
shown in the physiological exercise CMR experiments in this chapter, the exercise 
haemodynamics in Fontan patients are altered, resulting in a sub-optimal effect of the HR 
response on CO. During exercise, HR increased linearly with exercise in both Fontan patients 
and healthy volunteers. In healthy volunteers, the increase in HR was accompanied by a 
similarly large augmentation of mean diastolic LV filling rate. This compensated the 
shortening of diastole, allowing LV EDV to be maintained. Only at sub-maximal exercise, 
LV EDV fell mildly. In Fontan patients, the increase in filling rate was much lower. As a 
result, EDV fell progressively while HR increased. Interestingly, the ESV response during 
exercise was not significantly different between Fontan patients and healthy volunteers, 
suggesting that the contractile response of the Fontan cohort was not significantly impaired. 
However, this ESV response was not enough to compensate for the large drop in EDV, 
resulting in a progressive fall in SV during exercise. In contrast, SV increased during exercise 
in the healthy volunteers. As a result the CO response to exercise was significantly blunted 
during exercise, compared to the linear increase observed in healthy volunteers.  
So far, the mechanism behind the falling SV remains incompletely understood. Decreased 
contractile response and diastolic dysfunction could potentially play a role, however the 
current accepted view seems to be that the main factor limiting the increase in CO in the 
Fontan circulation is a lack of sufficient ventricular filling during exercise [19, 72]. This 
theory was build upon the observation that preload is low in adult Fontan patients during 
exercise [8]  and, in children, during dobutamine stress [191]. However, no comprehensive 
exercise imaging study has so far confirmed the abnormal ventricular behaviour in relation to 
the healthy biventricular heart. Moreover, the role of heart rate in this abnormal response has 
been overlooked. The fall in EDV that we report during exercise is in keeping with the 
observations by Bruaene et al. [96], who executed a exercise CMR study to investigate the 
impact of Sildenafil on exercise haemodynamics in Fontan patients. We show that, compared 
to healthy volunteers, this fall is indeed abnormal and is owed to a lack of augmentation of 
filling. Interestingly, the ESV response was not significantly different between healthy 
volunteers and Fontan patients, suggesting that contractile dysfunction did not contributed to 
the low SV. Indeed, a relatively preserved contractile reserve in Fontan patients has been 
previously reported by multiple groups [88, 90, 207]. The preserved contractile function 
during exercise suggests that the single ventricle could potentially generate more SV, were it 
not limited by sub-optimal filling. Sub-optimal ventricular filling as a result of shortening of 
diastole, in combination with preserved contractile function, can be a contributing factor in 
the previously observed more pronounced adverse impact of HR on ventricular mechanical 
and energetic efficiency of the single-ventricle compared to healthy volunteers [88, 191].  
Contrary our results, Van den Bruaene et al. did not observe a decrease in ESV from rest 
[96]. However, resting cardiac index in their study was relatively for Fontan patients (4.1 
L/min/m2). This was almost 40% larger than the resting cardiac index in our study and might 
have influenced further contractile augmentation.  
  
6.4.2  The role of HR in Fontan haemodynamics 
In the physiological test, it was observed that a lack in augmentation of ventricular filling 
limits SV and CO augmentation during exercise. However, whether this is caused by the 
decreased HR time or intrinsic diastolic dysfunction remains unclear. To investigate the 
impact of HR on ventricular behaviour during exercise, in its role in ventricular filling and 
efficiency, we performed a second test under selective HR inhibition using ivabradine.  
During the HR-inhibited test, the mean diastolic filling rate of the ventricle was not 
significantly different from the physiological test, which is contrary to augmentation in 
diastolic filling rate seen after HR inhibition in the healthy volunteers in Chapter 7. This 
reflects the relative inability of the single-ventricle circulation to impact ventricular filling 
during exercise. However, due to the longer duration of diastole, ventricular filling was 
increased in the HR-inhibited test, as illustrated by the increased EDV response (see Figure 
6.5 and Figure 6.6). Moreover, SV increased from the physiological to the HR-inhibited test, 
leading to a seemingly contradictory increase in CO despite a lower HR.  
This series of events induced by HR-inhibition can be interpreted as follows: Firstly, diastolic 
time is the limiting factor in filling of the ventricle during exercise in this group of Fontan 
patients. Whereas diastolic dysfunction is frequently reported in Fontan patients, this 
observation seems to suggest that such dysfunction is either not present or not a limiting 
factor. Secondly, SV increases with improved filling. This demonstrates that impaired filling 
and not impaired / inadequate systolic function limits SV augmentation in Fontan patients. 
Even more, the increase in SV was obtained without an increase in contractility, as shown by 
the unchanged ESV and Ees responses. This suggests that myocardial contractile function is 
not well utilized during exercise of the single ventricle circulation due to relative underfilling, 
an observation also previously suggested by Senzaki et al. [88] and that the improved filling 
during HR-inhibition allowed the ventricle to make more optimal use of the Frank-Starling 
forces. Finally, these experiments therefore illustrate that passive filling of the ventricle, in 
particular diastolic filling time, is pivotal for the delivery of CO in the Fontan circulation.  
The inhibition of the HR response resulted in a significant improvement in ventricular 
efficiency during exercise, as shown in Figure 6.7. The more efficient ventricular 
contractions, combined with the lower heart rate also significantly reduced the estimated 
oxygen consumption needed to deliver CO (COeff) during exercise in the HR-inhibited test. 
At rest, a statistical significant effect was not reached, but there was a strong trend towards 
improved VA coupling and ventricular energetic efficiency due to HR-inhibition, see Table 
6-3 and Figure 6.7. As exercises work of the heart, the changes are more exaggerated, it is 
likely that in a larger study, powered for studying impact at rest, a positive effect of HR-
inhibition might also be present a resting state.  The improved ventricular and total efficiency 
of the heart was the consequence of a range of improvements in the system. Firstly, the 
increased length of diastole resulted in better filling. This likely improves utilization of the 
Starling mechanism in the heart and resulting in a larger SV without an increase in 
contractility, as observed in our HR-inhibited test. Secondly, due to the larger SV, CO is 
delivered using less beats, reducing the number of times the heart has to overcome aortic 
pressure (afterload).  As volume work is less energy costly than pressure work, oxygen 
consumption per Liter of CO generate decreases [208, 209]. Thirdly, Ea increased due to the 
larger SV. This improved VA-coupling. Better coupling of ventricular and arterial elastance 
results in increased mechanical and energetic efficiency of the ventricle [201, 210]. In total, 
these factors together are likely to explain the significant decrease of estimated myocardial 
oxygen consumption per Liter generated CO (-9%). Additionally, although not assessed in 
this study, the prolongation of diastole in the HR inhibited test provides more time for 
coronary blood flow and oxygen supply to the myocardium of the single ventricle. 
Despite the increase in CO, blood pressure did not significantly change between the 
physiological and HR inhibited test. This was the result of a fall in SVRi, which matched the 
increase in CO, see Table 6-3. In Fontan patients, resting and exercise SVRi are high 
compared to healthy volunteers. This is partly a consequence of the two circulations in series. 
However, it has also been suggested that the high SVRi, and especially limited drop in SVRi 
during exercise, is an important secondary mechanism in Fontan patients to ensure adequate 
systemic pressure, and therefore perfusion and flow through the circulation, in the light of a 
low CO [19]. We observed that SVRi fell with improving CO. Furthermore, the magnitude of 
this fall matched the CO increase and therefore left blood pressure unchanged. This suggests 
that in our cohort of asymptomatic Fontan patients, at least part of the high SVR during 
exercise can be explained by a deliberate self-regulated response of the body to maintain 
adequate body organ perfusion pressure in the face of a blunted CO increase. This 
observation is important in the light of afterload reducing treatment strategies in patients with 
Fontan circulation. While such strategies have been suggested in the light of the high SVRi 
[111], our work seems to suggests that it might counteract a useful protective response of the 
body to low CO. This would explain the unsatisfying clinical results of long-term ACE-
inhibition on functional capacity in Fontan patients [111, 211] and therefore our observations 
provide further evidence against routine ACE-inhibiting treatments in asymptomatic Fontan 
patients. These findings are made in a small cohort of TCPC Fontan patients and therefore 
might not be generalizable to a larger population and across all Fontan patients. However, 
these results demonstrate that cautious consideration of the potential protective mechanism of 
increased SVR remains important while determining treatment.  
6.4.3  Implications for clinical management 
The results of this study demonstrate the importance of HR and filling time in optimization of 
haemodyanmics of the Fontan circulation. Whereas the concept of limited preload in Fontan 
patients due to the lack of a sub-pulmonary ventricle has been well described [19, 20, 72, 88], 
its implications, i.e. the importance of filling time and thus HR, for adequate function of the 
Fontan circulation has so far been overlooked.  
In order to minimize the seemingly inevitable functional decline of patients with Fontan 
circulation, optimization of cardiac and circulatory function has become a central goal in 
treatment of Fontan patients. While all patients seem to be affected by declining functional 
status, there is currently no scientifically backed routine treatment available that effectively 
prevents or slows down the functional decline. Recently, promising results have been booked 
with regard to pulmonary vasodilator therapies (PVD). Both in the short and long-term, 
improvements of functional status have been reported [117, 212–214]. However, it is hard to 
see such treatment as a routine option in all Fontan patients. Most patients do not have an 
elevated pulmonary vascular resistance. We have previously shown children with HLHS 
rarely had an elevated PVR, despite being symptomatic, and that PVD did not improve 
pulmonary blood flow or filling [98]. In such patient the efficacy of PVD might be 
questionable. Therefore, the potential side effects and costs of PVD might outweigh potential 
benefits in asymptomatic patients [114, 115, 117]. Another important consideration is that 
PVD, especially Sildenafil, can result in a degree of systemic vasodilatation. Careful analysis 
of the impact of Sildenafil on Fontan haemodynamics in the Exercise CMR study by van 
Bruaene et al. [96] shows that PVD did not improve blood flow towards the heart or 
ventricular, filling despite a lower PV, but did result in a significant decrease in SVRi. This 
drop SVRi was only partly compensated by an increase in HR and lower ESV, resulting in 
decrease in systemic blood pressure and, more importantly, increased arterial lactate levels 
and a decreased arteriovenous oxygen difference, suggesting a deterioration of blood flow 
towards the working muscles. In the light of the self-regulation of SVRi found in our study 
and the unsuccessful trails of afterload reducing treatments [211] this suggests that one needs 
to be cautious of the systemic vasodilation effect of Sildenafil. Whereas this in the short-term 
increasing CO, which might explain the acute effects in improved functional capacity, in the 
long term, Sildenafil could potentially an adverse effect on the Fontan haemodynamics. 
It is clear from both in vivo experiments [88–90] and computational modelling [77, 88, 89, 
91] studies that the single-ventricular circulation is an inefficient pump in which, even at rest, 
HR adversely affects ventricular efficiency more significantly than in healthy controls [89]. 
While the absence of a sub-pulmonary ventricle is inherent to the Fontan circulation, HR and 
filling time can potentially be targeted. As this study showed, selective modulation of HR 
results in an acute improvement of CO and efficiency of cardiac performance in a group of 
patients with Fontan circulation during exercise. These findings are only done in a small 
group of patients, which do not include all the different variants of Fontan modifications. 
Whether they therefore apply to the general to the principles of single-ventricular 
haemodynamics in all Fontan patients remains unclear. However this proof-of-concept study 
seems to suggest that selective HR inhibition could be potentially have a role in optimization 
of ventricular performance in the Fontan circulation. Selective HR inhibition does not exhibit 
the negative inotropic effect of beta-blocker treatments. It therefore suits the potential target 
of treatment in Fontan patients, reducing HR and filling time targets, instead of restraining all 
facets of cardiac function to minimize metabolic demand (the main target in ischaemic heart 
disease).  
This study was set up to investigate the role of HR in the exercise response of the Fontan 
circulation and therefore merely assessed the direct effect of HR-inhibition using ivabradine 
on exercise in a subgroup of patients with TCPC Fontan circulation. To determine the value 
of selective HR inhibition as a realistic treatment option, randomized controlled trials, 
designed for this assessment, are needed. 
6.4.4  Limitations 
Previous studies have highlighted the importance of respiratory and muscle pump in Fontan 
haemodynamics during exercise [216]. Our methodology did not allow us to investigate the 
impact of HR-inhibition on these factors separately. However, respiratory correction was 
used for analysis of cardiac volumes, avoiding the potential confounding of impact of 
respiration on cardiac volumes between the two tests and between individuals. 
Non-invasive estimates of VA-coupling were used in this study. The values for V0 and α
were obtained only at one initial stage (physiological rest) to calculate all VA-coupling and 
efficiency in the other stages. This approach was taken to avoid the impact of errors in 
estimaton of Ees on the assessed changes in VA-coupling over the stages. V0 and αare 
related to inherent myocardial structural properties and have previously been reported to be 
constant for an individual independent of inotropic or chronotropic drive [197, 199, 201]. 
Most studies obtaining non-invasive measures of VA coupling disregard V0, assuming its 
value is neglectable [217, 218].  However, others have argued a potential change of V0 during 
exercise [219]. It was felt that utilizing a single estimate and hereby avoiding an estimation 
error outweighs the potential adaptions of V0, especially as only relative changes between two 
exercise tests within individual subjects were assessed. For calculation of Ees at 
physiological rest state, systolic time intervals were obtained from high temporal resolution 
cine imaging (~17ms per frame). Cine CMR uses averaging over multiple beats, which is 
different than the real time assessment during echocardiography. However, the other 
parameters included in the calculation, blood pressure and volumes, were also obtained over 
multiple beats. Furthermore, real time echocardiographic measurements are in essence also 
averaged, as good practise described taking the mean of at least 3 separate measurements. 
Altogether, we therefore think the use of high temporal cine CMR did not result in significant 
errors in measurement of systolic intervals.   
Due to the physical constraints of the CMR, the exercise CMRs were performed in a supine 
position. Therefore the gravitational forces on the body are different to an upright position, 
most likely influencing the observed cardiovascular function and haemodynamics. It is likely 
that venous return towards the heart in an upright position is more impaired, potentially 
further reducing the ventricular filling reserve, in particular in Fontan patients.  These results 
can therefore not directly be extrapolated to an upright position.    
Lastly, invasive central aortic pressures were not measured during this study. Therefore, Pes 
was defined as 0.9 x SBP.  This method has often been described and has also been used 
before during exercise [200]. However it is not validated, and might result in an error with 
increased exercise level. Radial tonometry might have provided a better estimate of Pes, 
however such methods are not MRI-compatible. Furthermore, as we assessed the relative 
changes in parameters between two exercise CMRs in individual patients, we felt that most of 
such error would be systematic and, whereas it most likely impacted the estimated real 
values, the impact on the relative changes will be small.  
6.5  Conclusion 
In this chapter, the experiments are described that aimed to investigate the impact of HR on 
haemodynamics of the Fontan circulation during exercise. The results of this work show that 
the physiological HR response to exercise is inappropriately high in the Fontan circulation, as 
the lack of a sub-pulmonary ventricle does not allow ventricular filling to be maintained 
during increasing HR. As a result, the CO response is blunted and ventricular efficiency 
deteriorates. Selective inhibition of the HR response improved filling, CO and ultimately 
cardiac efficiency during exercise. Selective HR inhibition might be a potential target for  
optimizing Fontan haemodynamics. 
 
Chapter 7  Computational Modelling of the 
Dobutamine Stress Response in Fontan 
Patients 
The computational modelling work presented in this chapter was executed in close 
collaboration with Dr. R. Chabiniok, who developed the model and supervised me during the 
implementation. 
 
In the previous chapters, several experiments were executed to demonstrate the role of the 
RV during exercise and impact of its absence on exercise haemodynamics in adult 
asymptomatic patients with Fontan circulation. These experiments gave a fundamental 
insight into Fontan physiology and the negative impact of the inappropriately increase in HR 
during exercise. In this chapter, the focus of explaining (patho)physiology is shifted from the 
general perspective to a patient-specific approach. The aim of the following set of 
experiments was to explore the added value of a closed loop heart-circulation biomechanical 
modelling framework for diagnostic assessment of the stress response in patients with Fontan 
circulation and symptoms of progressive exercise intolerance.  
7.1  Introduction 
As discussed in Section 2.2, the Fontan circulation is burdened by a progressive decline in 
cardiac function resulting in a high incidence of heart failure. Unfortunately, the mechanism 
of failure in individual patients is often hard to detect. Routine diagnostic investigations used 
in cardiology clinics, such as echocardiography or cardiac magnetic resonance imaging 
(CMR) are frequently unable to identify the cause of failure. As a result, determining 
effective treatment is challenging. Exercise intolerance is a relatively common early symptom 
of the failure of the single ventricle. In several specialized clinics, simultaneous cardiac 
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catheterization and CMR (XMR) at rest and during pharmacological stress is used to simulate 
an exercise response in order to better understand causes of failure in Fontan patients. Rich 
datasets of combined pressure, flow and ventricular volume measurements are obtained 
during these exams. However, the complex physiology of Fontan circulation and large inter-
individual variations make it difficult to obtain direct conclusions from these investigations. 
7.1.1  Modelling Fontan Physiology 
Biophysical modelling has in recent years advanced into clinical applications by assisting 
diagnosis [21]  and therapy planning [220, 221]  in non-congenital heart disease patients, see 
also a recent review by Chabiniok et al. [24] and references therein. It allows for integration 
of various data-modalities into a single framework. As opposed to image or signal analysis, 
the physical and physiological principles of these models have the potential to assess the 
tissue properties of the heart and vascular system – quantities not directly measurable from 
the image and pressure data but accessible via constitutive relations and equilibrium 
equations. Such modelling techniques have also been previously applied to investigate Fontan 
physiology. Most work so far has focused on predictions of flow characteristics in the total 
cavo-pulmonary connection (TCPC) and the impact of geometrical shapes of the surgically 
created TCPC on blood flow through the system [222]. Recently, several authors investigated 
overall circulatory function of Fontan circulation using lumped parameter networks 
resembling the single ventricular circulation. Kung et al. used a closed loop lumped 
parameter network of the Fontan circulation during exercise to investigate exercise 
intolerance in patients with Fontan circulation [22]. Their proposed model was tuned based 
on population trends and available clinical data during model development. By adapting only 
a few input parameters of their predefined model based on individual patient characteristics  
(HR and exercise capacity), this method allowed insight in disease processes, however it 
lacks the detailed patient specific input that would be needed to predict absolute output 
parameters. Puelz et al. recently used a similar closed loop circulation to study the impact of 
anatomical variations of the Fontan circulation in general, without considering specific 
patients [23]. While useful in assessment of general characteristic of the Fontan circulation in 
individual patients, these models lack the detail to assess patient-specific causes of failure or 
guide treatment decisions.  
7.1.2  Aims of this work 
The goal of this work was to develop a patient-specific modelling framework to augment the 
diagnostic value of the XMR dobutamine stress studies. Integrating XMR data (flow, 
pressure, ventricular behaviour and vascular function) into a closed looped computational 
model of the heart and circulation allows access to key clinical parameters of cardiovascular 
function (such as myocardial stiffness, contractility and venous return) in individual patients. 
This potentially aids the identification of the pathophysiological mechanisms underlying 
heart failure in individual patients. In this work, the value of using such computational 
models in diagnostic assessment of XMR dobutamine stress exams was evaluated. 
Additionally, the potential use of the calibrated models for investigating the impact of 
therapeutic interventions was explored. 
The heart model employed was a reduced-dimensional (0D) biomechanical model detailed in 
previous work [223, 224]. In order to interpret the acquired XMR data in varying 
physiological conditions in a relatively short time (or possibly nearly real time), the actual 3D 
anatomy of patients' ventricles was reduced into a sphere together with a complete reduction 
of biophysical model as described in Caruel et al. [225]. While the geometry and kinematics 
of the heart were simplified, all the constitutive relations were preserved, i.e. the model used 
is a full biophysical model. The principal unknowns of the reduced model are therefore the 
displacement of the ‘spherical ventricle’ in the radial direction (capturing the variations of 
ventricular volume and systolic wall thickening during the cardiac cycle) and pressure in the 
ventricular cavity. 
The continuum mechanics based model of the ventricle was connected to a Windkessel-type 
model of circulation to obtain arterial characteristics (peripheral and distal resistance and 
capacitance). A closed loop circulation was created by modelling the venous return flow to 
the systemic ventricle according to a venous return law that was linearly proportional to the 
distal venous and atrial pressure. This venous return law, that assumes an equilibrium 
between the cardiac output and venous return, is a generally accepted concept used in 
cardiovascular physiology [178] and was put into the modelling context in previous work by 
Chabiniok et al. [221]. This closed loop circulation of the cardiac, arterial and venous 
systems creates a representation of the patient's cardiovascular system suitable for the 
analysis of inotropic and chronotropic changes, i.e. changes in myocardial contractility and 
heart rate. This therefore allows investigation of stress and exercising responses using the 
model. See Figure 7.1 for a schematic representation of the coupled heart-Windkessel 
circulation and venous return model. 
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Figure 7.1 Left: Scheme of 0D heart model connected with a 2-stage Windkessel model (Rp, Cp, Rd, Cd stand for 
proximal and distal resistances and capacitances, Par and Pd stand for proximal aortic, distal circulation pressure). 
Right: Closing of the heart-circulation circuit by a linear venous return law defining the preload of systemic 
ventricle according to the cardiac output  (MSFP stands for mean systemic filling pressure and Qve-max for 
maximum achievable venous flow). 
 
In this chapter, the type of data acquired during the XMR procedure and the model used are 
first presented in Sections 7.2.1 and Section 7.2.2. Next, the step-wise method for calibration 
of the model using the obtained patient data is discussed in Section 7.2.3. After this, it is 
demonstrated in Section 7.3.1 that the proposed modelling framework successfully represents 
the cardiovascular system of Fontan patients at rest and provides physiological parameters 
related to the properties of myocardial tissue, hereby translating the image and pressure data 
into functional properties of myocardium, such as passive tissue stiffness and active 
contractility. Next, the performance of the modelling framework in improving diagnostic 
assessment of exercise intolerance in individual patients during the dobutamine stress XMR 
are presented in Section 7.3.2. Finally, the potential predictive value of the model for 
investigating the impact of a therapeutic intervention (heart rate inhibition) was explored in 
one of the cases in Section 7.3.3 and the obtained results are discussed in Section 7.4. 
7.2  Methods 
7.2.1  Acquired Data 
Five patients with Fontan circulation that underwent a clinically indicated XMR dobutamine 
stress exam for progressive symptoms of exercise intolerance were included in this study. In 
all patients, the underlying congenital heart defect was hypoplastic left heart syndrome.  
Additionally, two 'controls' with a biventricular heart and normal circulation were studied to 
compare the model estimates in Fontan patients to model predictions in a biventricular heart. 
These control patients had Allagile's syndrome and mild branch pulmonary artery stenosis 
and underwent an XMR dobutamine stress study for risk assessment prior liver 
transplantation [226]. One of the cases (control 2) had a clinically unremarkable 
cardiovascular response to dobutamine (‘good stress response’) whereas the other (control 1) 
had an impaired stress response, which was indicated by an insufficient increase in cardiac 
output (<30% increase from rest). 
During the XMR exams, pressure signals (aortic, ventricle, venae cavae, and pulmonary 
capillary wedge pressures) were obtained at rest, and under continuous infusion of 
dobutamine 10 mcg/kg/min (dob10) and 20 mcg/kg/min (dob20) mimicking moderate and 
strenuous exercise stress, respectively. Simultaneously, CMR imaging data was recorded, 
consisting of a stack of ventricular volumes throughout the cardiac cycle and 2D flow data 
(ascending aorta, descending aorta, venae cavae, and branch pulmonary arteries). The 
obtained CMR data were post-processed into 0D signals of time-versus-flow or time-versus-
ventricle volume, and these signals were temporally aligned with the time-vs-pressure, see 
Figure 7.2. 
This study was performed under the ethical approval of our regional research ethics 
committee (Ethics Number 09H0804062) and all participating patients (or their parents) gave 
written consent for participation in the study. 
 
 
Figure 7.2 Data of Fontan patient 1 acquired at rest (left) and during low- and high-dose dobutamine infusion 
(center and right). 
 
7.2.2  Biomechanical model 
The reduced order heart model used in this work was in detail described in [225]. The main 
ingredients of the model are described below.  
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The passive part of myocardium is modelled by an exponential law inspired by Holzapfel et 
al. [227] as a hyperelastic material, while taking into account anisotropy given by the 
direction of the myocardial fibres. The ventricular volume at reference configuration Vo (the 
volume of the ventricle at zero pressure) was assumed to correspond to 50% of the end 
diastolic volume (EDV) at rest, which is close to values described in previous experimental 
studies in hearts with a wide range of geometries (both normal and dilated) [228]. Using V0, 
EDV and preload, the end-diastolic pressure volume relationship (EDPVR) was obtained 
according to the experimentally defined single-beat method of Klotz et al. [228].  
The active component of the heart was modelled by a system of ordinary differential 
equations representing chemically controlled actin-myosin interactions – formation of cross-
bridges – generating active stress and active stiffness in each sarcomere at a certain 
sarcomere length [224]. The symptomatic active stress, σ 0,  generated by the sarcomere is in 
related to myocardial contractility. Contractility was modeled to be dependent on actin-
myosin overlap (sarcomere length) based on the Frank-Starling law, as shown in Figure 7.3 
(left panel). Activation of the cardiac myocytes was modeled by an activation function based 
on ECG signals, see Figure 7.3 (right panel).  
 
 
Figure 7.3 Left: Frank-Starling function n0. Right: Profile of the electrical activation function u with a rescaled 
ventricular volume plot. The measured durations of QRS, PQ and ST segments of ECG at rest are used to 
impose timings for the electrical activation function and for the atrial contraction. 
The peripheral circulation receiving flow (Q) from the heart was modeled using a 2-stage 
Windkessel model (see schematics in Figure 7.1). The proximal part of the circulation (aorta 
and large arteries) was represented by a proximal capacitance and resistance (Cp and Rp). The 
peripheral circulation was represented by a distal resistance and capacitance (Rd and Cd). 
The final modeling ingredient – the venous system – provides the preload to the systemic 
ventricle, closing the cardiovascular circuit. The venous return is governed by the 
physiological state of the circulatory system and cardiac output. The relationship between 
distal venous pressure Pvs and venous return flow Qve has previously been described by 
Chabiniok et al. [229]. This model of venous return is based on Guyton’s law [178]. This law 
describes that cardiac output is a function of venous return, which itself can be modeled as a 
linear relationship between Pvs and venous flow, see Figure 7.1. The x-axis intersect of the 
venous law represents the pressure at zero flow, the so-called mean systemic filling pressure 
(MSFP), while the maximum venous return flow Qve-max is reached at a venous pressure of 0 
mmHg, with no further increase at lower venous pressure due to collapse of the large veins 
[178].  
7.2.3  Model calibration 
The biomechanical model was calibrated following a fixed step-by-step protocol that 
minimizes the chance of a non-unique set of parameters describing the data. 
First, the geometrical relations of the 0D model (the ventricular volume and myocardial 
mass) were prescribed based on the MRI derived values for EDV and ventricular mass. After 
this, each component of the full heart-circulation was calibrated as described below: 
 1) Windkessel calibration: the Windkessel model was decoupled from the heart and 
MR derived aortic flow was directly imposed into the system. Resistances and capacitances 
were adjusted to match the aortic pressure waveform in the data. The distal properties, Rd and 
Cd, were calibrated to obtain the height of the dicrotic notch and the time constant of the 
diastolic pressure decay. The proximal part was then tuned to obtain peak systolic pressure. 
Figure 7.4 shows the result of calibration in a patient with excellent agreement of the 
simulated aortic pressure in the proposed Windkessel system with the data. The parameters of 
the Windkessel model were then fixed for the rest of the study (both at rest and during 
dobutamine stress). Whereas dobutamine might have an effect on the peripheral resistance 
[132] we did not have aortic pressure data during the dobutamine stress stages of the CMR 
study, as the pressure catheter was left in the ventricle.  
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Figure 7.4 Calibration of the Windkessel model (left), and of the heart model at rest with prescribed level of 
preload (right). 
.  
2) Calibration of the passive component of the heart:  The passive tissue properties 
of the myocardium in the heart model were adjusted based on end-diastolic pressure and 
volume data. End diastolic pressure was imposed onto the ventricle and the hyperelastic 
potential of the ventricular model was adjusted by multiplying the linear stiffness coefficients 
C1 and C2 by a ‘relative stiffness’ parameter to obtain the right end-diastolic volume. This 
relative stiffness parameter was based on Klotz et al. [228] and allows comparison of 
stiffness values between patients  (see Table 7-2). 
3) Calibration of the active component of the heart: Active calibration consisted of 
adjustment of electrical activation and myocardial contractility, σ 0. In this step, the heart 
model is connected to the previously calibrated Windkessel system while imposing preload as 
measured at end-diastole. The activation function u is calibrated based on the QRS and ST 
durations measured from the ECG at rest. Likewise, the atrio-ventricular activation delay in 
the model was adjusted according to the PQ-interval, see Figure 7.3(right panel) for the 
profile of the activation function. After obtaining the personalised activation function, 
contractility at rest was adjusted to reach the same SV and aortic flow as observed in the data. 
Figure 7.4 demonstrates the results of calibration steps 1-3 in a patient, showing excellent 
agreement between the heart model and the data. 
 
Figure 7.5 The complete heart model looped with venous return calibrated at rest. 
 
4) Venous return calibration: The last step of the calibration of the close loop heart-
circulation model and consists of identifying the parameters of the effective volume Veff  and 
capacitance Cvs of the venous system. The linear venous return law can be uniquely 
parameterized using the working point of the heart at rest (intersection of the measured 
preload and cardiac output) marked by the rest star in Figure 7.1 and the assumption that 
maximum venous return Qve-max is 150% of cardiac output at rest. This assumption lead in all 
cases to a mean systemic filling pressure between 10-20 mmHg, values which are 
physiologically to be expected [178]. 
 
Table 7-1 Measured indicators and parameters of calibrated models at rest. 
 
7 .3  Experiments and Results 
7.3.1  Coupled heart-circulation model at rest  
By following the calibration process described in section 7.2.3 models of the rest state were 
set up for all the cases. Table 7-1 shows the main model output parameters in all patients. 
Notably, contractility at rest seems to be equal in Fontan patients compared to the healthy 
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control case 2, whereas the clinically used, load-dependent parameter, EF, suggested 
impairment of systolic function in all Fontan patients. The preload measured at rest was 
higher in the two control cases than in any of the Fontan patients Figure 7.5 illustrates an 
excellent level of accuracy of the closed-loop heart-circulation model calibrated at rest 
conditions with respect to measured data. 
7.3.2  Coupled heart-circulaton model under dobutamine stress 
After calibration at rest, the effects of dobutamine stress were introduced into the model to 
obtain the stress states observed in the data. First, the chronotropic effect was accounted for. 
We adjusted the cardiac cycle duration according the heart rate at dob10. As the ECG device 
was not MR compatible, a detailed ECG was only available at rest. While we assumed PQ 
and QRS durations did not change significantly from rest, the ST interval is known to shorten 
with increasing heart rates [230]. Therefore, the ST interval was adjusted in order for the 
simulated pressure waveform to match the one observed in the catheter data.  
The purple plot in Figure 7.6 demonstrates the prediction of the model at dob10 after only 
adjusting the chronotropic effect (heart rate and ST segment duration). As can be seen, such a 
hypothetical scenario would not lead to an actual increase of cardiac output, and the 
maximum systolic pressure and maximum aortic flow would be much below the measured 
values at dob10 stress. By adding the inotropic effect into model – by increasing contractility 
with a factor of 1.75 in this particular case – the simulation reached the level of cardiac 
output observed in the data (blue plots in Figure 7.6). Note that the simulation did not capture 
the high pressure spike in the data at dob10 (blue dashed line). Review of the pressure traces 
revealed a typical pattern of overshooting resulting in overestimation of the peak systolic 
pressure and the model-predicted pressure might actually be closer to the real value. 
Figure 7.7 demonstrates the result of model calibration for both low and high level of 
dobutamine stress in an example Fontan patient. This well matched calibration was achieved 
by adjusting the cycle duration and ST interval (chronotropic effects), and tissue contractility 
(by a factor of 1.75, and  2.75, for low and high dobutamine levels, respectively) without any 
adjustments of the venous return law, which was kept identical to the rest state (black line in 
panel A of Figure 7.7).  A direct interpretation of this result is that in this individual patient 
the myocardial contractile reserve appears to be good. However, venous return augmentation 
seems to be limited and negatively impacts filling and stroke volume of the ventricle during 
higher heart rates and inotropic activation. 
 
Figure 7.6 The full heart-circulation model for Fontan patient 3 calibrated at rest (black) and the predicted 
chronotropic effect for heart rate as during low-dose dobutamine stress (purple). The additional inotropic effect 
(blue) brings the simulation close to the data. The asterisks represent the cardiac output-venous return 
equilibrium points of the closed-loop system. 
 
The assumption of a fixed venous return law from rest to dobutamine stress was valid for all 
Fontan cases, except for patients 2 and 4. In these cases, a fixed venous return law resulted in 
a lower end-diastolic volume and preload than observed in the clinical data. As demonstrated 
in Figure 7.7 for patient 2 and 4, the venous return law therefore had to be adapted (a right 
and upward shift of the venous return relationship) to match the behaviour observed in the 
data. Both these patients had a patent fenestration (a shunt between the systemic venous 
system and common atrium that allows a portion of the blood to bypass the pulmonary 
circulation and therefore improve preload). The model accurately predicted the existence of 
such a boost in preload, and it is clear that during stress this leads to an improvement in 
venous return to the heart due to the increase in venous pressures. The change in venous 
return in the cases with fenestration are in keeping with the pattern seen the biventricular 
control cases as illustrated in Figure 7.10, suggesting augmentation of venous return, which is 
normally seen to an even larger extend in the healthy biventricular heart during exercise 
[178].  
Table 7-2 summarizes the adaptions in model parameter estimates needed to match the 
obtained clinical data of the dobutamine stress exam. All the patients were able to increase 
the contractility by factor 2-3, except for control 1. Control 1 had a higher contractility at rest 
compared to the others and only increased contractility during dobutamine by a factor of 1.5. 
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As shown in Table 7-3, the changes in Dp/Dt from rest, a surrogate measure of changes in 
contractility, showed similar behaviour as the predicted contractility changes in the model. 
Augmentation of venous return during dobutamine stress was present in both control cases 
and the two Fontan patients with a patent fenestration, while in Fontan patients~1, 3 and 5 
venous return was fixed.  
Altogether, these results suggest that our model was able to characterise the different 
components of the dobutamine stress response in individual patients, allowing patient-
specific investigation of the factors causing an impaired stress response. 
 
Table 7-2 Summary of the changes in cardiovascular systems in patients and controls during dobutamine stress. 
 
 
Figure 7.7 Simulations for Fontan Patient 3 at rest and during two levels of dobutamine stress: low (dobutamine 
10 mcg/kg/min, blue) and high (dobutamine 20 mcg/kg/min, red). The asterisks represent the cardiac output-
venous return equilibrium points of the closed-loop system. 
   
146 Computational Modelling of the Dobutamine Stress Response in Fontan Patients 
 
7.3.3  Prediction for therapeutic intervention: heart rate inhibition 
In patients~1,3 and 5 our model estimates suggest that the dobutamine exercise response was 
limited due to a lack in augmentation of venous return, while the contractile reserve seemed 
to be unaffected. An inability to augment venous return significantly impacts ventricular 
filling and subsequently SV and CO during increases in HR. As became clear from the 
previous chapter, Chapter 6, selective inhibition of the heart rate response can improve 
haemodynamics of the Fontan circulation. Therefore, the potential of the model to reflect the 
impact of this therapeutical intervention was explored. 
The patient-specific calibrated model of patient 3 was used to investigated the impact of HR 
modulation in the setting of a fixed venous return law at each observed stress stage. A closed 
loop simulation was run with varying heart rates for multiple levels of inotropy (rest, dob10, 
dob 20 and two levels in-between). From each simulation, the model’s predicted end-diastolic 
volume, SV and CO was obtained and these values were plotted against HR. The results are 
shown in Figure 7.8. Each colour represents one ``iso-inotrope'' curve – a set of simulations at 
a given contractility level differing only in chronotropy (heart rate and duration of ST; 
linearly interpolated between the values at rest, low and high level of dobutamine). The 
asterisks represents the measured data at rest, dob10 and dob 20 (recall Figure 7.7). 
 
 
Figure 7.8 Functional indicators of cardiac output (CO), end-diastolic volume (EDV) and stroke volume (SV) 
for simulated cardiac cycles with heart rates varying between 50 and 160bpm (x-axis) for inotropic states 
increasing from the level of contractility at rest (dark blue). The asterisks (*) shows the actually measured data 
at rest, low and high dose of dobutamine. 
 
As explained in the previous chapters and control cases 1 and 2, CO and HR are linearly 
related in the healthy heart during exercise, as SV is maintained due to augmentation of LV 
filling by the RV. This relation was not linear for Fontan patient 3 during dobutamine stress. 
As shown in the left panel of Figure 7.8 the contribution of heart rate to CO is limited above 
100-110 bpm, as can be appreciated by the decrease in slope CO curves after this heart rate. 
In the middle and right panel of the figure it is shown that this is the result of a significant 
decrease in end-diastolic filling and stroke volume with increasing HR. From these plots, it 
can be appreciated that at the two stress stages (light and dark blue star for dob10 and dob20 
respectively) a 10% decrease in the heart rate would not significantly impact CO, as filling of 
the ventricle is better with a lower heart rate.  
These simulations suggest that for both dob10 and dob20, at heart works at a point (asterisks) 
where the CO – HR relationship is very flat, as a result of the increasing fall in EDV and SV 
with HR. Based on this, a hypothetical decrease in HR by ~10%, the postulated effect of 
selective HR-inhibition, would lead to an improvement in EDV and SV, while not resulting 
in a significant fall in CO.  
 
 
Table 7-3 Summary of peak ventricular pressure increase (Dp/Dt, mmHg/msec) from rest in Fontan patients and 




7 .4  Discussion 
In this study, the applicability of the 0D reduced model [225] looped with venous return 
[221] was demonstrated for investigation of cardiovascular haemodynamics at rest and during 
dobutamine stress in patients with Fontan circulation. We showed that employing this 
modelling technique improves the interpretation of XMR dobutamine stress exams by 
allowing evaluation of the impact of key components of the cardiovascular system on the 
dobutamine stress response. 
Firstly, the model with prescribed preload was used to characterize stiffness and contractile 
state of the single ventricle at rest in each individual patient. Such quantities are normally not 
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directly accessible from the clinical data. The modelling results showed that in all Fontan 
patients, the contractile state at rest was comparable to the measurements in the two control 
cases and was not lower than values for healthy myocardium obtained from the literature 
[231]. This is clinically relevant as the conventional MRI derived measures of systolic 
function, EF, suggested a decreased systolic function in the Fontan cases, see Table 7-1. EF is 
load- and geometry-dependent and it is widely known that it does not accurately reflect 
systolic function in patients with Fontan circulation. The modelling results might even 
suggest an increased contractility in these young Fontan patients. Contractility values were 
similar to the control case 1, an Allagile’s patient. Patients with Allagile’s are likely to be in a 
mildly excited contractile state as a consequence of the hyperdynamic circulation that 
accompanies their liver disease [226]. This is reflected by the high cardiac index at rest in the 
control cases (control 1: CI 5.5 L/min/m2, control 2: CI 4.1 L/min/m2), in particularly in 
control case 1, who had a high contractile state at rest, see Table 7-2 and Table 7-3. This 
could mean that the Fontan patients, as a consequence of ventricular dilatation, low 
myocardial mass and the abnormal circulation, require larger levels of contractility to 
maintain cardiac output. Whereas the study population is too small to be certain, this would 
be in keeping with previous observations by Saiki et al. [89] and Szabo et al. [232], who 
showed that contractility in the Fontan circulation is increased to match the higher afterload. 
Using the closed-loop model, it was also possible to investigate the response to dobutamine 
stress in individual patients. By evaluating the parameter changes from baseline, the 
individual components that make up this response – such as the heart rate, contractile reserve 
and venous return augmentation – could be evaluated. We showed a good contractile reserve 
in all Fontan patients. During exercise contractility increased 2-3 fold, similar to the reserve 
observed in the control case (control 2). This increase was also in keeping with the changes in 
Dp/Dt and estimates of ventricular elastance obtained using pressure-volume loops in the 
same cohort in a previous study [191]. This was again contrary to the clinical data that 
suggested a reduced systolic reserve. The model was also able to detect abnormalities in 
contractile response. It marked a blunted contractile response observed in control 1, whom 
clinically was suggested to be already in a high cardiac output state at rest, and identify the 
oversensitive response to dobutamine in patient 4. In the latter, a clinical over-reactivity for 
dobutamine was observed, with a large increase in heart rate and blood pressure at dob10 
(systolic blood pressure rose to 180mmHg), resulting in abortion of the XMR exam. 
Altogether, these results suggest that the closed-loop reduced order model is able to 
accurately estimate contractility and contractile reserve using data obtained from clinical 
examinations, providing additional diagnostic information to the exam.   
Using the closed-loop simulations of the dobutamine stress response, it was also possible to 
investigate changes in venous return. As discussed in Chapter 5 and Chapter 6, the lack of a 
sub-pulmonary ventricle is likely to reduce augmentation of venous return, affecting 
ventricular filling and thus CO [72]. In the biventricular case with a good dobutamine 
response (control 2), venous return increased by ~50% during exercise. However, in Fontan 
patients 1, 3 and 5 the venous return was completely fixed. Only in Fontan patients 2 and 4 
venous return was mildly augmented. These patients had a patent fenestration, that allowing 
blood to bypass the pulmonary circulation and flow directly towards the atrium. Using the 
models, it is possible to investigate the impact of venous return on the individual patients. 
Figure 7.9 shows a summary of the calibrated model of patient 3. As can be observed, the 
fixed venous return (black line upper panel) results in a significant fall in EDV and SV during 
dobutamine (lower panel; volume curves), as the CO line moves towards lower preload. On 
the other hand, Figure 7.10 shows that in control case 2, venous return was augmented during 
dobutamine (upper panel black to blue and red line) and preload was maintained resulting in 
preserved EDV, higher SV and a larger increase in CO. 
 
Figure 7.9 Simulations for Fontan Patient 3 at rest 
and (black) during two levels of dobutamine stress: 
low (dobutamine 10 mcg/kg/min, blue) and high 
(dobutamine 20 mcg/kg/min, red). Note the fall in 
ventricular volume during dobutamine stress (lower 
right) due to the fixed venous return (upper right). 
Figure 7.10 Simulations for Control2 at rest (black) 
and during dobutamine stress: low (dobutamine 10 
mcg/kg/min, blue) and high (dobutamine 20 
mcg/kg/min, red). Note the upward shift in the venous 
return curve that maintains EDV and significantly 
improves the ability to augment CO. 
 
Figure 7.11 shows the model results for Fontan patient 2, with a patent fenestration. This 
figure shows that if, hypothetically, venous return would have been fixed (e.g. fenestration 
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closed; purple curves) preload during dobutamine would have significantly fallen, resulting in 
a decrease in EDV and a lower CO. However due to the augmented venous return through the 
fenestration, preload was maintained during dobutamine in the actual patient and EDV, SV 
and CO were higher.  
Together, these examples illustrate that the patient-specific analysis venous return using the 
model can help guiding potential therapies in Fontan patients, such as enlargement or closure 
of a fenestration (or other shunts such as veno-venous collaterals). The impact of desaturation 
of the systemic blood due to mixing of deoxygenated and oxygenated blood should also be 
taken into account for such decisions. Integration of this information into the model using 
oxygen saturation levels is an aim of future work. 
 
Figure 7.11 Cardiac output curves of Patient 2 at rest (black) and during low dobutamine stress (blue) with the 
cardiac output-venous return equilibrium points of the closed-loop system marked by asterisks – purple for the 
cardiac output at stress and the venous return kept as at rest, and blue allowing an increase of venous return 
during dobutamine stress. 
    
Using the personalized model of Fontan patient ~3, it was shown that this modelling 
framework simulations potentially allows exploration of treatment effects in individual 
patients in-silico in Fontan. These simulations suggested that a hypothetical decrease in HR 
by ~10% would lead to an improvement in EDV and SV, while not resulting in a significant 
fall in CO. These results are in keeping with the in vivo results of HR-inhibition seen in our 
adult cohort of asymptomatic Fontan patients, described in Chapter 6. This shows that our 
modelling framework is able to grossly predict the impact of treatment. Ofcourse, such 
treatment simulations are only estimates, as the simplified heart-circulation model does not 
take into account all the complex regulatory and response mechanisms of the human body. 
However, treatment predictions using a well-calibrated, personalized heart-circulation model, 
like the one shown here, can provide a helpful first assessment to better understand the 
consequences of potential treatment options. This is especially the case in patients Fontan 
circulation, as rationale behind and impact of treatment in these patients is often not well 
understood.  
7.5  Limitations 
In this work, a simple linear venous return model was used to allow closed-loop simulations 
of the dobutamine stress response. This is a simplification reality. However, the changes 
represented in the our modelling framework fit the physiological expectations in the the 
different circulations included in this work [178]; in patients without a fenestration 
augmentation of return was almost fixed, in patients with a fenestration some augmentation 
(20-30%) of venous return was suggested and in a biventricular control case with an 
unremarkable dobutamine stress response this response was even better. This suggests that 
the simplified model of venous return might be sufficient to represent physiology of stress 
responses. The two points defining the linear venous return law (the maximum achievable 
venous return, Qve-max,  and MSFP) are  unknown. The assumption of Qve-max being 150% higher 
than the cardiac output at rest is reasonable taking into account physiological experiments 
[178]. As the working point for cardiac output at a measured EDP is also known, the venous 
law could be modelled. Using these points all modelled cases had a MSFP between 10-20 
mmHg at rest, values that are in the range of previously published physiological experiment 
in humans [233, 234]. Whereas average values of MSFP in patients with Fontan circulation 
are unknown, they are likely to be increased as a consequence of decreased venous 
capacitance and compliance [85]. An estimate of MSFP might be obtained during the 
intervention by varying the level of positive end-respiratory pressure and can be a potential 
subject of study in future works. 
The 2-stage Windkessel model used here did not allow separation of the impact of the 
systemic and lung vasculature in the model in Fontan patients. Such separation can help 
investigating targeted therapies, such as pulmonary vasodilators, in patients with raised 
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pulmonary vascular resistance. Including a more detailed Windkessel network into the heart-
circulation model is therefore another aim for future work. 
The clinical data obtained to inform the models was highly detailed. This resulted in accurate 
calibration of the models. However, slight discrepancies between the simulations and data 
were expected due to the inherent differences in CMR and pressure data acquisitions (e.g. 
averaging of data over several heart beats in CMR and real-time acquisition of pressures). 
Furthermore, these measurements can carry inherent errors, such as overshooting of the 
ventricular pressure trace due contact between the tip of the fluid filled catheter and the 
ventricular wall, as shown in Figure 7.7 or errors in volume segmentations from cine CMR 
(e.g. due to a limited temporal resolution or suboptimal data quality). This last issue was 
demonstrated in the case of Fontan patient 4  (Figure 7.12) where the model-predicted end-
systolic volumes lower than measured from the data. The stroke volume obtained by 
processing the aortic flow phase contrast CMR data however suggests that the end-systolic 
volume might have been overestimated in the cine CMR data. Such potential errors illustrate 
the need for careful verification of the data prior to model-calibration. Biomechanical models, 
possibly coupled with atlas based statistical methods, can potentially automatically filter out 
these errors once sufficiently validated. 
7.6  Conclusion 
This chapter described the use of a heart-circulation model for interpretation of XMR 
dobutamine stress exams in patients with Fontan circulation. The experiments described were 
aimed to evaluate the usefulness of such a framework in augmenting diagnostic capabilities 
of the XMR stress exam. The results showed that the heart-circulation model supplied 
additional information to the XMR exam by allowing evaluation of key features of the 
cardiovascular stress response, such as contractility at rest, contractile reserve and venous 
return. Furthermore, it was shown that the calibrated models could be used to estimate the 
gross effects of potential treatments on the stress response in individual patients. 
This work was a proof of concept of the model’s ability to accurately represent Fontan 
physiology using highly detailed clinical data. Future investigations will look at the capability 
of the modelling framework to represent patient specific physiology using less detailed 
(potentially totally non-invasive) data. This could potentially allow detailed investigation of 
the stress response with physiological techniques such as exercise CMR. 
 
 
Figure 7.12 Simulations and data for Patient 4, for whom only low dose of dobutamine data was available, 
however increasing the contractility as for the high dose and with the increase of venous return by 20%. 
 
 
Chapter 8  Conclusion and Perspectives 
In this last chapter of the thesis a summary of the original contributions is given in Section 
8.1, combined with an assessment of their clinical impact. Next, an analysis of the current 
limitations of both Exercise CMR and the obtained experimental results are provided in 
Section 8.2, along with possible future directions to address these limitations. Finally, an 
overall conclusion will be drawn in Section 10.4  
8.1  Summary and Clinical Impact 
This thesis focused on investigation of the role of the sub-pulmonary ventricle (the RV in a 
healthy heart) in overall cardiac function during exercise and the impact of its absence in 
patients with Fontan circulation.  As was described in the introductory chapters, the role of 
the RV in overall cardiac performance has so far been unclear. This is the result of a lack of 
adequate imaging techniques that allow investigation of the biventricular cardiac function 
when it is most visible, i.e. during physiological exercise. In order to investigate the role of 
the RV, a comprehensive method for CMR imaging during exercise needed to be developed. 
Previous published work illustrated the potential of real-time imaging to overcome the 
problem of bodily motion and disturbances in ECG signals during exercise [4, 6–8, 135]. 
However, due to the lack in motion compensation, significant inaccuracies can occur in 
quantification of cardiac volumes using these techniques [9], unless time-intensive manual 
respiratory correction is used [4]. Moreover, none of the existing exercise CMR studies 
reported a methodological examination of the best available technique for real-time image 
acquisition.  
Therefore, the first major contribution of this thesis was the development of a comprehensive 
framework for Exercise CMR. As shown in Chapter 3, first several different real-time 
acquisition techniques were evaluated for their potential use during exercise. It was shown 
that a real-time acquisition using relatively standard acceleration techniques, rt-SENSE, was 
the most robust imaging method for Exercise CMR. Two more advanced acceleration and 
acquisition techniques, KT-BLAST and CASPR-TIGER, performed worse. Whereas the 
latter techniques would theoretically result in a lower loss of image quality for the 
acceleration needed, due to their more complex reconstruction algorithms, the irregularity 
and severity of exercise motion impacted the reconstruction significantly more in these cases 
compared to the simpler rt-SENSE images. This illustrates that, while these acceleration 
techniques have shown to deliver fast and high quality imaging at rest, their use during 
exercise is not directly beneficial, as motion and machinery can significantly impact the 
complex reconstruction algorithms.  
After establishing the most appropriate acquisition technique for exercise CMR, the aim was 
to develop an automated method for correction of breathing and exercise motion. As shown 
in Chapter 4, a retrospective cardiac and respiratory gating technique was developed to 
reconstruct a conventional cine image stack of 24 to 30 cardiac phases from the real-time 
motion corrupted image-sequence. The framework utilized the high temporal resolution of 
real-time imaging to estimate cardiac periodicity and breathing motion. Based on these 
motion signals, the images at end-expiration were selected and subsequently reordered and 
resampled in predefined cardiac phases. In order to make this technique accessible in clinical 
CMR environments, special attention was given to speedy, relatively computer-inexpensive 
motion estimation techniques that were not vendor-specific nor dependent on complex k-
space based reconstructions or advanced image-processing software. The resulting pipeline 
can be run relatively fast on a standard personal computer. As shown in the validation stage, a 
significant improvement in image quality and inter- and intra-observer variability for 
quantitative assessment of cardiac volumes was obtained with this technique, as the 
respiratory motion was eliminated and the real time data was averaged to a single beat 
Altogether, the developments presented in Chapters 3 and 4 resulted in a methodologically 
developed, clinically accessible and accurate framework for Exercise CMR. 
The second contribution was the demonstration of the pivotal role of the RV in optimizing 
performance of LV during exercise. The experiments in Chapter 5 were executed in order to 
investigate the mechanism of SV preservation and augmentation during exercise. To do so, 
the normal physiological cardiac responses during exercise in healthy volunteers was 
observed and compared to two situations of an augmented SV response; firstly in the same 
healthy volunteers using selective heart rate inhibition as a pharmacological intervention to 
increase inotropic drive in the heart and secondly by evaluating the SV response in endurance 
trained athletes. These experiments demonstrated that LV SV augmentation during exercise 
relies on increased LV filling, which is supported by increased contraction in the RV. A 
personalized anatomically correct biventricular biomechanical model of a volunteer was used 
to further explain this behaviour. This showed that during exercise the LV is dependent on 
augmentation of LV filling during SV augmentation to prevent an excessive increase in 
contractile costs. By utilizing increased contractility in the RV, which pumps against a low 
afterload, to augment LV filling the heart optimizes the total cost of contraction (in active 
stress). These experiments demonstrate a fundamental principle of cardiac function. It shows 
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that the RV and LV do not act as individual entities, but cooperate in an integrated synergetic 
system to optimize efficiency of total cardiac performance. This observation explains why 
RV function has an independent impact on prognosis and treatment efficacy of typical LV 
diseases [11, 12, 183], and proves previous suspicions that the RV plays a central role in 
athletic performance [13, 170]. More importantly, it illustrates that the two ventricles cannot 
be regarded as individual entities, but must be viewed as one synergetic system in the organ 
with a high interdependency of ventricular function. This notion suggests that current clinical 
practice in cardiology, in which the two ventricles are often assessed and treated separately, 
should shift towards a more integrated assessment of biventricular function.  
After establishing the role of the sub-pulmonary ventricle (RV) in the healthy circulation, the 
impact of absence of this ventricle in patients with Fontan circulation was assessed in Chapter 
6. The aim of these investigations was to better understand the Fontan haemodynamics and 
potentially find new targets for treatment to improve Fontan haemodynamics. Using the 
Exercise CMR, the cardiac response to exercise in Fontan patients was evaluated and 
compared to the behaviour in age and gender matched healthy controls. As expected based on 
the results in Chapter 5, patients with a TCPC-type Fontan circulation suffered from a fall in 
ventricular filling with increasing heart rates, as filling rate was not sufficiently augmented 
during exercise compared to the healthy controls. Subsequently, it was shown that selective 
inhibition of the heart rate response during exercise improved filling, by allowing a longer 
filling time. As a result, SV increased. This led to an increase in CO, even despite the lower 
heart rate. Based on these results it can be concluded that in healthy asymptomatic Fontan 
patients, the physiological heart rate response during exercise is inappropriately high, due to 
the lack of a sub-pulmonary ventricle. Furthermore, the results of the experiments showed 
that selective heart rate inhibition significantly improved mechanical and energetic efficiency 
of the single ventricle, resulting in lower estimated oxygen consumption per litre of generated 
CO. The higher CO, combined with the improved efficiency of the heart suggests that HR-
inhibition can potentially be a target for treatments aimed at improving efficiency of the 
Fontan circulation.  
Finally, in Chapter 7 an initial step was taken to evaluate the potential use of a computational 
modelling framework to augment the diagnostic value of stress / exercise exams in individual 
patients with Fontan circulation. In collaboration with Dr. R. Chabiniok a computational 
modelling framework was developed to integrate the data obtained during combined cardiac 
catheterisation and cardiac CMR (XMR) exams. Subsequently, this framework was used to 
create patient-specific models of 5 Fontan patients and 2 biventricular control patients. The 
aim of this work was to investigate the potential of this modelling framework in improving 
diagnostic assessment during stress. In particular, the ability to identify key factors of 
cardiovascular function (contractile reserve, myocardial stiffness and venous return) was 
assessed. These factors cannot be readily assessed using the clinical data alone. The results 
showed that the model allowed detection of impaired and preserved contractile responses. It 
also allowed to determine the impact of venous return on the exercise response in Fontan 
patients.  Furthermore, it was illustrated that the impact of treatments can potentially be 
evaluated using this simple model. The work presented in Chapter 7 showed that the 
diagnostic value of XMR stress exams could be improved using computational modelling. 
This means that there is a scope for further development of this modelling framework in 
order to enhance diagnostic value of exercise and stress examinations. 
8.2  Current Limitations and Future Directions 
In this section, the main limitations of the presented works are analysed. For each limitation, 
possible solutions that could represent future investigations are discussed and presented.  
Quantitative flow assessment during Exercise CMR. In the currently developed 
CMR set-up, quantification of blood flow was not integrated. Several real-time sequences 
have been explored during this PhD (data not presented here). During phantom tests and in-
vivo dobutamine stress exams real time phase contrast flow sequences revealed good 
correlation with routine ECG gated sequences. However, during exercise large discrepancies 
in quantified volumes between flow measurements were noted. This was likely a combination 
of 1) the effect of bodily motion on flow encoding, 2) the need to acquire images outside of 
the isocentre, resulting in magnetic field inhomogeneity’s, and 3) artefacts arising from the 
exercise bicycle ergometer. Other groups such as Muthurangu et al. and Quinlan et al. have 
reported the use of real time flow sequences during exercise [6, 8]. However, these are 
available only on Siemens CMR systems. Furthermore, their flow measurements were not 
validated during exercise and were only used in the ascending aorta and not in smaller 
vessels. More advanced flow acquisitions, for example the compressed sensing flow 
acquisitions described by Kwak et al. can provide better real time flow quantification during 
exercise and are worth evaluating [235, 236]. Also, development of a motion-correction and 
reconstruction framework, similar to the one described in Chapter 4 for cine imaging, could 
potentially provide more accurate flow quantification. 
Influence of training on biventricular function during exercise. In Chapter 5 the 
pivotal role of the RV in cardiac function was demonstrated. Endurance trained athletes were 
part of the evaluated study cohort. This group clearly had an improved interventricular 
cooperation leading to larger increases in SV during exercise. The total cohort of healthy 
volunteers undergoing Exercise CMR was not large enough to investigate whether habitual 
158 Conclusion and Perspectives 
 
exercise also influences the interventricular cooperation. Qualitative assessment of the 
cardiac volume responses during exercise in individuals seems to suggest such an improved 
cooperation in more fit participants. In order to assess this, a larger population needs to 
undergo exercise CMR. This is one of the many questions to address based on the presented 
conclusions.  
Clinical impact of heart rate inhibition on functional status of Fontan 
patients. In Chapter 6 the acute impact of selective heart rate inhibition on exercise 
haemodynamics in Fontan patients was presented. These results suggest a significant 
beneficial impact on cardiac output and efficiency of the heart in a small group of patients 
with TCPC-type Fontan circulation. This raises the question whether selective heart rate 
inhibition can potentially positively impact ventricular function in the long term, by 
preserving efficiency. Selective heart rate inhibition is a low-cost drug with minimal side 
effects. Therefore, such treatment could provide a valuable option for routine maintenance 
therapy. In order to address this question, a multi-centre randomized controlled trial needs to 
be undertaken that evaluates the impact of routine administration of selective HR inhibition 
over multiple months and in larger cohorts of Fontan patients.  
All exercise studies in this thesis were perfomed in a supine position. The different 
gravitational forced on the body in this position, in comparison to upright exercise, impact 
haemodynamics, in particular venous return towards the heart. The observations in these 
studies can therefore not directly be extrapolated to exercise in an upright position.    
Intergration of computational modelling frameworks into clinical practise. In 
Chapter 7 the first steps were taken to integrate a modelling framework into diagnostic 
assessment of the XMR stress exam for patients with Fontan circulation who undergo 
evaluation for symptoms of heart failure. This work only encompassed a limited number of 
patients. Whereas the first results are promising, several steps need to be undertaken before 
such a framework can be readily implemented in clinical practice. Firstly, the computational 
model could be expanded. In the current model, the systemic and pulmonary circulations 
were not separately modelled. While this reduced the amount of model parameter to be 
estimated, and thus decreases the chance of errors in model calibration, it does not allow 
investigation of pulmonary circulation as an individual entity. Current treatment of patients 
with failing Fontan circulation often involves pulmonary vasodilation, and therefore 
assessment of this circulation could provide meaningful insights into treatment efficacy. 
Furthermore, there is currently no option to model fenestration or collateral flow in the 
system. While this flow is detected as increased venous return (as shown in Section 7.3.2) 
this does not allow separation of the two mechanisms (fenestration vs. collateral flow). 
Expansion of the model to include such the pulmonary circulation and potential R-L shunts is 
likely to improve the usability of the model. Lastly, the process for obtaining CMR 
parameters could be improved. Currently, manual segmentation of all cine frames is needed 
to get accurate cardiac volume and flow curves.  This is time-consuming. Recently, several 
highly accurate automated segmentation pipelines have been developed, using deep learning 
algorithms. In collaboration with Dr Puyol-Anton, it was shown in preliminary work that 
such networks could be adapted to allow segmentation of cardiac volumes over time [167]. 
Further adaptions to also allow automated flow quantification will significantly simplify the 
use of computational models in clinical research, hereby allowing larger studies that will 
support future integration into clinical practice. 
8.3  Conclusions    
In thesis, the role of the sub-pulmonary ventricle on cardiac function during exercise and the 
impact of its absence were investigated. Fundamental principles in cardiac function are best 
assessed when the heart is under stress. Therefore, investigation during physiological exercise 
is vital. The work in this thesis therefore started with the development of a comprehensive 
technique for Exercise CMR using MRI and image-processing techniques. This was followed 
by utilization of this technique during clinical research studies in the healthy heart and 
patients with Fontan circulation. These experiments demonstrated a new fundamental 
physiological mechanism of biventricular cardiac function in the healthy heart and provided a 
new insight into the pathophysiological exercise response in the Fontan circulation. Finally, 
the use of advanced computational biomechanical modelling framework in providing 
additional diagnostic value to a clinical stress examination in patients with Fontan circulation 
developing exercise intolerance was presented. This sequence of studies is a demonstration of 
cross-disciplinary, translational project aimed at answering clinical questions using new 
technology. As scientific knowledge has grown, so have the borders between different 
disciplines in science. Therefore, developing knowledge across different fields of science has 
become key for rapid and effective translational development. This thesis hopefully displays 
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